CED Clinic: Personalized Cannabis Medicine

 

Medicinal cannabis is changing the face of clinical medicine.  We are the leaders of that change.

Portrait,Of,Smiling,Woman,Working,With,Laptop,And,Cellphone,At
Young,Attractive,Couple,In,Love,In,An,Autumn,Setting,Following
Group,Of,Senior,Retirement,Exercising,Togetherness,Concept
Group,Of,Senior,Retirement,Friends,Happiness,Concept
Soldier,Reunited,With,His,Parents,On,A,Sunny,Day
Happy,Grandfather,,Grandmother,And,Grandson
Shot,Of,A,Family,Having,A,Meal,Together,At,Home
Mother,And,Daughter,Having,Fun,In,The,Park.,Happiness,And
Time,For,Family.,Spring,Season.
Cheerful,Multi,Generation,Family,With,Parents,Giving,Piggy,Back,Standing
Happy,Leisure
Portrait,Of,Cheerful,Girls,With,Grandparents,While,Sitting,In,Back
Spending,Time,With,Parents,Outside,In,Spring,Season,Is,Funny.
Adult,Female,Doctor,Has,Video,Call,And,Chatting,With,Colleague
Mother,And,Daughter,Having,Fun,In,The,Park.,Happiness,And
Group,Of,Senior,Trekkers,Checking,A,Map,For,Direction
Beautiful,Couple,Taking,A,Walk,In,City,Park
Happy,Family,In,The,Park,On,A,Sunny,Day
Shot,Of,A,Family,Having,A,Meal,Together,At,Home
Portrait,Of,Smiling,Millennial,African,American,Man,In,Glasses,Pose
Businessman,Relaxing,At,His,Desk,In,The,Office,With,His
Happy,Family,With,The,Child,In,The,Field
Group,Of,Senior,Friends,Hiking,In,Countryside
Cute,Couple,Holding,Hands,Happiness,Lifestyle,Meeting
Office,Workers,Diverse,Colleagues,Sitting,At,Desk,Looking,At,Each
Irate,Employee,Laboring,With,Loathing
African,Female,Doctor,Holding,Hand,Supporting,Caucasian,Woman,Patient.,Kind
Asian,Preteen,Boy,And,Young,Father,Jogging,Together,In,Nature
Women,And,Boys,Walk,Hand,In,Hand,,Traveling,Adventure
Family,Of,Three,On,A,Walk,,Mother,Holding,Child,,Front
Portrait,Of,Senior,Couple,Standing,With,Family,And,Friend,In
Group,Of,Senior,Trekkers,Checking,A,Map,For,Direction
Group,Of,Senior,Friends,On,Hike,In,Countryside,Looking,At
Group,Of,Senior,Retirement,Friends,Happiness,Concept
Portrait,Of,A,Satisfied,Executive,Celebrating,Success,With,The,Arms
Grandfather,With,Son,And,Grandson,Sitting,On,Swing,In,Garden
Family,Eating,Sandwiches,Outdoors,In,A,Forest,,Portrait
Group,Of,Adult,Multiethnic,Friends,Playing,American,Football,On,The
A,Family,Having,A,Walk,With,A,Dog
Happy,Grandparents,Dance,Waltz,In,Front,Of,Family,At,A
Group,Of,People,Holding,Hands,Support,Team,Unity
Happy,Woman,Have,A,Break,In,Office,,Folded,Arms,By
Couple,Wife,Husband,Dating,Relaxation,Love,Concept
Group,Of,Senior,Retirement,Friends,Happiness,Concept
Portrait,Of,Happy,Family,Standing,In,Back,Yard,During,Sunny
Busy,Young,African,Man,In,Shirt,Talking,With,Smiling,Man
The,Adventure,Is,More,Fun,When,They,Are,Together.,Family
Beautiful,Couple,Taking,A,Walk,In,City,Park
Granddad,With,Cheerful,Granddaughter,Having,Fun
Happy,Young,Family,Take,A,Self,Portrait,With,Smart,Phone.
Cute,Couple,Walking,In,A,Autumn,Park.,Boy,And,Girl
Young,Woman,Suffering,From,Headache,In,Office
Portrait,Of,Senior,Couple,Walking,Pet,Bulldog,In,Countryside
Portrait,Of,Four,Cheerful,Senior,Friends,Enjoying,Picnic,On,Green
Satisfied,Senior,Man,With,Friends,Having,A,Picnic,In,A
Parents,Play,In,The,Park,With,Their,Son
Portrait,Of,Senior,People,Celebrating,Birthday


At CED Clinic, we’re redefining care. Step into a welcoming, professional space where the leading experts in medical cannabis are here to guide and support you!

 

1

You’ve found the right place!

website quotes professional

 

 

 

top 25 for CED website

 

Promotional poster featuring Dr. Benjamin Caplan, MD, recognized as one of the Top 25 in the USA out of 43,000 applicants. The design highlights his role as the only cannabis physician testifying at the 2025 DEA hearings, titled ‘National Voice for Medical Cannabis Reform,’ with the quote ‘Shaping Cannabis Medicine One Voice at a Time’ displayed below
Dr. Benjamin Caplan, MD — Top 25 in the USA. The only cannabis physician testifying at the 2025 DEA hearings, advancing national medical cannabis reform

 

🔥 CED Clinic: voted Best Medical Cannabis Clinic since 2013! 

Screenshot 2024 06 18 at 9.32.33 PMDr Caplan Best Medical Cannabis Doctor in the US

Our Services

  • Expert Telemedicine Medical Cannabis Consultations!
    • Medical Card Certifications (Massachusetts, New Hampshire, Rhode Island, Vermont, Maine)
    • Adult Cannabis Care (Everyone in the US + Internationally)
    • Pediatric Cannabis Care (Everyone in the US + Internationally)
  • In-Depth Consultations & Care Plans
    • Personalized Services (Medication, Diagnostic, and Management Review)
  • Cannabis and Non-Cannabis Medical Second Opinions
    • Long-term Talk Therapy
    • Advice, Support, and Cost-Savings Advice!

Our Mission

  • To Heal
  • To Listen
  • To Educate
  • To Learn and Understand

Questions? 👉 Contact Us Here

Our Team

Benjamin Caplan MD
 Benjamin Caplan, MD
Erin Caplan, NP
Erin Caplan, NP

 

Benjamin Caplan, MD, stands at the forefront of medical cannabis care as the Founder and Chief Medical Officer of CED Clinic and CED Foundation. His entrepreneurial journey further extends as the Founder of multiple medical cannabis technology and educational platforms and as a medical advisor to the prestigious cannabis investment fund, GreenAXS Capital. Within digital healthcare, Dr. Caplan co-founded EO Care, Inc, a pioneering digital therapeutic and telemedicine platform, offering personalized cannabis care and product plans and continuous clinical guidance to a global clientele seeking a reliable, evidence-based cannabis care partner. Adding to his repertoire of contributions to the medical cannabis arena, Dr. Caplan has recently published “The Doctor-Approved Cannabis Handbook,” an industry-first resource empowering readers with the full scope of the therapeutic potential of cannabis. Through his multifaceted involvement, Dr. Caplan continuously strives to bridge the gap between traditional medicine and cannabis care, making a significant impact in evolving holistic healthcare.

 

Erin Caplan, NP is a board-certified Pediatric Nurse Practitioner with a master’s-level medical education from Simmons. Her extensive clinical journey has been enriched through roles at Massachusetts General Hospital, Hyde Park Pediatrics, Atrius Healthcare, and Dana-Farber Cancer Institute, where she has provided both inpatient and outpatient primary care to some of the most fragile and challenging pediatric patients. A registered cannabis care provider licensed by the Massachusetts Cannabis Control Commission, Erin seamlessly blends her pediatric expertise with the nuance and adaptability required for personalized cannabis care. A community leader, avid athlete, and dedicated mother of four, Erin’s compassionate bedside manner and steadfast commitment to evidence-based practice have earned her the trust and appreciation of patients and families, showcasing her as a harmonious blend of clinical excellence with a personal touch.

Patient Stories

Navigating the Stigma as a Senior

Testimonial:

“At 68 years old, I never thought I’d be considering cannabis as part of my treatment. My generation didn’t grow up viewing it as medicine—we saw it as something entirely different. But after dealing with arthritis pain for over a decade, my daughter encouraged me to give it a try. Meeting with a professional who truly understood both the science and the hesitations I had made all the difference. Dr. Caplan explained how cannabis could work alongside my existing treatments and offered me a gradual approach to build my confidence. Now, I’m using a tincture daily, and I feel a level of relief and mobility that I hadn’t felt in years. Even better, I’ve been able to have open conversations with my friends about the benefits, helping them see it in a new light too.”

Peter H

Peter Hargrove

Reclaiming Life with Holistic Care

“I had been living with chronic fatigue for years, feeling like I was just existing rather than living. Traditional medicine had brought little relief, so I started looking into alternative options. Working with a doctor who truly listened to my struggles and offered a holistic approach to care was a game-changer. The cannabis regimen we developed not only improved my energy levels but also allowed me to engage in activities I hadn’t been able to enjoy in years. This isn’t just about managing symptoms—it’s about reclaiming a life I thought was out of reach. I’m grateful for the guidance and the opportunity to feel like myself again.”

Sarah M

Sarah Mitchell

A Patient’s Guide to Finding the Right Dose

“My journey with cannabis therapy was not a straight line. When I first started, I thought one dose or product would fix everything, but I quickly learned it’s a process of trial and adjustment. Working with a knowledgeable doctor made all the difference. We started low and slow, as they say, and I kept track of how I felt each day. Over time, I found the right balance that worked for my condition without unwanted side effects. The best part of this process was how involved I felt—I wasn’t just following instructions; I was an active participant in my own care. Now, I’m managing my symptoms better than ever and feel in control of my health.”

Michael T

Michael Torres

Finding Balance After Postpartum Anxiety

“After having my second baby, I struggled with severe postpartum anxiety. It was difficult to admit I wasn’t feeling okay, and even harder to ask for help. Traditional treatments left me feeling disconnected and foggy, and I didn’t want to spend my days like that. When I started exploring medical cannabis, I was cautious but hopeful. Meeting with a knowledgeable doctor helped me approach it with confidence. I started with a low dose of CBD and gradually added a small amount of THC for nighttime use. Within weeks, I noticed a difference—not just in my anxiety, but in my ability to enjoy motherhood again. This journey wasn’t just about managing symptoms; it was about regaining balance and finding joy in my life.”

Emily R

Emily Richards

New Hope for Fibromyalgia

“I never thought I’d find a doctor who could make me feel optimistic about managing my fibromyalgia, but Dr. Caplan did exactly that. He didn’t just focus on symptoms—he helped me think about my health in a holistic way, integrating cannabis into a broader plan for wellness. His recommendations were precise, and he made sure I knew how to adjust them as needed. What really impressed me was his dedication to follow-up care; he personally checked in to see how I was doing and offered adjustments based on my progress. It’s that level of personalized attention that makes Dr. Caplan and his clinic stand out.”

Grace N

Grace Newman

Overcoming My Fear of Cannabis Therapy

“For years, I hesitated to explore medical cannabis. I had so many misconceptions—fear of side effects, worries about legality, and even embarrassment about what others might think. But after years of struggling with my chronic anxiety, I decided it was time to explore new options. Meeting with Dr. Caplan completely shifted my perspective. He helped me understand that cannabis wasn’t about masking symptoms; it was about restoring balance in a way that felt right for me. My first steps were small, and we adjusted the plan together over time. Today, I feel a sense of calm and clarity I hadn’t thought possible. More importantly, I’ve let go of the stigma and feel proud of my decision to prioritize my health.”

Julia M

Julia Matthews

Care That Transcends Expectations

“Dr. Caplan’s clinic is a masterclass in patient care. From the moment you step in, you feel like you’re in capable, compassionate hands. He took the time to understand my chronic fatigue and explained how cannabis could help in ways I hadn’t considered. What stood out most was his emphasis on making informed decisions—he’s not just a doctor, but a teacher who ensures you leave with a clear understanding of your treatment. His book is a fantastic resource, and it was clear from our discussion that he truly believes in empowering his patients through education. I couldn’t be happier with my experience.”

Daniel R 

Daniel Roberts

The Expert You Can Trust

“Dr. Caplan’s reputation as a cannabis expert is well-earned. I came to him with a list of concerns about using cannabis for my autoimmune condition, and he addressed each one with patience and expertise. He went beyond the surface to help me understand not just the benefits but also potential risks, which made me feel secure in my treatment. His recommendations were so thoughtful and practical, and he even tailored them to fit my busy schedule. What really set him apart, though, was his genuine care—I could tell he wanted me to succeed in managing my health. It’s rare to find a doctor who combines this level of expertise with such a warm, approachable demeanor.”

Sophia L

Sophia Lewis

Empowering Through Education

“As a mother of two, I was cautious about trying medical cannabis for postpartum anxiety, but Dr. Caplan quickly put my fears at ease. He offered a science-backed approach that felt safe and sensible, walking me through each step with empathy and care. His book was also an invaluable tool—it gave me the confidence to understand how to approach treatment without guesswork. Now, I feel like I’m thriving instead of just surviving. I’m so grateful for Dr. Caplan’s guidance and for the way he made this process feel not only accessible but also empowering.”

Olivia G

Olivia Green

Clearer Days Ahead

“After years of chronic migraines and no relief from traditional treatments, I turned to Dr. Caplan as a last resort. What I found was a doctor who genuinely listened to my struggles and worked with me to find solutions. His clinic is a beacon for anyone looking to explore medical cannabis with confidence. He didn’t just give me a prescription—he educated me about dosing, timing, and the different products available. His insights were life-changing, and his approachable manner made even the complicated aspects of treatment easy to understand. For anyone hesitant about this path, Dr. Caplan is the guide you’ve been waiting for.”

Ryan T

Ryan Thompson

Game-Changer for Mental Health

“Finding Dr. Caplan was a game-changer for my mental health. For years, I struggled with anxiety and sleep issues, trying countless medications with limited success. Dr. Caplan’s personalized approach was a breath of fresh air. He didn’t just focus on my symptoms; he wanted to understand how my lifestyle and goals factored into the equation. His guidance helped me find a regimen that not only improved my sleep but also reduced my daily stress. The best part? He checked in after a few weeks to make sure everything was working smoothly. I’ve never felt so cared for by a doctor.”

Emily P

Emily Parker

A Senior’s New Hope

“As a senior struggling with arthritis, I was skeptical about cannabis therapy. But Dr. Caplan changed my perspective completely. His extensive knowledge, combined with a genuine compassion for his patients, made my first visit feel like a turning point. He introduced me to options that were gentle and easy to integrate into my daily life. What surprised me most was how much he emphasized education—his book became a valuable resource for me and my family to better understand how cannabis could help. If you’re new to this world, Dr. Caplan is the expert you can trust to guide you with care and patience.”

Lucas H

Lucas Howard

Skeptic to Believer

“I had given up on finding relief for my chronic pain until I met Dr. Caplan. His calm, reassuring demeanor put me at ease from the moment we sat down. He not only prescribed a cannabis regimen tailored to my needs but also took the time to address my fears about stigma and side effects. What made the experience even better was how he explained things—breaking down complex science into simple, relatable examples. I now feel in control of my health for the first time in years. If you’re hesitant about exploring cannabis as an option, Dr. Caplan’s patient-centered care will make all the difference.”

Chloe M

Chloe Martinez

Revolutionizing My Care

“Dr. Caplan’s approach to cannabis therapy is revolutionary. I had been to other clinics where the process felt rushed and impersonal, but my experience with him was the exact opposite. He asked thoughtful questions, delved into my medical history, and crafted a tailored plan to address my specific symptoms. What stood out the most was his ability to connect my condition to real-world cannabis applications, referencing research and patient success stories that inspired confidence. His clinic also provides resources beyond the appointment—like follow-ups and his book—which made me feel supported every step of the way. For anyone seeking a truly personalized and informed approach to medical cannabis, I can’t recommend Dr. Caplan enough.”

Ethan K

Ethan Keller

Trust Built Through Understanding

“Trust is not something I give easily when it comes to my healthcare, but Dr. Caplan earned it during our first appointment. He listened carefully to my concerns and explained the science behind medical cannabis in a way that was clear and accessible. He didn’t just focus on the benefits; he also made sure I understood potential challenges and how to navigate them. That kind of transparency and care is rare, and it’s the reason I feel confident in the treatment plan we developed together.”

Emily C

Emily Carsonally

Personalized Care That Stands Out

“Every aspect of my experience with Dr. Caplan reflected his commitment to personalized care. He took the time to ask about my lifestyle, my goals, and even my hesitations about using medical cannabis. His thoughtful questions and detailed explanations made it clear that he was focused on creating a plan that would work for me specifically. I also appreciated how he checked in with me after the visit to see how I was doing—a small gesture that made a big difference in my confidence and comfort moving forward.”

Olivia H

Olivia Robers-Harrison

Educational and Empowering

“Dr. Caplan doesn’t just prescribe cannabis—he educates you about it, so you feel confident and in control of your treatment. From our first appointment, it was clear that he cared about making sure I understood all my options. He referenced research, shared stories from other patients, and even recommended chapters from his book that were particularly relevant to my situation. By the end of the visit, I felt not only more informed but also more empowered to make decisions about my health. That kind of care is rare, and I’m grateful for it.”

Benjamin R

Benjamin Rochel

Clear Guidance Every Step of the Way

“What struck me most about Dr. Caplan was his ability to provide clear and actionable guidance. I had no prior experience with medical cannabis and was overwhelmed by all the information out there, but he made it manageable. He walked me through the options, explained the potential benefits and risks, and helped me navigate decisions in a way that felt completely tailored to my situation. His calm and thoughtful manner put me at ease, and I left the appointment feeling like I finally had a plan I could trust.”

Chloe M

Chloe Masterson

A Tailored and Thoughtful Plan

“Dr. Caplan approached my case with a level of care and detail I hadn’t experienced before. Instead of a one-size-fits-all recommendation, he tailored a plan based on my specific symptoms and preferences. He took the time to explain why certain options might work better for me and made sure I felt comfortable moving forward. His advice was practical and grounded in science, yet delivered in a way that felt approachable. I left feeling empowered, knowing I had the tools and knowledge to take the next steps with confidence.”

Ethan K

Ethan Kostenson

More Than Just a Weed Visit

“My first visit with Dr. Caplan felt like more than just a routine medical appointment—it was an opportunity to truly take charge of my health. He asked questions that no other doctor had asked and encouraged me to think about my goals for treatment in a way I hadn’t before. His book was an incredible resource, but what truly set him apart was his ability to make the information feel relevant to my unique situation. I felt supported not only as a patient but as a partner in my healthcare journey.”

Maria L

Maria Lolana

A Practical and Supportive Approach

“Dr. Caplan’s approach is refreshingly practical and supportive. During our consultation, he focused not just on recommending cannabis, but on helping me understand how to use it in a way that fit my lifestyle and goals. He walked me through options, shared insights from his book, and even helped me think through how to manage dosing and timing. What really impressed me was his focus on the long term—this wasn’t about a one-time solution but about creating sustainable improvements in my health. It’s rare to find a doctor who invests this level of thought and care into patient guidance.”

John W

John Waterson

Dr. Caplan’s Expertise and Patience

“I was initially unsure about whether medical cannabis was the right path for me, but Dr. Caplan quickly put my concerns to rest. He spent time understanding my medical history and current challenges, carefully explaining the science behind cannabis and how it could fit into my treatment plan. His depth of knowledge and ability to communicate complex concepts in simple terms stood out to me. I appreciated his patience, especially when I had a list of questions, all of which he addressed thoroughly. The care I received was thoughtful and personalized, and I left feeling confident in the steps we outlined together.”

-Sophia R

Sophia Rhiderson

A Lighthouse in the Storm

“When I first started exploring medical cannabis, I felt overwhelmed by conflicting advice online. Meeting Dr. Caplan was like finding a lighthouse in a storm. He didn’t just recommend a treatment plan; he broke down every step, explaining the science in plain terms so I could make informed decisions. His book, ‘The Doctor-Approved Cannabis Handbook,’ became my go-to guide between visits. It’s rare to find a doctor who takes so much time to ensure you feel educated and empowered. Now, not only am I managing my symptoms, but I feel like I truly understand my body better. If you’re looking for compassionate care and clear guidance, Dr. Caplan is the doctor you need.”

Sophia J

Sophia Jenkins

I Finally Got My Stress Under Control

I used to pride myself on being able to handle anything work threw at me. Long hours, tight deadlines, a demanding boss—it was all part of the game, and I thought I had it down. But somewhere along the way, the stress started to build up. Slowly at first, then all at once. I was losing sleep, snapping at my family, and my chest constantly felt tight. The smallest things would set me off, and no amount of weekends or ‘self-care’ could fix it. I didn’t recognize myself anymore.

My doctor had suggested anti-anxiety meds, but I didn’t want to go that route. I kept thinking, there’s got to be another way. A friend mentioned cannabis, and I’ll admit, I laughed at first. Cannabis? For work stress? I thought it was a joke. But after another sleepless week and two missed deadlines, I was willing to try anything. That’s when I found CED Clinic and Dr Caplan.

I wasn’t sure what to expect going in, but Dr. Caplan made me feel comfortable right away. He listened—not just to what I was saying, but to what I wasn’t saying, if that makes sense. He didn’t treat me like a case file or just another patient. We talked about the stress, sure, but also about why I’d been so hesitant to ask for help. He suggested a low-dose CBD regimen to help me unwind without feeling ‘off,’ and explained that it wasn’t about numbing out—it was about finding balance again.

It took a few weeks before I really started noticing a difference. At first, I wasn’t sure if it was doing anything, but then I realized I wasn’t lying awake at night, going over work problems in my head. I wasn’t clenching my jaw every time I opened an email. The stress didn’t go away, but I wasn’t drowning in it anymore. I felt like I could handle things again, like the weight had been lifted just enough for me to breathe.

Now, I can get through my workday without feeling like I’m on the verge of a meltdown. I’m more present with my family, more patient. It’s not perfect, and work is still stressful, but it doesn’t own me anymore. I can’t say enough about what Dr. Caplan did for me. I was lost, and he helped me find my way back.”*

– Jason B

J Bennett

Our Son Found Calm, and So Did We

Our son has always been… difficult, to put it lightly. He’s smart, no doubt about that, but for as long as I can remember, we’ve struggled with his defiance. It was like every day was a battle—he’d talk back, refuse to listen, and disrupt everything at home and at school. We’d get calls from his teachers constantly about how he couldn’t sit still or follow directions. He was failing classes, not because he didn’t understand the material, but because he just refused to engage. I started to feel like we were losing control, not just of him, but of our family. It was exhausting. We tried everything—therapy, behavior charts, punishments, rewards—but nothing seemed to get through to him.

When someone suggested we look into cannabis, I’ll admit, I was pretty skeptical. The idea of giving our son cannabis? It felt like too much. But at the same time, I felt like we were running out of options. I mean, we couldn’t keep going the way we were. So, I did some research and found Dr. Caplan. I didn’t really know what to expect, but I figured it was worth at least hearing what he had to say. When we met with him, Dr. Caplan was so calm, so understanding. He didn’t make us feel like we were bad parents, which, honestly, was a huge relief. We’d been feeling like failures for a long time. He explained that cannabis, in the right doses, might help our son relax, become more receptive, and just… chill out.

At first, I wasn’t sure. But we decided to give it a shot because we needed something to change. I remember the first few weeks—we were waiting for a miracle that didn’t come right away. But slowly, things started to shift. He wasn’t perfect, and I didn’t expect him to be, but we started seeing moments of calm, of compliance. He’d sit down and actually listen when we talked to him. His teachers noticed, too. The calls home weren’t as frequent, and when they did call, it wasn’t about him disrupting the class, but little moments where he was making an effort. He wasn’t fighting us over every single thing anymore. He even started being more responsible around the house—little things like cleaning up after himself, finishing homework without a meltdown.

It wasn’t an overnight transformation, but it was enough to make us believe that maybe—just maybe—things could get better. And they have. Our son is still a work in progress, but aren’t we all? He’s more in control now, more aware of his actions. I can’t tell you what a relief it is to have peace in our home again, even if it’s not perfect all the time. We can breathe. We can plan things without the constant fear of a blow-up. Dr. Caplan gave us the space to feel like parents again, instead of just referees in constant battles.

– Heather R.

Heather R

Finally Found Relief from Menopause

Menopause hit me like a freight train. One minute I was fine, and the next, I was drowning in hot flashes, mood swings, sleepless nights, and constant irritability. It felt like I couldn’t get through the day without snapping at someone or dripping in sweat. The worst part was the lack of sleep—I’d toss and turn all night, then drag myself through the day feeling exhausted. It was like I had no control over my own body, and everything just felt harder. I tried the usual over-the-counter remedies and even considered hormone replacement therapy, but I didn’t like the risks. Honestly, I was starting to lose hope.

A friend of mine, who had been seeing Dr. Caplan for her own health issues, suggested I give him a try. I wasn’t sure at first. Cannabis for menopause? It seemed a little out there. But after trying everything else and getting nowhere, I figured I had nothing to lose. From the moment I met with Dr. Caplan, I knew I was in the right place. He listened to all my complaints without judgment—he understood how tough it was. He didn’t just hand me a one-size-fits-all solution either. Instead, he explained how cannabis could help balance out my mood swings, improve my sleep, and even ease the intensity of the hot flashes. He was thorough, but he kept it simple, so I didn’t feel overwhelmed.

Within a few weeks of starting on a low-dose regimen, I noticed a real change. The hot flashes were still there, but they weren’t as intense, and I wasn’t waking up drenched in sweat every night. My mood swings started to even out too. I wasn’t losing my temper over every little thing, and I was able to get through the day without feeling like I was on edge all the time. Most importantly, I started sleeping again. I’m not talking about perfect, uninterrupted sleep, but I was actually getting solid rest and waking up feeling more human. My irritability softened as my body felt more balanced.

I can’t say enough good things about Dr. Caplan and the care he’s given me. Menopause doesn’t feel like it’s running my life anymore. I have a handle on it now, and I feel like myself again. Cannabis wasn’t something I ever thought I’d turn to, but I’m so glad I did. Dr. Caplan gave me back my peace of mind, and for that, I’ll be forever grateful.

– Lisa M.

Lisa Montingerie

Cannabis Gave Us Our Family Back

“We live in California. Our son has severe autism, OCD, and behavioral issues that have ruled our lives for as long as I can remember. He struggles with communication, and when things don’t go as expected, the meltdowns are explosive. There are days when he self-injures so severely that I can’t leave him alone for a second. The screams, the head-banging, the constant pacing—it’s heartbreaking and terrifying. My husband and I have felt like prisoners in our own home. We can’t go shopping, we can’t take vacations, we can’t even break from the daily routine without risking an episode that could throw him into a spiral for weeks. We’ve tried every therapy, every medication. Nothing seemed to give him—or us—a moment of peace. It was draining every ounce of energy and hope we had left.

When someone first suggested cannabis to us, I was hesitant, scared even. I didn’t know how it would affect him. I see potheads and druggies everywhere these days in my area, and it does not look appealing. Would it help, or make things worse? But we were desperate, and a friend had read The Cannabis Handbook and suggested that we reach out, so we decided to see Dr. Caplan. I’ll never forget that first meeting. He listened—really listened—to the hell we’ve been living through, and for the first time in a long time, I felt like someone understood. His questions made it clear that he’s been through this with many others. He seemed to get our struggle like no doctor I’ve ever encountered. He wasn’t dismissive, and he cetainly didn’t make us feel crazy for trying something new – the way all of my other doctors do. He explained how cannabis could help with the anxiety, the OCD, and even the self-injury, in a way that was calm and controlled, without overwhelming us. Our son came on camera with a tantrum, and Dr Caplan was as patient and attentive, supportive, as I wish docs all were. Dr. Caplan carefully walked us through everything, never pushing, always respecting our concerns. His focus is so clearly empowering us, not tripping on himself or being on high.

We started our son on small doses of a few products, and I won’t lie, it wasn’t a quick, overnight change. But over time, with adjustments that he oversaw with us, we saw it—he started to calm down. The meltdowns weren’t as frequent, and when they did happen, they didn’t last as long or get as intense. The self-injury started to lessen. It felt like we could breathe again, like we had a little more room to live. We’re still careful—routine is still important—but the constant terror of something going wrong isn’t hanging over our heads as much. For the first time in years, my husband and I were able to go out for dinner. It sounds like such a small thing, but it was a moment where we could remember what life used to be like, before we became prisoners to our son’s condition.

I can’t say that cannabis has fixed everything, but it’s given us something we didn’t have before: hope. We’re seeing glimpses of who our son is underneath the anxiety and the behavioral issues. Dr. Caplan’s patience and understanding have been a lifeline for us. He gave us a way to manage our lives again. We’re still on this journey, but for the first time, it feels like there’s light at the end of the tunnel.”

– Sarah W.

Sarah W

Finding Comfort and Connection Again

“Loneliness had been creeping up on me for years, but it really hit hard when I retired. My social circle started shrinking, and the days just felt longer and emptier. I had been keeping busy with hobbies, but the silence in my house became unbearable. I’d wake up in the morning with no motivation to get out of bed because I didn’t have anyone to talk to, nowhere I really needed to be. I tried to reach out to old friends, but it always felt awkward, like I didn’t fit into their lives anymore. My primary doctor referred me to Dr. Caplan, not because of anything physical, but because they thought cannabis might help me with the emotional side of things. I was pretty skeptical. Cannabis? For loneliness? I didn’t see how it could possibly make me feel less isolated.

When I met with Dr. Caplan, he listened without judgment. I explained how I felt like I was drifting through my days, disconnected from everyone around me. He was calm and compassionate, and he didn’t rush me at all. Instead of dismissing my feelings, he talked me through how cannabis might help me not feel so ‘stuck’ in my emotions. We started with a low-dose regimen that focused on CBD to help with the feelings of overwhelm and helplessness. It wasn’t a quick fix, but after a few weeks, I noticed I felt lighter, more at ease. I found it easier to pick up the phone and call an old friend, easier to motivate myself to go out for a walk or run errands.

It’s hard to explain, but it felt like a weight had lifted off my chest. The loneliness was still there, but it didn’t feel so suffocating. I could breathe again, could start imagining a life where I wasn’t so isolated. Over time, I’ve been able to reconnect with people, even make new friends. Cannabis didn’t solve everything, but it gave me the space I needed to start living again. Dr. Caplan was there every step of the way, adjusting the treatment as we went and always making sure I was comfortable. I never thought something like this could help with how I was feeling, but I’m so glad I gave it a chance.”*

– Tom B.

Tom B

Does Cannabis Work for Pediatric Autism? Yes!

“I wanted to take a moment to share a heartfelt message we recently received from one of Dr. Caplan’s patients. It’s moments like these that remind us why we’re so passionate about the work we do. The incredible progress described below is a testament to the power of personalized care and cannabis therapy. We’re grateful to witness such transformations and hope this story provides inspiration for others seeking hope and relief.”

Jack Thompson, CED Clinic Operations Manager

 

For anyone interested in seeing Dr. Caplan as a consulting physician, please visit this link:Book an Appointment to complete our intake form, make a payment, and schedule your visit—all in one easy step.

Screenshot 2025 12 07 at 3.22.20 PM

 

 

 

 

A heartfelt email from a patient expressing gratitude to Dr. Caplan for recommending a CBD/THC tincture that significantly improved their son’s behavior and well-being, detailing the progress in areas such as sleep, car rides, and eating habits.
Jack Thompson

Managing Anxiety with Cannabis: A Personal Story of Relief

“I heard about Dr. Caplan through a friend who had been his patient for a couple of years. I had been struggling with anxiety for a while but didn’t think cannabis was something I could handle. The stigma around it made me nervous, and I wasn’t sure it was for me. But my friend couldn’t stop raving about the difference Dr. Caplan had made in her life, so I finally decided to check him out. From the moment I sat down with him, I knew I was in good hands. He took the time to understand my situation, explaining how cannabis could be used to manage anxiety in a safe, controlled way. It wasn’t about pushing a product—it was about finding the right balance for my body and my needs. Now, I feel more in control of my anxiety than I have in years, and I’m grateful for Dr. Caplan’s thoughtful and thorough care.”

– Maria S.

Maria Sintira

Finally Found Relief for My Back Pain

“I was at my wit’s end with my lower back pain, and nothing seemed to work—painkillers, physical therapy, injections—you name it. My orthopedist mentioned Dr. Caplan, and honestly, I wasn’t sure about the whole cannabis thing. I mean, I wasn’t against it, but I didn’t think it was for me. Still, I was desperate, so I made the call. Dr. Caplan wasn’t like any other doctor I’d met. He really took the time to get to know me, my history, and my concerns about cannabis. He didn’t push anything but explained how it could help manage pain and inflammation in a way I could understand. He helped me feel like this was something worth trying, not some weird ‘last resort.’ Fast forward six months, and I’m moving around a lot better than I have in years. I never thought I’d say it, but cannabis has made a huge difference in my life. Dr. Caplan’s been there for every step, making sure I get the right balance for what I need.”

– Mike T.

Michael Tertansky

From Total Skeptic to Success: How Cannabis Helped My Skin Condition

“I came to CED Clinic on the recommendation of my dermatologist after battling severe eczema for most of my life. I’d tried everything from steroid creams to light therapy, but nothing seemed to keep the flare-ups at bay for long. The idea of using cannabis for my skin condition seemed strange at first, and I was pretty skeptical. It wasn’t something my friends or family had ever talked about, and I wasn’t sure how it could really help. But my dermatologist convinced me to at least have a conversation, and I’m so glad I did. Dr. Caplan didn’t make me feel awkward or silly for being uncertain. Instead, he walked me through how cannabis could potentially reduce inflammation and improve my skin health. A few months into the treatment plan, and my skin has never looked better. I wish I had come to him sooner.”

– Lindsey P.

Lindsey Peterson

Cannabis Helped Me Feel Less Alone

“I’ve been dealing with loneliness for years. After my kids moved out and my spouse passed away, the days just felt so empty. I tried therapy and even medication, but nothing really touched the feeling of being alone. A friend mentioned Dr. Caplan and how cannabis had helped her with anxiety, but I wasn’t sure if it could help with loneliness. It felt strange to think about cannabis as an option for something like that. Still, I figured it was worth a shot. Dr. Caplan was kind and understanding right from the start. He didn’t make me feel silly for bringing up something as hard to explain as loneliness. He explained how cannabis might help ease the constant heaviness I was feeling, not by curing loneliness but by helping me feel more connected to myself and the world around me. We started slow, and over time, I noticed a shift. The emptiness didn’t go away, but it didn’t feel so overwhelming anymore. I started going out more, seeing friends again, and just feeling a little lighter. I’m still working through it, but cannabis—along with Dr. Caplan’s care—has made it easier to handle.”

– Susan R.

Susan Ringly

Overcoming Arthritis Pain: My Journey to Relief at CED Clinic

“I was referred to Dr. Caplan by my podiatrist, who suggested I look into cannabis after dealing with arthritis in my feet for years. Honestly, I was hesitant. I’d never been a fan of the idea of using cannabis—it seemed like a last resort. But after cycling through endless medications with little success, I was willing to try something new. From the first consultation, Dr. Caplan made me feel completely at ease. He spent time learning about my history and concerns, and he carefully explained the options in a way that was easy to understand. He wasn’t just throwing solutions at me—he was building a plan around my life. I’ve been on the regimen we discussed for about four months now, and the improvement is undeniable. It’s not just the relief, but the care and commitment Dr. Caplan shows that keeps me confident in the process.”

– Robert H.

Robert Hickenlooper

I Overcame Insomnia with Dr. Caplan’s Help.

“I was referred to Dr. Caplan by my PCP after months of struggling with severe insomnia. For years, I had relied on prescription sleep aids, but over time, they stopped working, and the side effects were unbearable. I had heard about cannabis being used for sleep, but I wasn’t convinced it would work for me. The idea of using cannabis made me nervous—I had no experience with it and didn’t want to feel ‘high.’ But my doctor insisted that I give Dr. Caplan a try, so I booked an appointment. From the very first meeting, Dr. Caplan took the time to understand my fears and hesitations. He didn’t push anything on me but explained how cannabis, especially CBD, could help regulate my sleep cycle without the psychoactive effects I was worried about. His calm, knowledgeable approach reassured me, and we crafted a plan that I felt comfortable with. After just a few weeks on the treatment, I started sleeping better than I had in years. It wasn’t an overnight solution, but Dr. Caplan was with me every step of the way, adjusting the plan as needed. I’ve regained the energy I thought I had lost forever, and for that, I’m incredibly grateful.”

– Rachel S.

Rachel Samuelson

Finding Hope After Chronic Migraines: Dr. Caplan Helped Me See Cannabis

“I found Dr. Caplan after reading The Doctor-Approved Cannabis Handbook. I had been suffering from chronic migraines for years, but the idea of using cannabis never crossed my mind. To be honest, I had a lot of doubts—would it work? Would it make me feel ‘off’? But the book opened my eyes to the science behind it, and I decided it was time to explore other options. When I reached out to Dr. Caplan, I was still on the fence, but he took the time to listen, explain, and answer every question I had. He didn’t push anything on me, but instead guided me through the possibilities. Fast forward six months, and I’ve seen such a huge improvement in my quality of life. Dr. Caplan’s approach is professional, but also deeply personal. It’s clear he cares about getting things right for each patient.”

– Jessica M.

Jessica Montrouse

No More Painful Periods

“I’ve had awful period cramps for as long as I can remember, and nothing ever worked to ease the pain. My gynecologist suggested Dr. Caplan, but I wasn’t sure about using cannabis for menstrual pain—it seemed kind of odd to me. Still, I was tired of being in pain every month, so I decided to at least talk to him. Dr. Caplan was great—he explained how cannabis could help with cramps and inflammation and answered all my questions without making me feel rushed. He worked with me to figure out a plan that I was comfortable with, and within a few cycles, I started noticing a big difference. The pain isn’t completely gone, but it’s so much more manageable now. I don’t dread that time of the month anymore. I’m so glad I gave it a try—Dr. Caplan’s made this whole process easier than I expected.”

– Emily K.

Emily Kingston

Trustworthy & Easy

From the moment I first connected with Dr. Caplan on a telemedicine visit, I felt an immediate sense of relief. I had been struggling with anxiety for years, and previous doctors had only offered quick fixes that never addressed the root of the problem. Dr. Caplan took the time to understand my history, my triggers, and my lifestyle. The discussion was open and flowed easily and  to me, clearly shows that he actually cares. During our consultation, he explained the complex medical stuff in a way that made sense to me, and made sure I felt informed and empowered every step of the way. When I had a panic attack late one night, I emailed him in desperation, and to my surprise, he responded almost immediately with calming words and practical advice. His personalized follow-up call the next day was the reassurance I needed to stay on track. Dr. Caplan’s unwavering commitment and compassionate care have truly transformed my life.

— Michael Anderson

Michael Anderson

My anxiety is manageable!

Dr. Caplan’s thoughtful approach turned my anxiety into a manageable journey, offering not just treatment but a renewed sense of hope and understanding.

– S Christianson

Sandra Christianson

I’m a whole person. And I’m complicated.

“I found Dr Caplan after reading his book, The Doctor-Approved Cannabis Handbook. Dr. Caplan doesn’t just treat symptoms—he treats the whole person. From my very first appointment, he made sure I understood every part of my treatment plan, and I left feeling hopeful for the first time in years. His book has been a helpful resource, but it’s his personal touch and thoughtful care that really sets him apart. I’ve never felt rushed or like just another patient in a long line. Instead, I feel truly heard.”

– Sarah W.

Sarah W

My Son Was Right About Cannabis

“Funny enough, my teenage son was the one who pushed me to see Dr. Caplan. I’ve had a stressful job for years, and it’s been taking a toll on my health. My son did a project on cannabis for school and said I should check it out for stress. I was pretty hesitant—I mean, cannabis? It wasn’t something I ever thought I’d try. But after hearing my son talk about it for weeks, I figured, why not? I went to Dr. Caplan with a lot of questions, and he took the time to answer every one of them. He explained how I didn’t have to get ‘high’ to use cannabis for stress and that it could help me feel calmer without messing with my head. He started me on a low-dose CBD plan, and within a couple of weeks, I started noticing a difference. I was less anxious at work, more patient with my family, and just felt more balanced. Honestly, I owe my son for nudging me, but I’m grateful to Dr. Caplan for helping me find a solution that really works.”

– Janet W.

Janet Wishingsly

From Sleepless Nights to Peaceful Mornings

“I was dealing with sleepless nights for months—maybe even years—when my primary care doctor suggested I check out Dr. Caplan. I’d been on sleeping pills for ages, but they stopped working, and I was left exhausted all the time. The idea of using cannabis for sleep honestly sounded weird to me. I didn’t know much about it, and I figured it would just make me feel groggy or out of it. But I was tired of being tired, so I made the appointment. Dr. Caplan really gets it—he wasn’t pushy at all. He explained how CBD could help me without the ‘high’ I was worried about, and he was super patient with all my questions. Within a couple of weeks, I was actually sleeping through the night. It’s not an overnight fix, but it’s the best sleep I’ve had in years. I wake up feeling refreshed instead of like a zombie. Dr. Caplan’s follow-ups have been a game-changer too—he checks in to make sure everything’s working. It feels good to have a doctor who cares.”

– Laura B.

Laura Bonintue

Genuine care and great medical advice

Dr. Caplan’s genuine care and commitment are evident in every interaction. At CED Clinic, I received more than just medical advice; I gained a trusted advisor in my health journey. His use of personalized treatment plans and educational resources helped me understand and manage my condition better than ever before.
– Michael T.

Michael T

Awesome experience!

I never felt like just another patient at CED Clinic; Dr. Caplan made sure of that. His thorough understanding of my health needs, paired with his deep knowledge of cannabis therapy, provided a tailored experience that truly catered to my well-being. Every visit felt like a step forward in my journey dealing with sleeplessness, stress, and PTSD.
– Denise H.

 

Denise H

Happy customer!

My visit to CED Clinic was absolutely amazing, and it all started with Kim. She was so friendly and helpful right from the get-go, making the whole scheduling thing a breeze – a real breath of fresh air! Then there was Dr. Caplan. Honestly, chatting with him felt more like catching up with an old friend than a typical doctor’s visit. He didn’t seem to be watching the clock at all; he was all in, really getting to grips with what I’ve been going through, and dishing out advice that hit the nail on the head. And get this – he’s even written a book about it all! I can’t wait to get my hands on a copy. The whole experience at CED Clinic was just so warm and genuine. They’ve got something special going on over there, for sure.

Amanda Kimmel

I’m Free: My Journey Beyond Chronic Pain!

I felt trapped in a cycle of chronic pain, where prescription and over-the-counter meds were just dead ends. Then I found Dr. Caplan. His blend of medical expertise and cannabis knowledge opened a door I didn’t know existed. I read ‘The Doctor-Approved Cannabis Handbook’ and it was/is a turning point—packed with research and actionable advice, it guided me to a pain management plan that actually worked. Thanks to Dr. Caplan, I’m living with less pain and more hope. Highly recommend for anyone stuck in the pain cycle.

Emily Brasston

From Frayed Edges to Balance: Found My Center with Cannabis

Let me paint you a picture of my life not too long ago: a job that never hit ‘pause,’ kids that always needed me in a hundred different ways, and a level of work stress that had me teetering on the edge. I was juggling more plates than I had hands for, and it felt like I was one strong breeze away from watching them all come crashing down. Sleep was a luxury I couldn’t afford, and ‘me time’ was a concept so foreign it might as well have been from another planet.

Enter Dr. Benjamin Caplan and his life-altering approach to managing stress through cannabis medicine. At first, I was skeptical—could this really be the answer I’d been searching for? But from the moment we began, it was clear Dr. Caplan wasn’t just any doctor. His blend of traditional medical insight and innovative cannabis expertise was like a breath of fresh air.

What truly transformed my journey, though, was diving into ‘The Doctor-Approved Cannabis Handbook.’ This wasn’t just another self-help book; it was a treasure trove of evidence-based research, clinical wisdom, and, most importantly, actionable advice that felt like it was written just for me. It became my North Star, guiding me through the haze of stress and sleepless nights to a place of understanding and balance.

Thanks to the personalized strategy Dr. Caplan crafted with me, I’ve been able to reclaim control over my stress and find a sense of equilibrium I didn’t think was possible. My work no longer feels like a constant battle, and I’ve found more joy and presence in the time I spend with my kids. The difference is night and day.

I’m beyond grateful to Dr. Caplan and the invaluable lessons from his handbook. For anyone feeling overwhelmed by the demands of work, family, and everything in between, Dr. Caplan’s compassionate, evidence-based approach might just be the lifeline you need. I can’t recommend him enough.

Sam Dexter

My Journey to Conquering Chronic Insomnia with Dr. Caplan and Cannabis Medicine

I’ve been in this battle with chronic insomnia for what feels like forever. I hit a point where I felt completely out of options. I mean, you name it, I tried it—all those over-the-counter fixes, prescriptions from my doctors, and I even got creative mixing up my own cannabinoid solutions. But nothing worked. Those endless nights of tossing and turning weren’t just annoying; they were wrecking my health and my spirits.

Then, almost out of nowhere, I stumbled upon Dr. Benjamin Caplan and his work in the world of cannabis medicine. From the moment we started talking, I knew this was different. He’s got this unique blend of traditional medical wisdom and cutting-edge cannabis knowledge. It’s like he sees the whole picture in a way no one else had shown me before.

But here’s the real game-changer: “The Doctor-Approved Cannabis Handbook.” That book blew my mind. It’s packed with solid science and real-deal clinical insights on how cannabis can tackle not just insomnia but a whole list of issues. More than that, it gave me straightforward, practical steps tailored just for me. It turned into my guide on this journey to use cannabis safely and super effectively.

I owe so much to Dr. Caplan and the wisdom packed into that book. I’ve finally found some peace from my insomnia—a relief I thought was off the table for me. My sleep’s way better, and my days? They’ve transformed. I can’t thank Dr. Caplan enough. And seriously, if you’re hitting a wall with insomnia or any health problem that just won’t budge with the usual treatments, Dr. Caplan’s approach could be the breakthrough you’re looking for. Certainly was for me.

 

My Journey to Conquering Chronic Insomnia with Dr. Caplan and Cannabis Medicine

Hashimoto’s Disease and Cannabis: How I Found the Right Balance with Dr. Caplan’s Help

“My endocrinologist recommended Dr. Caplan after I’d been diagnosed with Hashimoto’s disease. I was dealing with a range of symptoms—fatigue, joint pain, brain fog—but I was really hesitant to try cannabis. I didn’t have any experience with it and was worried about how it might affect me. Still, after years of feeling like nothing was really working, I was ready to explore new options. Dr. Caplan’s approach made all the difference. He took the time to understand not only my medical history but also my reservations. He patiently explained how cannabis could help with my symptoms without overwhelming me. It wasn’t an instant fix, but over the months, I started noticing real improvements. What sets Dr. Caplan apart is how much he truly listens and adapts the treatment plan to my needs. I’ve never felt more supported by a doctor.”

– Megan L.

Megan Lincoln

A Lifeline in Chronic Pain: Cannabis Changed My Life

“I was referred to Dr. Caplan by my orthopedist after years of dealing with debilitating lower back pain. I had been through physical therapy, painkillers, and injections, but nothing offered lasting relief. Honestly, I was skeptical about trying cannabis. I had always associated it with recreational use and didn’t see how it could be a solution for chronic pain. But after my orthopedist explained the potential benefits and encouraged me to meet with Dr. Caplan, I decided to give it a chance. From the moment I walked into Dr. Caplan’s office, I felt like he was different from any doctor I’d seen before. He listened carefully to my history and my concerns, and instead of pushing cannabis on me, he educated me on the science behind it. He explained how it could help reduce inflammation and manage pain without the foggy side effects I was used to with traditional medications. Now, after six months of working with Dr. Caplan, my pain is more manageable than I ever thought possible. I’m not saying it’s a magic cure, but for the first time in years, I feel like I have control over my life again. His compassion and expertise have been a lifeline for me.”

– David P.

David Pelonsky

Used as a Human Target as a Kid, Medical Cannabis is the answer.

I’m totally blind. I live in a rural area. So when I was 12, same-age peers thought zapping the blind girl’s eyes with laser pointers would be a great idea. It got bad enough that my paraprofessional had to have the devices banned from the school for my safety. Shortly after, I began having intense eye aches. I differentiate them from headaches because even a 12 year old can tell the difference. Doctors told my parents and I they were migraines. It wasn’t until later in life that I began realizing there was something else going on here. Really studying migraines, studying the eye, studying neurology and understanding not all was as it seemed. I began developing my own theories as to what these “migraines” were. I take migraine meds, but they don’t treat the eye aches. They treat the other migraine symptoms just fine. My younger brother suggested I try edibles last year. Because by this point, I was in enough pain where I believed I’d have to have my eyes removed. None of us wanted to see that happen. So he took me to a dispensary, (he had spoken with someone he knew there about me prior, and they’d come up with a regimen they thought would work.) The first clue I had that we were on the right track, was that I slept for 14 hours. So I kept a calendar and a spreadsheet full of virtual sticky notes, and 2 weeks later came to Dr. Caplan for my medical card, crazy theories about optic neuropathy in underdeveloped optic nerves and all. A year later, I’m studying cybersecurity, because that’s something I found I’m passionate about, and I can do it now!

Krista Pennell

To sleep well again is life-changing

Dr. Caplan was coincidentally recommended by both my dentist and a close friend. I was concerned about finding a high level, knowledgeable, physician in a professional setting who understood using cannabis in a safe and effective manner. I can’t recommend Dr. Caplan more highly. His knowledge is vast and I am grateful for his expertise, care and compassion. To sleep well again is life-changing. Very few things literally change someone’s life. Dr. Caplan’s knowledge and guidance on cannabis did that for me.

Barbara M.

Not once did I feel rushed or embarrassed, in fact I felt like he really does care about my circumstances, and wanted for me to feel confident and prepared

Honestly, I was hesitant to try cannabis. I have debilitating menstrual cramps and my OB/GYN recommended Dr. Caplan. I was more than a little hesitant to try cannibas because all I really knew about it was that people used it to get “high” – and that was not something I was interested in. This perspective totally changed when I actually came in and met with Dr. Caplan. He was incredibly understanding and really took the time to ease my mind about the whole process, what kind of options there were to choose from, what they might do, and what would probably appeal to me. He spent a lot of time answering all my questions (and I had a lot!). Not once did I feel rushed or embarrassed, in fact I felt like he really does care about my circumstances, and wanted for me to feel confident and prepared.

Mark L.

Dr. Caplan was thorough in his evaluation and friendly and accessible in his approach

Dr. Caplan was thorough in his evaluation and friendly and accessible in his approach. He provided in depth information and step by step guidance for beginning the process of utilizing cannabis therapies. He is available to his patients by email and phone. I highly recommend an appointment with him if you are even remotely considering medicinal use. I was hesitant about this approach before my appointment but now, after talking with Dr. Caplan and learning a little bit more about the science, I am eager to explore and I feel better already!

Rachel M.

I saw Dr Caplan a few months ago, and from even before I met him, he has made himself available to me over email, for questions, more than even my regular doctor

I came into marijuana medicine with zero experience. I must say, I’ve been learning a ton, and I would recommend it to anyone with terrible anxiety and depression. I saw Dr Caplan a few months ago, and from even before I met him, he has made himself available to me over email, for questions, more than even my regular doctor. A friend told me that I should see Dr Caplan, but I was still unsure about becoming a medical marijuana patient. I called and was able to speak with Dr Caplan directly. He took time, on the phone, even before he had met me, to explain the whole process, which helped me feel more comfortable putting a voice and personality to the process. Later, when I finally came in, during the visit, he spent almost 40 minutes with me, walking me through how cannabis might fit in with some of the other treatments I currently use. We have kept in touch over email since, like 3 or 4 random questions, and has always responded promptly. I think he is a truly special doctor, and from what I’ve read on Twitter, has a passion for educating and helping improve the perception of cannabis.

Alan T.

I had an enjoyable visit with clear information and education about medical marijuana and the dispensaries

Full stars. I appreciate the great parking and simple scheduling system. I had an enjoyable visit with clear information and education about medical marijuana and the dispensaries. No fancy language, no time wasted. Works for me.

Michael J.

I am a survivor of breast, uterine, and ovarian cancers, and Dr Caplan of CED Clinic is, hands down, the favorite voice of support and cannabis education for our hospital list-serv care group

I am a survivor of breast, uterine, and ovarian cancers, and Dr Caplan of CED Clinic is, hands down, the favorite voice of support and cannabis education for our hospital list-serv care group. I have seen him speak publicly, and on TV, and of course he is also my doctor. In spite of having what seems to be a crowd of patients who are mostly in terrible pain or have a generous helping of emotional/mental issues, I see him work tirelessly for his patients and for the cause, in general. I appreciate his leadership in the cannabis field. He is one in a million.

Stephanie W.

Dr. Caplan is an extremely knowledgeable doctor in his field and very easy to speak with about any questions and concerns you may have

Dr. Caplan is an extremely knowledgeable doctor in his field and very easy to speak with about any questions and concerns you may have. As a person that suffers from anxiety, upon arriving at the office I felt welcomed and relaxed because the doctor is compassionate and kind. The office atmosphere is not what I expected at all and was very peaceful and relaxing, also there were snacks and beverages which I have never seen before in a doctor’s office. I would highly recommend Dr. Caplan because he will take the time to answer every question that you may have about treatment. I made an appointment on a Saturday and was seen right away on the same day! Very easy process and very responsive. I am happy I chose Dr. Caplan!

Joshua C.

This is our second visit to Dr. Caplan in a year, and on both occasions, we were just blown away by his caring and compassion

This is our second visit to Dr. Caplan in a year, and on both occasions, we were just blown away by his caring and compassion. He is a true healer, with a great heart, enormous patience, and extraordinary expertise. My wife and I were amazed to find a physician who truly puts his patients first, and who is passionate about figuring out the best way to help us with our chronic pain. In our 60+ years of experience with health care providers, Dr. Caplan is among the most committed, generous, and caring healers we have ever met.

Heather F.

I can’t recommend Dr. Caplan highly enough

I can’t recommend Dr. Caplan highly enough. This was my third medical marijuana certification review (original plus two renewals), and the previous two doctors were just perfunctory form-fillers in shabby offices in remote office parks. Dr. Caplan is a REAL cannabis doctor who’s deeply knowledgeable about medical marijuana and clearly explains EXACTLY how to use it for YOUR specific conditions. He also has a real doctor’s office in a real medical building right on Boylston Street (Route 9) in Chestnut Hill ( not far from NETA Brookline, my dispensary of choice.) AND THE VISIT IS COVERED BY MEDICAL INSURANCE! I’ve become somewhat knowledgeable about what works for my primary complaint (chronic pain from spinal stenosis w/ radiculopathy) and what to avoid, but he gave me brand new ways to deal with my insomnia (including how and when to use edibles, which hadn’t worked for me before b/c I didn’t really know what I was doing) and arthritis in my hands (including a simple recipe to make topical lotion that’s stronger and cheaper than the commercial products). I interrupted him with frequent questions, which he answered at whatever level of detail and technical information I wanted. I had been deeply dissatisfied with the cannabis doctors I went to before, but Dr. Caplan is an outstanding DOCTOR who happens to specialize in medical marijuana because he cares about helping patients for whom traditional medicine hasn’t fully met their needs. You can book appointments on his web site, although my wait time was more than 10 minutes (during which I filled out his online patient questionnaire on my phone and ate all the Kit Kats in his candy basket), it was well worth it. This is a relatively new practice, I believe, and it’s going to get a lot busier as word spreads. But just do yourself a favor and go: this is what state-of-the-art medical marijuana care is supposed to be like.

Steve G.

Dr. Caplan patiently explained how there are so many options to chose from and exactly what each was helpful for

I recently had my first appointment with Dr. Caplan after reading negative reviews of so many other medical marijuana certification “places”. I can’t say enough good things about my visit with him. To start with he’s a very compassionate, caring doctor. I’m a 63 yr old woman and had never used marijuana or “street drugs”, so I was feeling nervous about trying it. I recently started chemo therapy at Dana-Farber and the side effects have been difficult to deal with. In particular, insomnia and a bit of evening anxiety. He is extremely knowledgeable about all aspects of medical marijuana. Dr. Caplan patiently explained how there are so many options to chose from and exactly what each was helpful for. With that said, he suggested several products for me to try. I now know what helps me, but each person has to use the information he gives and then try different products from a reputable medical dispensary. I plan to have a 2nd appt. with him in a few months just to get his feedback on my experiences and possibly more recommendations. It’s not necessary to go back to him after getting your certification, but he truly knows so much about the medicinal benefits that I’d like to learn even more. I highly recommend him.

Nancy O.

I would highly recommend Dr. Caplan because he will take the time to answer every question that you may have about treatment

Dr. Caplan is an extremely knowledgeable doctor in his field and very easy to speak with about any questions and concerns you may have. As a person that suffers from anxiety, upon arriving at the office I felt welcomed and relaxed because the doctor is compassionate and kind. The office atmosphere is not what I expected at all and was very peaceful and relaxing, also there were snacks and beverages which I have never seen before in a doctor’s office. I would highly recommend Dr. Caplan because he will take the time to answer every question that you may have about treatment. I made an appointment on a Saturday and was seen right away on the same day! Very easy process and very responsive. I am happy I chose Dr. Caplan!

Robert M.

Dr. Caplan is extremely patient and compassionate

Dr. Caplan is extremely patient and compassionate. He answered all of my questions and gave me a great deal of useful information (while emphasizing that I didn’t have to absorb all of it right away). He encouraged me to contact him with any more questions I might have after the appointment, and began the process of registering me immediately after I left. I had an email from the Commonwealth of MA before I got home, and completed the application online within a few minutes. It couldn’t have been an easier or more stress-free experience. Dr. Caplan truly believes in the effectiveness of cannabis as a medicinal tool, and is committed to making it more widely available for that purpose and in dispelling the ocean of ignorance that has unfortunately been created around it in our society. I can’t recommend him highly enough.

Justice S.

Excellent Experience, top to bottom

Excellent Experience, top to bottom. I scheduled my appointment on CED clinic website, got in the next day – and visit was informative, and doc was kind, compassionate, and amazingly knowledgeable. I intend to follow him as a permanent addition to my healthcare and would recommend widely.

Ellison M.

I’m shy but felt comfortable and supported

Awesome doctor. Super easy to talk to. I’m shy but felt comfortable and supported. Great teacher too. I had no idea there was so much to know!

Sara E.

I learned about different options and lots of choices, and received handouts to learn even more

First heard of Dr Caplan on /r/BostonTrees subreddit. Made my appointment online, for the next day, and did all paperwork online before I came in. Building is very professional and comfortable, with great parking, and close to where I live. As I expected, doc was kind, thorough, and efficient. We reviewed my medical history, talked about what I had been doing in the past, and discussed a host of treatment ideas, and not just marijuana. I learned about different options and lots of choices, and received handouts to learn even more. I plan to follow up in a few months, and I look forward to it.

Ryan H.

Every time I come in, I learn something new and amazing.

I followed Dr Caplan from his position as the Medical Director of Canna Care Docs to CED Clinic – and would follow him again. I have had years of back pain and arthritis – my wrists and knees and hips. Dr Caplan has helped me understand much more about marijuana, and I have to say, it has been a wonderful improvement for me. Every time I come in, I learn something new and amazing. It’s a new industry for me, and I feel very well supported.

Elizabeth P.

My visit with Dr. Caplan made it comforting to know that someone was on my side

My visit with Dr. Caplan made it comforting to know that someone was on my side. I was surprised to find that Dr. Caplan does more than just write scripts for people to take to dispensaries. He sees some of his patients on a regular basis to personalize treatment plans and it’s clear he cares about education and the destigmatization of medical cannabinoids. He goes to assisted living centers, medical expos, wellness centers, and more to speak with people on the matter. This is his passion!

Benjamin T.

Dr. Caplan is extremely patient and compassionate

Dr. Caplan is extremely patient and compassionate. He answered all of my questions and gave me a great deal of useful information (while emphasizing that I didnâ€t have to absorb all of it right away). He encouraged me to contact him with any more questions I might have after the appointment, and began the process of registering me immediately after I left. I had an email from the Commonwealth of MA before I got home, and completed the application online within a few minutes. It couldn’t have been an easier or more stress-free experience.†“— Dr. Caplan truly believes in the effectiveness of cannabis as a medicinal tool, and is committed to making it more widely available for that purpose and in dispelling the ocean of ignorance that has unfortunately been created around it in our society. I can€t recommend him highly enough.

Jeff E.

Very knowledgeable and compassionate

Very knowledgeable and compassionate.

Irene C.

I would highly recommend Dr. Caplan

I wasn’t sure what to expect from the initial appointment.  It was informative, educational and an overall great experience!  Dr. Caplan is easy-going, kind, and gave clear, detailed information about medical cannabis and MA medical dispensaries.  I would highly recommend Dr. Caplan.  His clinic and his knowledge are certainly worth 5-star reviews!

Ashley S.

I had such a good experience with Dr. Caplan of CED Clinic.  

I had such a good experience with Dr. Caplan of CED Clinic.

Medical: I had a lot of worries going in, and Dr. Caplan put me at ease with his knowledge and calm manner.  As a family doctor, he asked good questions about my extensive medical background, in a supportive way.  He used normal people words instead of medical gobbledygook!  (I had just an hour before been at an appointment with a medical person who thought I should understand when he talked about my distal iliolumbar neuropathy – or something like that, I had no idea what he was talking about – so I especially noticed when Dr. Caplan used normal words that any person would know.)

Educational: He provided excellent information for total newbies, showed some devices, talked about legal stuff, and gave great info about local clinics and huge discounts available.  I’m used to doctors providing pretty poor education materials, but Dr. Caplan’s infographics and handouts were a thing of beauty – informative, easy to read, and visually simple.  I hope Dr. Caplan writes a book because I will buy it.

Logistics: This is such a streamlined practice, it is easy to get in soon, and respectful of your time.  I got an appointment within less than 2 days, scheduled online, filled out my info online beforehand, found parking easily, was in and out quickly, and received the email with next steps instructions and application activation code in 1.5 hour!  Can’t possibly be easier than this.

Laura M.

Dr. Caplan was very friendly, extremely helpful and knowledgeable

Dr. Caplan was very friendly, extremely helpful and knowledgeable.  I would definitely recommend and I am looking forward to having him as a health resource.

Timothy Y.

I’ve switched 100% to cannabis as my go-to medicine

I’ve switched 100% to cannabis as my go-to medicine.  I’m sick of pharmaceuticals; the weight gain, the weird feelings like I’m a zombie, the miserable sleep…sorry, but hard pass.  Weed helps take the edge off and I’m still fully functional.

Anonoymous

Dr Caplan's Book: The Doctor-Approved Cannabis Handbook

FIN DoctorApprovedCannabisHandbook FullCover1024 1

"A wealth of information and a huge dose of compassion and clarity."

- Melissa Etheridge

Get To Know Your Medical Team!

We Stay Connected With Our Patients via Email, Online, and Even on the Airwaves!

Email | Instagram  |  Twitter  |  LinkedIn  |  YouTube  |  Spotify  |  Newsletter

CaplanCannabis.com | The Commonwealth Project | EO Care | Green Table Talk Podcast

Doctor and NP cartoon

😎
Sounds too good to be true? Put us to the test!

Send us an email to introduce yourself, and if we don’t respond within a day, we’ll knock $10 off as our apology!

SAVE Money 💰 with CED Clinic:

Save money

Your health shouldn’t break the banklet us help you save!

Contact us here for more

 

The Latest

CED Clinic Blog
March 25, 2026CED Clinical Relevance  #50Monitored Relevance  Early-stage or contextual signal requiring further evidence before action. 📋 Clinical Insight  |  CED Clinic Clinical EducationEvidence-Based MedicinePatient SafetyMedical Cannabis Audienceexample.comPrimary Topic2026-03-11T16:34:35.806134+00:00 Why This MattersWithout a specific clinical topic provided, I cannot generate meaningful clinical commentary. Accurate medical education requires precise subject matter to ensure evidence-based content that serves both patients and clinicians appropriately. Clinical SummaryClinical commentary must be grounded in specific medical topics, research findings, or therapeutic considerations. Without defined subject matter, any attempt at medical discussion would lack the precision and evidence base required for responsible clinical education. Effective cannabis medicine education depends on addressing concrete questions about mechanisms, dosing, drug interactions, or specific conditions rather than generating generic content. Dr. Caplan’s Take“I cannot provide clinical guidance without a clear medical topic—responsible cannabis medicine education requires specificity and evidence-based focus.” Clinical Perspective🧠 Patients seeking cannabis medicine information should look for content that addresses specific conditions, symptoms, or therapeutic questions rather than general commentary. When consulting with clinicians, come prepared with concrete questions about your particular health situation, current medications, and specific therapeutic goals to enable meaningful medical discussions. 💬 Join the ConversationHave a question about how this applies to your situation? Ask Dr. Caplan →Want to discuss this topic with other patients and caregivers? Join the forum discussion → Have thoughts on this? Share it:𝕏 Share on X in Share on LinkedIn 🦥 Share on BlueSky 📷 Follow on Instagram 📝 Read more on Substack 🔔 Subscribe via RSS 📰 Source: ingested Frequently Asked QuestionsWhy should clinicians care about this topic?Certificates of analysis, how patients can read between the lines #4Where can patients learn more?Visit cedclinic.com for evidence-based cannabis medicine resources, clinical consultations, and educational content from Dr. Caplan and the CED team.How does this relate to the endocannabinoid system?The endocannabinoid system is a fundamental regulatory network throughout the body. Understanding how it functions is essential for evidence-based cannabis medicine practice. {“@context”: “https://schema.org”, “@type”: “Article”, “headline”: “Certificates of analysis, how patients can read between the lines #4”, “url”: “”, “about”: “certificates analysis how patients can read”} [...] Read more...
March 25, 2026CED Clinical Relevance  #50Monitored Relevance  Early-stage or contextual signal requiring further evidence before action. 📋 Clinical Insight  |  CED Clinic Clinical PracticePatient SafetyEvidence-Based MedicineCannabis MedicineClinical Assessment Audience example.com Primary Topic 2026-03-13T10:34:35.806134+00:00 Why This Matters Without specific clinical content to analyze, I cannot provide evidence-based commentary on any particular cannabis medicine topic. Clinical education requires precise, sourced information to ensure patient safety and therapeutic accuracy. Clinical Summary Effective cannabis medicine practice depends on systematic evaluation of individual patient presentations, underlying pathophysiology, and available evidence for specific conditions. The endocannabinoid system’s complexity requires careful consideration of cannabinoid pharmacokinetics, receptor interactions, and potential therapeutic mechanisms. Clinical decision-making must integrate patient history, symptom patterns, and treatment goals with current research limitations. Without defined clinical parameters or specific medical questions, generalized recommendations cannot be responsibly provided. Dr. Caplan’s Take “I cannot offer clinical guidance without specific patient scenarios or defined medical questions, as responsible cannabis medicine requires precise, individualized assessment.” Clinical Perspective 🧠 Patients should prepare specific questions about their symptoms, current medications, and treatment goals when discussing cannabis medicine options. Clear communication about medical history, previous cannabis experiences, and therapeutic objectives helps clinicians provide targeted guidance. Consider documenting symptom patterns and treatment responses to facilitate meaningful clinical conversations. 💬 Join the Conversation Have a question about how this applies to your situation? Ask Dr. Caplan → Want to discuss this topic with other patients and caregivers? Join the forum discussion → Have thoughts on this? Share it: 𝕏 Share on X in Share on LinkedIn 🦥 Share on BlueSky 📷 Follow on Instagram 📝 Read more on Substack 🔔 Subscribe via RSS 📰 Source: ingested Frequently Asked Questions Why should clinicians care about this topic? Why older adults deserve better cannabinoid care options #1 Where can patients learn more? Visit cedclinic.com for evidence-based cannabis medicine resources, clinical consultations, and educational content from Dr. Caplan and the CED team. How does this relate to the endocannabinoid system? The endocannabinoid system is a fundamental regulatory network throughout the body. Understanding how it functions is essential for evidence-based cannabis medicine practice. {“@context”: “https://schema.org”, “@type”: “Article”, “headline”: “Why older adults deserve better cannabinoid care options #1”, “url”: “”, “about”: “why older adults deserve better cannabinoid”} [...] Read more...
March 25, 2026CED Clinical Relevance  #50Monitored Relevance  Early-stage or contextual signal requiring further evidence before action. 📋 Clinical Insight  |  CED Clinic Medical EducationClinical EvidencePatient SafetyHealthcare Communication Audience example.com Primary Topic 2026-03-11T02:34:35.806134+00:00 Why This Matters Without a specific clinical topic provided, I cannot generate accurate medical content. Clinical education requires precise, evidence-based information about defined medical conditions, treatments, or physiological processes. Clinical Summary I cannot provide clinical commentary without knowing the specific medical topic, condition, or therapeutic area to address. Responsible medical education demands that content be grounded in established clinical evidence and focused on well-defined health issues. Any clinical discussion must be anchored in peer-reviewed research, established mechanisms of action, and documented patient outcomes. Dr. Caplan’s Take “I require a clear medical topic to provide the evidence-based clinical perspective that patients and clinicians deserve.” Clinical Perspective 🧠 Patients should always seek specific, topic-focused medical information from qualified sources. When researching health topics online, look for content that addresses your particular condition or question with clear references to medical evidence. Bring specific questions about defined health issues to your healthcare provider rather than seeking general medical advice. 💬 Join the Conversation Have a question about how this applies to your situation? Ask Dr. Caplan → Want to discuss this topic with other patients and caregivers? Join the forum discussion → Have thoughts on this? Share it: 𝕏 Share on X in Share on LinkedIn 🦥 Share on BlueSky 📷 Follow on Instagram 📝 Read more on Substack 🔔 Subscribe via RSS 📰 Source: ingested Frequently Asked Questions Why should clinicians care about this topic? AI in medicine, where judgment still matters #5 Where can patients learn more? Visit cedclinic.com for evidence-based cannabis medicine resources, clinical consultations, and educational content from Dr. Caplan and the CED team. How does this relate to the endocannabinoid system? The endocannabinoid system is a fundamental regulatory network throughout the body. Understanding how it functions is essential for evidence-based cannabis medicine practice. {“@context”: “https://schema.org”, “@type”: “Article”, “headline”: “AI in medicine, where judgment still matters #5”, “url”: “”, “about”: “ai medicine where judgment still matters”} [...] Read more...
March 25, 2026CED Clinical Relevance  #50Monitored Relevance  Early-stage or contextual signal requiring further evidence before action. 📋 Clinical Insight  |  CED Clinic Clinical EducationEvidence-Based MedicineMedical Communication Audience example.com Primary Topic 2026-03-12T06:34:35.806134+00:00 Why This Matters I notice the content details appear incomplete or corrupted in your request. Without the specific clinical topic, research findings, or medical question you’d like me to address, I cannot provide the evidence-based commentary that patients and clinicians deserve. Clinical Summary To deliver clinically valuable content, I need clear information about the medical topic, relevant research data, patient population, or clinical question at hand. My approach requires specific clinical context to ensure accuracy and therapeutic relevance. Without these details, any commentary would lack the precision and evidence-grounding that effective medical education demands. Dr. Caplan’s Take “I cannot provide clinical guidance without knowing what medical topic or research we’re discussing. Please share the specific clinical question or content you’d like me to address.” Clinical Perspective 🧠 Patients should always expect their healthcare providers to base recommendations on clear, specific clinical evidence rather than general statements. When seeking medical information, ensure your sources reference particular conditions, treatments, or research findings. If content lacks specificity or clinical context, consider it insufficient for medical decision-making. 💬 Join the Conversation Have a question about how this applies to your situation? Ask Dr. Caplan → Want to discuss this topic with other patients and caregivers? Join the forum discussion → Have thoughts on this? Share it: 𝕏 Share on X in Share on LinkedIn 🦥 Share on BlueSky 📷 Follow on Instagram 📝 Read more on Substack 🔔 Subscribe via RSS 📰 Source: ingested Frequently Asked Questions Why should clinicians care about this topic? Menopause, the ECS, and why physiology matters more than slogans #3 Where can patients learn more? Visit cedclinic.com for evidence-based cannabis medicine resources, clinical consultations, and educational content from Dr. Caplan and the CED team. How does this relate to the endocannabinoid system? The endocannabinoid system is a fundamental regulatory network throughout the body. Understanding how it functions is essential for evidence-based cannabis medicine practice. {“@context”: “https://schema.org”, “@type”: “Article”, “headline”: “Menopause, the ECS, and why physiology matters more than slogans #3”, “url”: “”, “about”: “menopause ecs why physiology matters more”} [...] Read more...
March 25, 2026CED Clinical Relevance  #50Monitored Relevance  Early-stage or contextual signal requiring further evidence before action. 📋 Clinical Insight  |  CED Clinic Medical EducationClinical StandardsPatient SafetyEvidence-Based Medicine Audience example.com Primary Topic 2026-03-12T20:34:35.806134+00:00 Why This Matters Without specific clinical content provided, I cannot generate an evidence-based commentary that meets the standards of clinical education. Accurate medical information requires substantive source material to ensure patient safety and clinical validity. Clinical Summary I cannot provide clinical analysis without defined topic, evidence base, or therapeutic context. Medical commentary demands specific mechanisms, peer-reviewed data, and clear clinical parameters to avoid misinformation. Any cannabis medicine discussion must reference established research, dosing protocols, contraindications, and patient selection criteria to maintain clinical integrity. Dr. Caplan’s Take “I require substantive clinical content to provide meaningful medical commentary that serves both patients and clinicians appropriately.” Clinical Perspective 🧠 Patients should always seek specific medical information from qualified sources with clear evidence backing. Any therapeutic decisions require individualized clinical assessment with proper medical supervision. Generic or incomplete medical guidance can compromise patient care and safety outcomes. 💬 Join the Conversation Have a question about how this applies to your situation? Ask Dr. Caplan → Want to discuss this topic with other patients and caregivers? Join the forum discussion → Have thoughts on this? Share it: 𝕏 Share on X in Share on LinkedIn 🦥 Share on BlueSky 📷 Follow on Instagram 📝 Read more on Substack 🔔 Subscribe via RSS 📰 Source: ingested Frequently Asked Questions Why should clinicians care about this topic? Cannabis and sleep, what patients get wrong and what clinicians should explain #2 Where can patients learn more? Visit cedclinic.com for evidence-based cannabis medicine resources, clinical consultations, and educational content from Dr. Caplan and the CED team. How does this relate to the endocannabinoid system? The endocannabinoid system is a fundamental regulatory network throughout the body. Understanding how it functions is essential for evidence-based cannabis medicine practice. {“@context”: “https://schema.org”, “@type”: “Article”, “headline”: “Cannabis and sleep, what patients get wrong and what clinicians should explain #2”, “url”: “”, “about”: “cannabis sleep what patients get wrong”} [...] Read more...
March 24, 20260 Category: Unknown Audience: example.com Primary topic: 2026-03-06T06:28:53.017885+00:00 Read the source concept Frequently Asked Questions Why should clinicians care about this topic? Certificates of analysis, how patients can read between the lines #4 Where can patients learn more? Visit cedclinic.com for evidence-based cannabis medicine resources, clinical consultations, and educational content from Dr. Caplan and the CED team. How does this relate to the endocannabinoid system? The endocannabinoid system is a fundamental regulatory network throughout the body. Understanding how it functions is essential for evidence-based cannabis medicine practice. {“@context”: “https://schema.org”, “@type”: “Article”, “headline”: “Certificates of analysis, how patients can read between the lines #4”, “url”: “”, “about”: “certificates analysis how patients can read”} [...] Read more...
March 24, 20260 Category: Unknown Audience: example.com Primary topic: 2026-03-06T06:27:14.396188+00:00 Read the source concept Frequently Asked Questions Why should clinicians care about this topic? Certificates of analysis, how patients can read between the lines #4 Where can patients learn more? Visit cedclinic.com for evidence-based cannabis medicine resources, clinical consultations, and educational content from Dr. Caplan and the CED team. How does this relate to the endocannabinoid system? The endocannabinoid system is a fundamental regulatory network throughout the body. Understanding how it functions is essential for evidence-based cannabis medicine practice. {“@context”: “https://schema.org”, “@type”: “Article”, “headline”: “Certificates of analysis, how patients can read between the lines #4”, “url”: “”, “about”: “certificates analysis how patients can read”} [...] Read more...
March 24, 20260 Category: Unknown Audience: example.com Primary topic: 2026-03-08T00:28:53.017885+00:00 Read the source concept Frequently Asked Questions Why should clinicians care about this topic? Why older adults deserve better cannabinoid care options #1 Where can patients learn more? Visit cedclinic.com for evidence-based cannabis medicine resources, clinical consultations, and educational content from Dr. Caplan and the CED team. How does this relate to the endocannabinoid system? The endocannabinoid system is a fundamental regulatory network throughout the body. Understanding how it functions is essential for evidence-based cannabis medicine practice. {“@context”: “https://schema.org”, “@type”: “Article”, “headline”: “Why older adults deserve better cannabinoid care options #1”, “url”: “”, “about”: “why older adults deserve better cannabinoid”} [...] Read more...
March 24, 2026CED Clinical Relevance  #100High Clinical Relevance  Strong evidence or policy relevance with direct clinical implications. 📋 Clinical Insight  |  CED Clinic MenopauseEndocannabinoid SystemWomen’S HealthHormonesVasomotor Symptoms Category Condition Deep Dive Audience Women in midlife Primary Topic Cannabis and menopause Why This Matters Menopause represents a profound endocrine transition affecting every physiological system, yet treatment options remain limited and often inadequate. The endocannabinoid system’s intimate relationship with estrogen regulation and its role in thermoregulation, sleep, mood, and pain processing makes understanding this intersection clinically essential for the 1.3 million women entering menopause annually in the US. Clinical Summary During menopause, declining estrogen levels directly impact endocannabinoid system function through multiple pathways. Estrogen enhances fatty acid amide hydrolase (FAAH) expression, which degrades anandamide, leading to potentially altered endocannabinoid tone as hormones fluctuate. The ECS plays documented roles in thermoregulation through hypothalamic CB1 receptors, sleep architecture via interactions with circadian pathways, and nociceptive processing in conditions like arthralgia. Observational studies suggest cannabis may address vasomotor symptoms, sleep disturbances, and mood changes, though randomized controlled trials remain limited. The heterogeneity of menopause presentations—from sudden surgical menopause to gradual perimenopause transitions—requires individualized approaches rather than universal protocols. Dr. Caplan’s Take “I’ve observed that women experiencing menopause often respond differently to cannabis than younger patients, likely reflecting the complex interplay between changing hormone levels and endocannabinoid function. Understanding each patient’s specific symptom constellation and hormonal status is more clinically relevant than applying broad generalizations about ‘cannabis for menopause.’” Clinical Perspective 🧠 Women should recognize that menopause symptoms result from specific physiological changes, not inevitable suffering that must be endured. When considering cannabis, focus discussions with your clinician on your individual symptom pattern—whether hot flashes, sleep disruption, joint pain, or mood changes—rather than seeking a one-size-fits-all menopause solution. Hormone replacement therapy, lifestyle modifications, and other evidence-based interventions should be part of any comprehensive discussion. Ask your provider about timing, dosing considerations, and potential interactions with any current treatments. 💬 Join the Conversation Have a question about how this applies to your situation? Ask Dr. Caplan → Want to discuss this topic with other patients and caregivers? Join the forum discussion → Have thoughts on this? Share it: 𝕏 Share on X in Share on LinkedIn 🦥 Share on BlueSky 📷 Follow on Instagram 📝 Read more on Substack 🔔 Subscribe via RSS 📰 Source: https://example.com/blog/menopause-the-ecs-and-why-physiology-matters-more-than-slogans-3 Frequently Asked Questions Why should clinicians care about this topic? A concept focused on menopause physiology, symptom patterns, and endocannabinoid system relevance. Where can patients learn more? Visit cedclinic.com for evidence-based cannabis medicine resources, clinical consultations, and educational content from Dr. Caplan and the CED team. How does this relate to the endocannabinoid system? The endocannabinoid system is a fundamental regulatory network throughout the body. Understanding how it functions is essential for evidence-based cannabis medicine practice. {“@context”: “https://schema.org”, “@type”: “Article”, “headline”: “Menopause, the ECS, and why physiology matters more than slogans #3”, “url”: “”, “about”: “menopause ecs why physiology matters more”} [...] Read more...
March 24, 2026CED Clinical Relevance  #100High Clinical Relevance  Strong evidence or policy relevance with direct clinical implications. 📋 Clinical Insight  |  CED Clinic MenopauseEndocannabinoid SystemWomen’S HealthHormonesVasomotor Symptoms Category Condition Deep Dive Audience Women in midlife Primary Topic Cannabis and menopause Why This Matters Menopause represents a profound endocrine transition affecting every physiological system, yet treatment options remain limited and often inadequate. The endocannabinoid system’s intimate relationship with estrogen regulation and its role in thermoregulation, sleep, mood, and pain processing makes understanding this intersection clinically essential for the 1.3 million women entering menopause annually in the US. Clinical Summary During menopause, declining estrogen levels directly impact endocannabinoid system function through multiple pathways. Estrogen enhances fatty acid amide hydrolase (FAAH) expression, which degrades anandamide, leading to potentially altered endocannabinoid tone as hormones fluctuate. The ECS plays documented roles in thermoregulation through hypothalamic CB1 receptors, sleep architecture via interactions with circadian pathways, and nociceptive processing in conditions like arthralgia. Observational studies suggest cannabis may address vasomotor symptoms, sleep disturbances, and mood changes, though randomized controlled trials remain limited. The heterogeneity of menopause presentations—from sudden surgical menopause to gradual perimenopause transitions—requires individualized approaches rather than universal protocols. Dr. Caplan’s Take “I’ve observed that women experiencing menopause often respond differently to cannabis than younger patients, likely reflecting the complex interplay between changing hormone levels and endocannabinoid function. Understanding each patient’s specific symptom constellation and hormonal status is more clinically relevant than applying broad generalizations about ‘cannabis for menopause.’” Clinical Perspective 🧠 Women should recognize that menopause symptoms result from specific physiological changes, not inevitable suffering that must be endured. When considering cannabis, focus discussions with your clinician on your individual symptom pattern—whether hot flashes, sleep disruption, joint pain, or mood changes—rather than seeking a one-size-fits-all menopause solution. Hormone replacement therapy, lifestyle modifications, and other evidence-based interventions should be part of any comprehensive discussion. Ask your provider about timing, dosing considerations, and potential interactions with any current treatments. 💬 Join the Conversation Have a question about how this applies to your situation? Ask Dr. Caplan → Want to discuss this topic with other patients and caregivers? Join the forum discussion → Have thoughts on this? Share it: 𝕏 Share on X in Share on LinkedIn 🦥 Share on BlueSky 📷 Follow on Instagram 📝 Read more on Substack 🔔 Subscribe via RSS 📰 Source: https://example.com/blog/menopause-the-ecs-and-why-physiology-matters-more-than-slogans-3 Frequently Asked Questions Why should clinicians care about this topic? A concept focused on menopause physiology, symptom patterns, and endocannabinoid system relevance. Where can patients learn more? Visit cedclinic.com for evidence-based cannabis medicine resources, clinical consultations, and educational content from Dr. Caplan and the CED team. How does this relate to the endocannabinoid system? The endocannabinoid system is a fundamental regulatory network throughout the body. Understanding how it functions is essential for evidence-based cannabis medicine practice. {“@context”: “https://schema.org”, “@type”: “Article”, “headline”: “Menopause, the ECS, and why physiology matters more than slogans #3”, “url”: “”, “about”: “menopause ecs why physiology matters more”} [...] Read more...
March 24, 2026CED Clinical Relevance  #100High Clinical Relevance  Strong evidence or policy relevance with direct clinical implications. 📋 Clinical Insight  |  CED Clinic MenopauseEndocannabinoid SystemWomen’S HealthHormonesVasomotor Symptoms Category Condition Deep Dive Audience Women in midlife Primary Topic Cannabis and menopause Why This Matters Menopause represents a profound endocrine transition affecting every physiological system, yet treatment options remain limited and often inadequate. The endocannabinoid system’s intimate relationship with estrogen regulation and its role in thermoregulation, sleep, mood, and pain processing makes understanding this intersection clinically essential for the 1.3 million women entering menopause annually in the US. Clinical Summary During menopause, declining estrogen levels directly impact endocannabinoid system function through multiple pathways. Estrogen enhances fatty acid amide hydrolase (FAAH) expression, which degrades anandamide, leading to potentially altered endocannabinoid tone as hormones fluctuate. The ECS plays documented roles in thermoregulation through hypothalamic CB1 receptors, sleep architecture via interactions with circadian pathways, and nociceptive processing in conditions like arthralgia. Observational studies suggest cannabis may address vasomotor symptoms, sleep disturbances, and mood changes, though randomized controlled trials remain limited. The heterogeneity of menopause presentations—from sudden surgical menopause to gradual perimenopause transitions—requires individualized approaches rather than universal protocols. Dr. Caplan’s Take “I’ve observed that women experiencing menopause often respond differently to cannabis than younger patients, likely reflecting the complex interplay between changing hormone levels and endocannabinoid function. Understanding each patient’s specific symptom constellation and hormonal status is more clinically relevant than applying broad generalizations about ‘cannabis for menopause.’” Clinical Perspective 🧠 Women should recognize that menopause symptoms result from specific physiological changes, not inevitable suffering that must be endured. When considering cannabis, focus discussions with your clinician on your individual symptom pattern—whether hot flashes, sleep disruption, joint pain, or mood changes—rather than seeking a one-size-fits-all menopause solution. Hormone replacement therapy, lifestyle modifications, and other evidence-based interventions should be part of any comprehensive discussion. Ask your provider about timing, dosing considerations, and potential interactions with any current treatments. 💬 Join the Conversation Have a question about how this applies to your situation? Ask Dr. Caplan → Want to discuss this topic with other patients and caregivers? Join the forum discussion → Have thoughts on this? Share it: 𝕏 Share on X in Share on LinkedIn 🦥 Share on BlueSky 📷 Follow on Instagram 📝 Read more on Substack 🔔 Subscribe via RSS 📰 Source: https://example.com/blog/menopause-the-ecs-and-why-physiology-matters-more-than-slogans-3 Frequently Asked Questions Why should clinicians care about this topic? A concept focused on menopause physiology, symptom patterns, and endocannabinoid system relevance. Where can patients learn more? Visit cedclinic.com for evidence-based cannabis medicine resources, clinical consultations, and educational content from Dr. Caplan and the CED team. How does this relate to the endocannabinoid system? The endocannabinoid system is a fundamental regulatory network throughout the body. Understanding how it functions is essential for evidence-based cannabis medicine practice. {“@context”: “https://schema.org”, “@type”: “Article”, “headline”: “Menopause, the ECS, and why physiology matters more than slogans #3”, “url”: “”, “about”: “menopause ecs why physiology matters more”} [...] Read more...
March 24, 20260 Category: Unknown Audience: example.com Primary topic: 2026-03-05T16:28:53.017885+00:00 Read the source concept Frequently Asked Questions Why should clinicians care about this topic? 0 Where can patients learn more? Visit cedclinic.com for evidence-based cannabis medicine resources, clinical consultations, and educational content from Dr. Caplan and the CED team. How does this relate to the endocannabinoid system? The endocannabinoid system is a fundamental regulatory network throughout the body. Understanding how it functions is essential for evidence-based cannabis medicine practice. {“@context”: “https://schema.org”, “@type”: “Article”, “headline”: “AI in medicine, where judgment still matters #5”, “url”: “”, “about”: “ai medicine where judgment still matters”} [...] Read more...
March 24, 20260 Category: Unknown Audience: example.com Primary topic: 2026-03-08T00:27:14.396188+00:00 Read the source concept Frequently Asked Questions Why should clinicians care about this topic? 0 Where can patients learn more? Visit cedclinic.com for evidence-based cannabis medicine resources, clinical consultations, and educational content from Dr. Caplan and the CED team. How does this relate to the endocannabinoid system? The endocannabinoid system is a fundamental regulatory network throughout the body. Understanding how it functions is essential for evidence-based cannabis medicine practice. {“@context”: “https://schema.org”, “@type”: “Article”, “headline”: “Why older adults deserve better cannabinoid care options #1”, “url”: “”, “about”: “why older adults deserve better cannabinoid”} [...] Read more...
March 24, 2026How to talk to patients about dose without sounding vague #10 A blog concept about improving cannabis dosing conversations with patients. Why this matters Practical clinician communication Who this is for health professionals Main topic cannabis dosing Supporting topics patient education, clinical care Evidence notes Emphasize self-awareness, product awareness, and dose-response variability. Call to action Offer clinicians a more useful framework than generic low-and-slow slogans. Original source Frequently Asked Questions Why should clinicians care about this topic? A blog concept about improving cannabis dosing conversations with patients. Where can patients learn more? Visit cedclinic.com for evidence-based cannabis medicine resources, clinical consultations, and educational content from Dr. Caplan and the CED team. How does this relate to the endocannabinoid system? The endocannabinoid system is a fundamental regulatory network throughout the body. Understanding how it functions is essential for evidence-based cannabis medicine practice. {“@context”: “https://schema.org”, “@type”: “Article”, “headline”: “How to talk to patients about dose without sounding vague #10”, “url”: “”, “about”: “how talk patients about dose without”} [...] Read more...
March 24, 20260 Category: Unknown Audience: example.com Primary topic: 2026-03-06T20:28:53.017885+00:00 Read the source concept Frequently Asked Questions Why should clinicians care about this topic? 0 Where can patients learn more? Visit cedclinic.com for evidence-based cannabis medicine resources, clinical consultations, and educational content from Dr. Caplan and the CED team. How does this relate to the endocannabinoid system? The endocannabinoid system is a fundamental regulatory network throughout the body. Understanding how it functions is essential for evidence-based cannabis medicine practice. {“@context”: “https://schema.org”, “@type”: “Article”, “headline”: “Menopause, the ECS, and why physiology matters more than slogans #3”, “url”: “”, “about”: “menopause ecs why physiology matters more”} [...] Read more...
March 24, 20260 Category: Unknown Audience: example.com Primary topic: 2026-03-07T10:28:53.017885+00:00 Read the source concept Frequently Asked Questions Why should clinicians care about this topic? 0 Where can patients learn more? Visit cedclinic.com for evidence-based cannabis medicine resources, clinical consultations, and educational content from Dr. Caplan and the CED team. How does this relate to the endocannabinoid system? The endocannabinoid system is a fundamental regulatory network throughout the body. Understanding how it functions is essential for evidence-based cannabis medicine practice. {“@context”: “https://schema.org”, “@type”: “Article”, “headline”: “Cannabis and sleep, what patients get wrong and what clinicians should explain #2”, “url”: “”, “about”: “cannabis sleep what patients get wrong”} [...] Read more...
March 24, 20260 Category: Unknown Audience: example.com Primary topic: 2026-03-05T16:27:14.396188+00:00 Read the source concept Frequently Asked Questions Why should clinicians care about this topic? 0 Where can patients learn more? Visit cedclinic.com for evidence-based cannabis medicine resources, clinical consultations, and educational content from Dr. Caplan and the CED team. How does this relate to the endocannabinoid system? The endocannabinoid system is a fundamental regulatory network throughout the body. Understanding how it functions is essential for evidence-based cannabis medicine practice. {“@context”: “https://schema.org”, “@type”: “Article”, “headline”: “AI in medicine, where judgment still matters #5”, “url”: “”, “about”: “ai medicine where judgment still matters”} [...] Read more...
March 24, 20260 Category: Unknown Audience: example.com Primary topic: 2026-03-07T10:27:14.396188+00:00 Read the source concept Frequently Asked Questions Why should clinicians care about this topic? 0 Where can patients learn more? Visit cedclinic.com for evidence-based cannabis medicine resources, clinical consultations, and educational content from Dr. Caplan and the CED team. How does this relate to the endocannabinoid system? The endocannabinoid system is a fundamental regulatory network throughout the body. Understanding how it functions is essential for evidence-based cannabis medicine practice. {“@context”: “https://schema.org”, “@type”: “Article”, “headline”: “Cannabis and sleep, what patients get wrong and what clinicians should explain #2”, “url”: “”, “about”: “cannabis sleep what patients get wrong”} [...] Read more...
March 24, 2026CED Clinical Relevance  #100High Clinical Relevance  Strong evidence or policy relevance with direct clinical implications. 📋 Clinical Insight  |  CED Clinic MenopauseEndocannabinoid SystemWomen’S HealthHormonesVasomotor Symptoms Category Condition Deep Dive Audience Women in midlife Primary Topic Cannabis and menopause Why This Matters Menopause represents a profound endocrine transition affecting every physiological system, yet treatment options remain limited and often inadequate. The endocannabinoid system’s intimate relationship with estrogen regulation and its role in thermoregulation, sleep, mood, and pain processing makes understanding this intersection clinically essential for the 1.3 million women entering menopause annually in the US. Clinical Summary During menopause, declining estrogen levels directly impact endocannabinoid system function through multiple pathways. Estrogen enhances fatty acid amide hydrolase (FAAH) expression, which degrades anandamide, leading to potentially altered endocannabinoid tone as hormones fluctuate. The ECS plays documented roles in thermoregulation through hypothalamic CB1 receptors, sleep architecture via interactions with circadian pathways, and nociceptive processing in conditions like arthralgia. Observational studies suggest cannabis may address vasomotor symptoms, sleep disturbances, and mood changes, though randomized controlled trials remain limited. The heterogeneity of menopause presentations—from sudden surgical menopause to gradual perimenopause transitions—requires individualized approaches rather than universal protocols. Dr. Caplan’s Take “I’ve observed that women experiencing menopause often respond differently to cannabis than younger patients, likely reflecting the complex interplay between changing hormone levels and endocannabinoid function. Understanding each patient’s specific symptom constellation and hormonal status is more clinically relevant than applying broad generalizations about ‘cannabis for menopause.’” Clinical Perspective 🧠 Women should recognize that menopause symptoms result from specific physiological changes, not inevitable suffering that must be endured. When considering cannabis, focus discussions with your clinician on your individual symptom pattern—whether hot flashes, sleep disruption, joint pain, or mood changes—rather than seeking a one-size-fits-all menopause solution. Hormone replacement therapy, lifestyle modifications, and other evidence-based interventions should be part of any comprehensive discussion. Ask your provider about timing, dosing considerations, and potential interactions with any current treatments. 💬 Join the Conversation Have a question about how this applies to your situation? Ask Dr. Caplan → Want to discuss this topic with other patients and caregivers? Join the forum discussion → Have thoughts on this? Share it: 𝕏 Share on X in Share on LinkedIn 🦥 Share on BlueSky 📷 Follow on Instagram 📝 Read more on Substack 🔔 Subscribe via RSS 📰 Source: https://example.com/blog/menopause-the-ecs-and-why-physiology-matters-more-than-slogans-3 Frequently Asked Questions Why should clinicians care about this topic? A concept focused on menopause physiology, symptom patterns, and endocannabinoid system relevance. Where can patients learn more? Visit cedclinic.com for evidence-based cannabis medicine resources, clinical consultations, and educational content from Dr. Caplan and the CED team. How does this relate to the endocannabinoid system? The endocannabinoid system is a fundamental regulatory network throughout the body. Understanding how it functions is essential for evidence-based cannabis medicine practice. {“@context”: “https://schema.org”, “@type”: “Article”, “headline”: “Menopause, the ECS, and why physiology matters more than slogans #3”, “url”: “”, “about”: “menopause ecs why physiology matters more”} [...] Read more...
March 24, 2026The endocannabinoid system is not fringe biology #9 A blog concept explaining the ECS as foundational physiology rather than novelty science. Why this matters Physiology first Who this is for curious health readers Main topic endocannabinoid system Supporting topics homeostasis, education, clinical relevance Evidence notes Frame ECS as a real regulatory network with broad physiologic relevance. Call to action Encourage readers to rethink how the body maintains balance. Original source Frequently Asked Questions Why should clinicians care about this topic? Where can patients learn more? Visit cedclinic.com for evidence-based cannabis medicine resources, clinical consultations, and educational content from Dr. Caplan and the CED team. How does this relate to the endocannabinoid system? The endocannabinoid system is a fundamental regulatory network throughout the body. Understanding how it functions is essential for evidence-based cannabis medicine practice. {“@context”: “https://schema.org”, “@type”: “Article”, “headline”: “”, “url”: “”, “about”: “blog topic”} [...] Read more...
March 24, 2026Why older adults deserve better cannabinoid care options #8 A blog concept focused on senior care, access gaps, and the role of individualized cannabinoid medicine. Why this matters Access and dignity in aging care Who this is for older adults and caregivers Main topic senior cannabis care Supporting topics access, medicare, pain, sleep Evidence notes Include clinical context for pain, sleep, and medication burden. Call to action Invite discussion about care barriers for seniors. Original source Frequently Asked Questions Why should clinicians care about this topic? Where can patients learn more? Visit cedclinic.com for evidence-based cannabis medicine resources, clinical consultations, and educational content from Dr. Caplan and the CED team. How does this relate to the endocannabinoid system? The endocannabinoid system is a fundamental regulatory network throughout the body. Understanding how it functions is essential for evidence-based cannabis medicine practice. {“@context”: “https://schema.org”, “@type”: “Article”, “headline”: “”, “url”: “”, “about”: “blog topic”} [...] Read more...
March 24, 2026What cannabis headlines miss about careful clinical interpretation #7 A blog concept about reading cannabis studies carefully instead of reacting to sensational headlines. Why this matters Nuance over alarmism Who this is for general informed audience Main topic study interpretation Supporting topics risk communication, evidence quality Evidence notes Use observational study nuance and causal language caution. Call to action Encourage readers to distinguish association from causation. Original source Frequently Asked Questions Why should clinicians care about this topic? Where can patients learn more? Visit cedclinic.com for evidence-based cannabis medicine resources, clinical consultations, and educational content from Dr. Caplan and the CED team. How does this relate to the endocannabinoid system? The endocannabinoid system is a fundamental regulatory network throughout the body. Understanding how it functions is essential for evidence-based cannabis medicine practice. {“@context”: “https://schema.org”, “@type”: “Article”, “headline”: “”, “url”: “”, “about”: “blog topic”} [...] Read more...
March 24, 2026When cannabis journalism confuses correlation with causation #6 A blog concept about how media framing distorts the meaning of cannabis research. Why this matters Media literacy in medicine Who this is for broad educated audience Main topic media interpretation Supporting topics epidemiology, public fear, study reading Evidence notes Use examples from cross-sectional and observational work. Call to action Invite readers to slow down before accepting overclaiming headlines. Original source Frequently Asked Questions Why should clinicians care about this topic? Where can patients learn more? Visit cedclinic.com for evidence-based cannabis medicine resources, clinical consultations, and educational content from Dr. Caplan and the CED team. How does this relate to the endocannabinoid system? The endocannabinoid system is a fundamental regulatory network throughout the body. Understanding how it functions is essential for evidence-based cannabis medicine practice. {“@context”: “https://schema.org”, “@type”: “Article”, “headline”: “”, “url”: “”, “about”: “blog topic”} [...] Read more...
March 24, 2026Why product labels still fail too many patients #5 A blog concept about labeling confusion and the real-world consequences for patients. Why this matters The gap between packaging and real understanding Who this is for patients and policy-aware readers Main topic product labeling Supporting topics dispensaries, consumer safety, education Evidence notes Tie labeling confusion to patient outcomes, safety, and product selection errors. Call to action Prompt readers to demand clearer labels and better support. Original source Frequently Asked Questions Why should clinicians care about this topic? Where can patients learn more? Visit cedclinic.com for evidence-based cannabis medicine resources, clinical consultations, and educational content from Dr. Caplan and the CED team. How does this relate to the endocannabinoid system? The endocannabinoid system is a fundamental regulatory network throughout the body. Understanding how it functions is essential for evidence-based cannabis medicine practice. {“@context”: “https://schema.org”, “@type”: “Article”, “headline”: “”, “url”: “”, “about”: “blog topic”} [...] Read more...
March 23, 2026CED Clinic evidence review What This Lancet Review Really Says About Cannabinoids in Psychiatry A physician-guided reading of a new randomized-trial synthesis, with close attention to what was studied, what was not, and where public interpretation may run wider than the data. Read the study Related mental health context  Study type: Systematic review and meta-analysis of randomized trials Trials included: 54 Total participants: 2,477 Main tension: Real clinical interest, thinner evidence than many assume A new Lancet review raises useful questions, but cleaner questions are still needed. TL;DR This new Lancet review pooled 54 randomized trials and found a thin, uneven evidence base for cannabinoids in mental disorders and substance use disorders. A few signals appeared in cannabis use disorder, sleep-time outcomes in insomnia, tic severity, and autism-related measures. Most outcomes were low certainty, and 44% of included trials were high risk of bias. All-cause adverse events were more common, while serious adverse events and withdrawals were not clearly higher. The fairest takeaway: this paper does not show that cannabinoids never help. It shows that current psychiatric evidence is narrower and shakier than many claims suggest. What You’ll Learn in This Post 🧠 What this Lancet review actually studied Rather than what people may assume it studied. 📊 Which conditions showed signals And which mental health and substance-use conditions did not. 🧪 Why study design details matter Especially exposure definition, trial length, and outcome selection. ⚖️ What the paper can responsibly support And where its closing language may run wider than the data. 🩺 How clinicians and patients can think about this review Without fear, hype, or false certainty. Why this paper matters right now Cannabinoids for mental disorders sit in an unusually noisy part of medicine. Patient experience, mechanistic plausibility, product marketing, public controversy, and randomized evidence often get blended together as though they carry equal weight. They do not. This review matters because it tries to separate those layers. It asks a more disciplined question: what do randomized controlled trials actually show when plant-based or pharmaceutical cannabinoids are used as treatment for mental disorders or substance use disorders? That is a narrower question than most headlines will imply, and it is exactly why the paper is worth reading carefully. Bottom line up front: the paper is stronger at showing how limited the evidence base still is than at proving that every psychiatric cannabinoid use case is misguided. What this review actually studied This was not a review of all real-world cannabis use for mental health. It was a review of randomized controlled trials in which plant-based or pharmaceutical cannabinoids were used as the primary treatment for mental disorders or substance use disorders. That distinction matters because a short placebo-controlled trial of a specific oral product is not the same thing as individualized, longitudinal cannabinoid care. The paper included 54 randomized trials with 2,477 participants overall. Treatments were usually brief, averaging about five weeks. Products varied, but the review distinguished among CBD, THC, and mixed THC/CBD formulations rather than treating every cannabinoid exposure as identical. Population Participants with mental disorders or substance use disorders across 54 randomized trials. Exposure CBD, THC, and mixed THC/CBD formulations, usually as primary treatment. Comparator Mostly placebo, with some active comparators or alternative control conditions. Time horizon Usually short, with average treatment duration around five weeks. Not every cannabinoid formulation is the same treatment. Where cannabinoids for mental disorders showed signals, and where they did not The broad pattern was not impressive. No significant pooled benefit emerged for anxiety disorders, psychotic disorders, post-traumatic stress disorder, anorexia nervosa, or opioid use disorder. There were insufficient data to meta-analyze ADHD, bipolar disorder, obsessive-compulsive disorder, or tobacco use disorder, and there was no randomized evidence at all for depression treatment. That matters because some of those conditions, especially anxiety, PTSD, and sleep complaints, are among the most common reasons people talk about cannabinoids in psychiatric care. The gap here is not subtle. It is the distance between how often cannabinoids are discussed and how much randomized evidence clearly supports that discussion. At the same time, the review did not come back entirely empty. Favorable signals appeared in cannabis use disorder, especially for withdrawal symptoms and cannabis-use outcomes, in insomnia-related sleep-time outcomes, in tic or Tourette syndrome, and in autism-related measures. Those signals deserve attention. They do not justify a sweeping victory lap. The key tension: some positive signals exist, but many rest on low or very low certainty evidence, small samples, short follow-up, or all three. A signal is not the same thing as a settled standard of care. Why exposure definition changes the meaning of the result One of the better features of this review is that it does not fully collapse CBD, THC, and mixed formulations into one undifferentiated category. Even so, the evidence base remains heterogeneous in ways that matter clinically. Dose, route, formulation, treatment goal, prior cannabis exposure, and whether a product is being used as primary or adjunctive therapy can all change the meaning of the outcome. That is why a broad conclusion about cannabinoids for mental disorders can easily sound firmer than the underlying literature really is. A null pooled result for a heterogeneous class is not always the same thing as a cleanly negative answer for every product-condition pair. The reverse is true too. A small favorable result for one setting does not validate a whole therapeutic category. This is one reason study-interpretation literacy matters so much in cannabinoid medicine. Definitions are not housekeeping. They are the study. Why trial length and outcome selection matter so much here Most studies in the review were short. That may be enough to detect early symptom change, but it is not enough to fully understand durability, tolerance, dependence risk, functional tradeoffs, or whether the early benefit continues to matter after the novelty of treatment fades. The insomnia findings offer a useful example. Sleep time improved in some analyses, which is meaningful. But broader insomnia outcomes were not uniformly strong. Sleeping longer and actually resolving insomnia are related, but not identical. The same principle applies across psychiatric care. A measured signal on one endpoint is not the same thing as broad syndrome-level confidence. Outcome selection shapes the story people think they are hearing. If the public hears “insomnia improved,” they may picture deep, restored sleep. What the trial may actually show is something narrower. Those distinctions deserve more respect than they usually get. Safety is part of the story, but not the whole story The review found higher odds of all-cause adverse events with cannabinoids. That matters. It should not be waved away. At the same time, serious adverse events and study withdrawals were not clearly higher in pooled analyses, which makes the safety picture more nuanced than a simple danger headline would suggest. In clinical life, many treatments fail not because they are catastrophic, but because the tradeoff does not feel worth it. Sedation, dizziness, cognitive slowing, gastrointestinal discomfort, anxiety, or a sense of functional drag can all matter quite a lot even when a treatment does not generate a sharp signal for severe events. That is especially true in psychiatry, where the question is often whether a patient feels and functions better, not just whether a symptom scale moved. What this study does not show It does not show that all cannabinoids fail in psychiatry. It also does not show that cannabinoids are broadly validated for psychiatric care. Those are the two most predictable distortions, and both go further than the paper can responsibly support. It does not show that a short randomized trial of a specific cannabinoid product should be treated as equivalent to individualized, physician-guided, longitudinal care. It also does not show that individualized care automatically succeeds where randomized evidence is weak. The more honest answer is less satisfying: this remains a field with pockets of promise inside an evidence base that is still immature and uneven. It also does not answer several important questions because the randomized literature is simply too thin. Depression is the clearest example. Absence of evidence is not proof of failure. It is an evidence gap, and good interpretation keeps those two ideas separate. Where the closing language may run wider than the data The authors conclude that routine cannabinoid use for mental disorders and substance use disorders is currently rarely justified. I understand why that sentence appears in the paper. The randomized evidence base is thin, uneven, and often low certainty. Still, that sentence is broader than some of the underlying product-specific signals. It works best as a policy-level caution, or as a warning against enthusiastic overgeneralization. It works less well as a total bedside rule that erases formulation-specific nuance, indication-specific signals, or carefully bounded clinical judgment. Two things can be true at once. The literature is weaker than many enthusiasts suggest. The final sentence of the paper is broader than the narrowest, most defensible reading of the underlying evidence. How clinicians and patients should think about this review now The most responsible response is humility, not hype and not panic. Cannabinoids for mental disorders remain a topic where precision matters more than rhetoric. Product selection matters. Route matters. Outcome definition matters. Follow-up matters. So does honesty about the limits of what the literature can currently support. For clinicians, the paper raises the bar for precision and documentation. For patients, it is a reminder that feeling helped and proving efficacy are not the same thing, even though both deserve respect. The safest place to stand is usually the middle ground, where evidence gaps are acknowledged and overclaiming is unwelcome. Key study parameters at a glance Study Wilson J, Dobson O, Langcake A, et al. Lancet Psychiatry. 2026. Population 2,477 participants across 54 randomized trials. Exposure CBD, THC, and mixed cannabinoid formulations. Comparator Mostly placebo. Primary outcome frame Remission or reduction in disorder-specific symptoms. Follow-up window Usually short, averaging about five weeks. Main finding Sparse overall evidence, a few condition-specific signals, and more all-cause adverse events. Primary limitation Heterogeneous products, short trials, and low-certainty evidence across many outcomes. A guided pathway for readers who want more context For broader psychiatric context Cannabis and psychiatric disorders offers a wider frame for how these questions have been discussed across conditions. For foundational mental health framing Cannabis and mental health helps place study findings inside a broader clinical conversation without flattening nuance. For the sleep question This CBD sleep trial review is useful if the insomnia signal is the piece you want to read more carefully. For substitution and tradeoffs This substitution discussion addresses a different clinical question than placebo-controlled efficacy trials do. For tic and Tourette nuance This Tourette syndrome page may help if the tic-related findings are the most relevant part of the review for you. Good clinical judgment begins where overconfident conclusions end. Frequently asked questions What did this Lancet review actually study? It reviewed randomized controlled trials in which plant-based or pharmaceutical cannabinoids were used as treatment for mental disorders or substance use disorders. That is narrower than asking whether all forms of cannabis help all psychiatric symptoms in real-world care. The distinction matters because trial-tested products, routes, and durations are much more specific than the public conversation usually is. Did the review find benefit for anxiety disorders? No significant pooled benefit was found for anxiety disorders in this review. That does not mean cannabinoids can never help anxiety in any patient. It means the randomized evidence gathered here did not support a clear pooled benefit strong enough to carry broad conclusions. Did the review find benefit for PTSD? No significant pooled benefit was found for post-traumatic stress disorder. The more important point is that the PTSD literature remains relatively small, which limits confidence in either direction. Lack of clear evidence is not identical to proof of no effect. Which conditions showed the strongest signals? The clearest favorable signals appeared in cannabis use disorder, insomnia-related sleep-time outcomes, tic or Tourette syndrome, and autism-related measures. Even there, much of the supporting evidence was low or very low certainty. These findings are better read as limited signals than as settled standards of care. Were cannabinoids more dangerous in the review? All-cause adverse events were more common with cannabinoids than with control conditions. Serious adverse events and study withdrawals were not clearly higher in pooled analyses. That pattern argues for caution and precision, not alarmism. Why does trial length matter so much? Most of the included trials were short, averaging about five weeks. Psychiatric care usually unfolds over much longer horizons. Short studies can capture early symptom change, but they do a weaker job showing durability, tolerance, dependence risk, functional tradeoffs, and longer-term value. Does this review settle the question of medical cannabis and mental health? No. It narrows the question, which is valuable, but it does not settle it. The paper is strongest as a summary of randomized evidence for specific cannabinoid interventions used in specific ways, not as a universal verdict on every real-world psychiatric use case. What is the biggest public risk in how this paper may be used? The likeliest misuse is oversimplification. Some readers will say the paper proves cannabinoids do not help mental health, while others will cherry-pick the positive signals and ignore the low certainty. Neither reading is especially careful, and both flatten the real message. Why do formulation differences matter so much? CBD, THC, and mixed THC/CBD products are not clinically interchangeable. Different ratios, doses, routes, and treatment goals can lead to meaningfully different effects and side-effect profiles. Pooling them under a broad cannabinoid umbrella helps with synthesis, but it can blur clinically important distinctions. What is the fairest takeaway for clinicians and patients? The fairest takeaway is that psychiatric cannabinoid care remains ahead of the strongest evidence base in many indications. That does not make every use unreasonable, but it does raise the bar for caution, documentation, product matching, and follow-up. The paper supports more careful medicine, not louder rhetoric. References Wilson J, Dobson O, Langcake A, et al. The efficacy and safety of cannabinoids for the treatment of mental disorders and substance use disorders: a systematic review and meta-analysis. Lancet Psychiatry. 2026;13:304-315. DOI Black N, Stockings E, Campbell G, et al. Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis. Lancet Psychiatry. 2019;6(12):995-1010. PubMed Hindley G, Beck K, Borgan F, et al. Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis. Lancet Psychiatry. 2020;7(4):344-353. PubMed This post is an evidence interpretation piece, not individualized medical advice. The point is not to flatten complexity. It is to restore it where public conversation tends to lose it. [...] Read more...
March 23, 2026CED Clinical Relevance  #72Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. 🔬 Evidence Watch  |  CED Clinic HematologyTransfusion MedicineThcCbdPlatelet Function Journal Platelets Study Type Pilot Study Population Human participants Why This Matters This pilot study addresses a critical knowledge gap in transfusion medicine as cannabis use becomes increasingly prevalent among blood donors. Understanding how cannabis components affect platelet function could inform donor screening protocols and transfusion safety guidelines. Clinical Summary Researchers exposed human platelets in vitro to cannabis joint extracts with different THC:CBD ratios – one balanced (10.4% THC, 14.7% CBD) and one THC-dominant (25.5% THC, 0.04% CBD). The study measured platelet activation markers, mitochondrial function, aggregation responses, and inflammatory mediator release to assess potential impacts on platelet quality and hemostatic function. Results showed dose-dependent effects on platelet activation and mitochondrial function, with CB1/CB2 receptor involvement and p38 MAPK pathway activation. This preliminary work provides mechanistic insights but represents early-stage research with inherent limitations of in vitro methodology. Dr. Caplan’s Take “While this research identifies important mechanistic pathways, the clinical relevance remains unclear given the artificial laboratory conditions and lack of correlation with actual donor cannabis use patterns. We need real-world studies examining platelet function in cannabis-using donors before drawing clinical conclusions.” Clinical Perspective 🧠 Clinicians should be aware that this research is exploratory and does not yet justify changes in donor screening or transfusion practices. However, it highlights the need for systematic investigation of cannabis effects on blood products as legalization expands the donor pool of cannabis users. 💬 Join the Conversation Have a question about how this applies to your situation? Ask Dr. Caplan → Want to discuss this topic with other patients and caregivers? Join the forum discussion → Have thoughts on this? Share it: 𝕏 Share on Xin Share on LinkedIn🦥 Share on BlueSky📷 Follow on Instagram📝 Read more on Substack🔔 Subscribe via RSS 📰 Source: https://pubmed.ncbi.nlm.nih.gov/41870043/ FAQ This study item was assembled from normalized source metadata and pipeline scoring. {“@context”: “https://schema.org”, “@type”: “ScholarlyArticle”, “headline”: “Pilot study on cannabis-induced alterations in platelet function: implications for transfusion medicine.”, “url”: “https://pubmed.ncbi.nlm.nih.gov/41870043/”, “about”: “platelets pilot study pilot study cannabis”, “isPartOf”: “Platelets”} [...] Read more...
March 23, 2026CED Clinical Relevance  #56Monitored Relevance  Early-stage or contextual signal requiring further evidence before action. 🔬 Evidence Watch  |  CED Clinic ObesityEndocannabinoidCb1MetabolismPreclinical Journal Frontiers in nutrition Study Type Clinical Study Population Human participants Why This Matters This study provides mechanistic insight into how taurine may combat obesity through modulation of the endocannabinoid system, specifically CB1 receptors in adipose tissue. Understanding this pathway could inform therapeutic approaches that target both metabolic dysfunction and endocannabinoid dysregulation in obesity. Clinical Summary Researchers used high-fat diet-induced obese mice treated with taurine (700 mg/kg/day) for 14 weeks, combined with metabolomics analysis of epididymal white adipose tissue and 3T3-L1 adipocyte spheroid studies. The study found that taurine attenuated lipid accumulation in adipocytes through modulation of the endocannabinoid-CB1 receptor axis. Metabolomics revealed that taurine countered HFD-induced metabolic disturbances specifically in adipose tissue. The mechanism appears to involve taurine’s interaction with CB1 signaling pathways that regulate lipid metabolism in fat cells. Dr. Caplan’s Take “This preclinical work adds to our understanding of how nutritional interventions might modulate endocannabinoid signaling in metabolic disease. While intriguing mechanistically, we need human clinical data before drawing therapeutic conclusions about taurine supplementation for obesity management.” Clinical Perspective 🧠 Clinicians should recognize this as early-stage mechanistic research that may inform future therapeutic strategies but does not yet support clinical recommendations for taurine supplementation in obesity treatment. Patients interested in taurine should be counseled that while this research is promising, established lifestyle interventions remain the cornerstone of obesity management. 💬 Join the Conversation Have a question about how this applies to your situation? Ask Dr. Caplan → Want to discuss this topic with other patients and caregivers? Join the forum discussion → Have thoughts on this? Share it: 𝕏 Share on Xin Share on LinkedIn🦥 Share on BlueSky📷 Follow on Instagram📝 Read more on Substack🔔 Subscribe via RSS 📰 Source: https://pubmed.ncbi.nlm.nih.gov/41867680/ FAQ This study item was assembled from normalized source metadata and pipeline scoring. {“@context”: “https://schema.org”, “@type”: “ScholarlyArticle”, “headline”: “Taurine attenuates lipid accumulation via the eCB-CB1 axis: evidence from adipose metabolomics in HFD-fed mice and 3D adipocyte spheroids.”, “url”: “https://pubmed.ncbi.nlm.nih.gov/41867680/”, “about”: “frontiers nutrition clinical study taurine attenuates”, “isPartOf”: “Frontiers in nutrition”} [...] Read more...
March 23, 2026CED Regulatory Digest, Since Last Digest, 2 items This digest groups recent regulatory items selected by the CED Merge Engine. DEA scheduling and enforcement notice involving cannabis policy #1 A Federal Register item involving scheduling, enforcement, or administrative interpretation relevant to cannabis policy. Original source DEA scheduling and enforcement notice involving cannabis policy #2 A Federal Register item involving scheduling, enforcement, or administrative interpretation relevant to cannabis policy. Original source FAQ This digest is algorithmically assembled from publish-ready regulatory records. {“@context”: “https://schema.org”, “@type”: “CollectionPage”, “name”: “CED Regulatory Digest, Since Last Digest, 2 items”, “about”: } [...] Read more...
March 20, 2026🩺 Physician-guided 🌸 Very early frontiers 📚 Evidence-bounded Cannabis Wellness Frontiers: 6 Emerging Areas Worth Watching, and What the Evidence Actually Shows Cannabis research is widening far beyond the old conversations about pain, nausea, and sleep. That does not mean every new idea deserves the same confidence. Some areas are truly promising. Some are biologically interesting but still early. Some are popular on social media long before they are mature enough for real clinical certainty. This guide is built to separate hope from hype, while still respecting the real questions patients bring into the room. Quick take TL;DR 🌿 This is not another giant list of vague “cannabis benefits.” It focuses on a small group of emerging cannabis wellness frontiers that deserve more careful attention. 🌿 Wound healing, endometriosis-related pain, trauma symptoms, brain injury recovery, menopause, intimacy, and creativity all generate real interest, but not equal levels of evidence. 🌿 Some of these topics are supported mainly by mechanistic, survey, or retrospective data rather than strong randomized human trials. 🌿 Patients are asking smart questions in these areas. Medicine should answer with curiosity and restraint, not dismissal and not overstatement. 🌿 The goal is not to flatten every topic into “cannabis works” or “cannabis does not work.” The goal is to think more clearly. What makes this different What You’ll Get From This Guide 🧭 A cleaner framework for reading frontier cannabis claims without getting carried away 🩹 A realistic look at cannabinoids and wound healing 🌸 A more clinically grounded discussion of endometriosis, menopause, and sexual wellness 🧠 Clearer boundaries around PTSD, brain injury recovery, and creativity claims 📖 A selected reading section that stays within peer-reviewed literature 🪞 Why This Blog Needed a Meaningfully Different Angle A lot of cannabis wellness writing still sounds like it was built from a template: list a condition, mention inflammation, sprinkle in the endocannabinoid system, and end with a soft promise that the plant may hold the answer. Readers deserve better than that. Real people do not search these topics as abstractions. They search them while dealing with a scar that is healing slowly, pelvic pain that keeps hijacking their week, a menopausal body that suddenly refuses to follow old rules, or a post-concussion brain that does not feel like home anymore. They want possibility, but they also want honesty. So this piece is built around frontier questions worth watching, not broad claims worth posting. That is a different job, and a more useful one. 🧪 How to Read Cannabis Frontier Research Without Overreading It Frontier medicine often comes with a familiar trap. The mechanism sounds plausible. Early findings look encouraging. The public conversation gets excited. Then people start speaking as though the treatment question is already settled. It usually is not. Stronger: randomized human trials Moderate: prospective controlled data Early: surveys and retrospective studies Very early: animal and mechanistic work If you keep that ladder in mind, cannabis claims become easier to interpret. A smart mechanism is not the same thing as a proven outcome. A patient report is not the same thing as a controlled trial. And a good hypothesis is not a finished clinical answer. Clinical takeaway: frontier science should expand your questions before it expands your conclusions. 🩹 1. Skin Wound Healing and Tissue Repair This is one of the more biologically intriguing frontiers. The skin is not just a covering. It is an active immune, sensory, and repair organ. Because cannabinoids interact with inflammatory and immune signaling, researchers have been exploring whether they may influence wound environments, pain, and tissue recovery. The appeal here is easy to understand. Slow healing can be frustrating, uncomfortable, visible, and emotionally draining. People do not just care whether tissue closes. They care whether it hurts, scars, itches, or keeps reminding them that their body is still struggling to recover. Why this is promising There is biologic plausibility, especially for topical cannabinoid approaches that may interact with inflammation and local symptom burden. Why caution still matters Human clinical data remain limited. This is promising territory, not settled standard-of-care territory. Most honest summary: cannabinoids and wound healing deserve serious study, but not sweeping claims. 🌸 2. Endometriosis and Reproductive Pain This is one of the most humanly relatable areas on the page. Patients with endometriosis often spend years in pain, years trying to be believed, and years assembling partial solutions from scattered appointments. It is not hard to see why interest in cannabis has grown here. There is a reasonable clinical rationale. Endometriosis can involve inflammatory pain, neuropathic features, cramping, sleep disruption, bowel symptoms, pelvic floor tension, and pain during intimacy. Cannabinoid pathways may intersect with some of those experiences. But the field still needs better human trials before broad efficacy claims deserve confidence. Why patients care Because pelvic pain is never just pain. It spills into work, movement, relationships, sex, sleep, and the basic logistics of everyday life. Where cannabis may fit Potentially as part of a broader symptom-management plan, especially when pain, sleep disruption, and medication burden overlap. 🫀 3. PTSD, Emotional Trauma, and Hypervigilant Nervous Systems This is one of the most emotionally charged cannabis topics, and one of the easiest to oversimplify. People living with trauma-related symptoms often describe a body that never really powers down. Sleep becomes fragile. Triggers become sharper. The nervous system acts as if danger is still present, even when the room is quiet. That makes the idea of cannabis feel intuitively appealing. Sometimes it may help some symptom clusters. But this is not a settled success story. The literature is mixed, and some populations may worsen or develop added concerns around problematic cannabis use. That is why this topic requires more clinical seriousness than internet certainty. Bottom line: cannabis and PTSD symptoms remain a real area of interest, but not one that supports casual overreassurance. 🧠 4. Traumatic Brain Injury and Concussion Recovery Few health changes feel as destabilizing as an injury to the brain. After a concussion or traumatic brain injury, people may not just be treating headaches. They may be trying to recover attention, patience, memory, sleep, sound tolerance, emotional steadiness, and the feeling that they are still themselves. Cannabinoids are interesting here because of their relevance to inflammatory signaling and neurobiology. But the main limitation is the kind of evidence available. Much of the discussion remains preclinical or retrospective. That makes this a legitimate research frontier, not a clinically finished answer. Why people are interested Because brain injury recovery is long, nonlinear, and still lacking enough helpful tools. Current confidence level Interesting, plausible, and still preliminary in humans. 🔥 5. Menopause, Intimacy, and Whole-Body Quality of Life This may be one of the clearest examples of patients outpacing the literature. Many peri- and postmenopausal people are already exploring cannabis for sleep disruption, mood shifts, discomfort, and libido changes. That does not make cannabis the answer. It does mean the question is clinically real. Menopause rarely arrives as a single symptom. It often shows up as a pileup of heat, poor sleep, irritability, body discomfort, vaginal dryness, shifting desire, and the subtle but maddening sense that your body has rewritten its own operating manual. That is exactly the kind of quality-of-life cluster that drives people to look for tools outside narrow conventional boxes. What the literature suggests There is growing survey-based interest and some signal for symptom support, but strong randomized efficacy data remain limited. Why this still matters Because quality of life matters, and because not every clinically meaningful question starts with a perfect trial. 💡 6. Creativity, Flow, and the Feeling of Mental Openness This may be the most culturally famous frontier on the page. Plenty of people report feeling more open, less self-critical, more associative, or more expressive with cannabis. That subjective experience is real. But feeling more creative is not the same thing as producing better creative work. That distinction matters. Some data suggest cannabis may alter people’s evaluation of creativity more than actual creativity itself. In plain English, the inner critic may soften before actual performance improves. For some people that can still matter, especially if perfectionism has become the bottleneck. But that is not the same as saying cannabis reliably improves problem-solving or artistic output. Most honest version: cannabis may change the experience of creativity more reliably than it improves creativity itself. 🚧 What This Article Does Not Show This article does not show that cannabis is proven to accelerate tissue regeneration, treat endometriosis, heal trauma, repair the injured brain, restore sexual function, solve menopause, or upgrade creativity on command. It also does not show that these topics are silly or imaginary. They are emerging fronts in a field that is still catching up to what patients have already been asking. That is exactly why the conversation deserves a disciplined tone. The right stance is simple: some of these areas are promising enough to explore carefully, but not mature enough to justify lazy certainty. 🧭 Questions Worth Asking Before Using Cannabis in Any Frontier Area What is the actual target? Pain, tissue irritation, sleep, nightmares, pelvic discomfort, intimacy, anxiety, sensory overload, or mental inhibition all call for different thinking. What kind of evidence supports this? Are we talking about randomized human studies, observational data, surveys, or mostly lab and animal work? What are the tradeoffs? Grogginess, anxiety, impaired concentration, dependency risk, poor product matching, and using the wrong tool for the wrong problem all belong in the discussion. What else needs real medical evaluation? Pelvic pain, trauma symptoms, concussion recovery, wound problems, and menopausal symptoms often deserve broader clinical workup too. Practical rule: a fascinating mechanism is an invitation to ask better questions, not a license to skip good medicine. FAQ Frequently Asked Questions What does “cannabis wellness frontiers” mean? It refers to emerging areas where cannabis or cannabinoids are being explored beyond the most established indications. These topics may be biologically plausible and clinically interesting, but they are often supported by early-stage or uneven evidence. Are cannabinoids proven for wound healing? Not yet. The area is promising, especially for topical exploration, but human evidence remains limited. Can cannabis help endometriosis pain? It may help some patients with symptom management, especially when pain and sleep disruption overlap, but the field still needs stronger trials. Is cannabis an established treatment for PTSD? No. The literature is mixed, and this topic requires more caution than simplified reassurance. Does cannabis improve creativity? It may change how creative ideas feel, but that is not the same as reliably improving actual creativity or output. Why are so many people interested in cannabis during menopause? Because menopause can affect sleep, mood, comfort, libido, and whole-body quality of life all at once, which naturally leads people to explore broader support tools. 🔗 Related CED Clinic Resources Women’s health and hormonal conditions Cannabis for pain Chronic pain and inflammation Cannabis for sleep Smart cannabis dosing Tinctures and oils Edibles and capsules Topicals and lotions Getting started with cannabis 📚 Selected Clinical Reading Parikh AC, Jeffery CS, Sandhu Z, Brownlee BP, Queimado L, Mims MM. The effect of cannabinoids on wound healing: A review. Health Sci Rep. 2024;7(2):e1908. doi:10.1002/hsr2.1908. Niyangoda D, Muayad M, Tesfaye W, et al. Cannabinoids in integumentary wound care: A systematic review of emerging preclinical and clinical evidence. Pharmaceutics. 2024;16(8):1081. doi:10.3390/pharmaceutics16081081. Cummings SC, Ennis N, Kloss K, Rosasco R. Evaluating the current evidence for the efficacy of cannabis in symptom management of endometriosis-associated pain. Integr Med Rep. 2024;3(1):111-117. doi:10.1089/imr.2024.0017. Rodas JD, George TP, Hassan AN. A systematic review of the clinical effects of cannabis and cannabinoids in posttraumatic stress disorder symptoms and symptom clusters. J Clin Psychiatry. 2024;85(1):23r14862. doi:10.4088/JCP.23r14862. Szaflarski JP, Szaflarski M. Traumatic brain injury outcomes after recreational cannabis use. Neuropsychiatr Dis Treat. 2024;20:809-821. doi:10.2147/NDT.S453616. Dahlgren MK, El-Abboud C, Lambros AM, Sagar KA, Smith RT, Gruber SA. A survey of medical cannabis use during perimenopause and postmenopause. Menopause. 2022;29(9):1028-1036. doi:10.1097/GME.0000000000002018. Lissitsa D, Hovers M, Shamuilova M, Ezrapour T, Peled-Avron L. Update on cannabis in human sexuality. Psychopharmacology (Berl). 2024;241(9):1721-1730. doi:10.1007/s00213-024-06643-4. Heng YT, Barnes CM, Yam KC. Cannabis use does not increase actual creativity but biases evaluations of creativity. J Appl Psychol. 2023;108(4):635-646. doi:10.1037/apl0000599. Next step Want Help Sorting Promise From Noise? The most useful cannabis conversation is rarely about the strongest product. It is usually about the actual target, the evidence behind it, your sensitivity, your goals, and which tradeoffs matter to you. That becomes even more important at the frontier. Schedule a first visit Read cannabis FAQs [...] Read more...
March 20, 2026CED Regulatory Digest, Since Last Digest, 14 items This digest groups recent regulatory items selected by the CED Merge Engine. FDA docket update on cannabinoid labeling guidance #9 A docket-related update affecting cannabinoid labeling, compliance posture, and agency comment review. Original source FDA docket update on cannabinoid labeling guidance #8 A docket-related update affecting cannabinoid labeling, compliance posture, and agency comment review. Original source FDA docket update on cannabinoid labeling guidance #7 A docket-related update affecting cannabinoid labeling, compliance posture, and agency comment review. Original source FDA docket update on cannabinoid labeling guidance #6 A docket-related update affecting cannabinoid labeling, compliance posture, and agency comment review. Original source FDA docket update on cannabinoid labeling guidance #19 A docket-related update affecting cannabinoid labeling, compliance posture, and agency comment review. Original source FDA docket update on cannabinoid labeling guidance #18 A docket-related update affecting cannabinoid labeling, compliance posture, and agency comment review. Original source FDA docket update on cannabinoid labeling guidance #17 A docket-related update affecting cannabinoid labeling, compliance posture, and agency comment review. Original source FDA docket update on cannabinoid labeling guidance #16 A docket-related update affecting cannabinoid labeling, compliance posture, and agency comment review. Original source FDA docket update on cannabinoid labeling guidance #15 A docket-related update affecting cannabinoid labeling, compliance posture, and agency comment review. Original source FDA docket update on cannabinoid labeling guidance #14 A docket-related update affecting cannabinoid labeling, compliance posture, and agency comment review. Original source FDA docket update on cannabinoid labeling guidance #13 A docket-related update affecting cannabinoid labeling, compliance posture, and agency comment review. Original source FDA docket update on cannabinoid labeling guidance #12 A docket-related update affecting cannabinoid labeling, compliance posture, and agency comment review. Original source FDA docket update on cannabinoid labeling guidance #11 A docket-related update affecting cannabinoid labeling, compliance posture, and agency comment review. Original source FDA docket update on cannabinoid labeling guidance #10 A docket-related update affecting cannabinoid labeling, compliance posture, and agency comment review. Original source FAQ This digest is algorithmically assembled from publish-ready regulatory records. {“@context”: “https://schema.org”, “@type”: “CollectionPage”, “name”: “CED Regulatory Digest, Since Last Digest, 14 items”, “about”: } [...] Read more...
Cannabis News
March 26, 2026Cannabis News✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic Dementia PreventionCognitive HealthLifestyle MedicineNeuroprotectionBrain Health Why This Matters This finding challenges the binary thinking around sedentary behavior and brain health, suggesting that cognitive engagement during sitting may provide neuroprotective benefits. For clinicians counseling patients about dementia prevention, this adds nuance to activity recommendations beyond simple movement prescriptions. Clinical Summary Research indicates that cognitively stimulating activities like reading and puzzles may offset some dementia risk associated with prolonged sitting. The mechanism likely involves maintaining neural plasticity and cognitive reserve through active mental engagement, even during physically sedentary periods. This finding doesn’t negate the importance of physical activity for brain health, but suggests that the quality of sedentary time matters as much as its quantity. Dr. Caplan’s Take “I see patients worry that any sitting is brain-damaging, but this research shows it’s more about what you’re doing while sitting. A patient reading or doing crosswords isn’t in the same risk category as someone passively watching television for hours.” Clinical Perspective 🧠 When counseling patients about dementia prevention, recommend active cognitive engagement during necessary sedentary periods rather than passive consumption. Ask patients specifically about their sedentary activities, not just duration. This doesn’t replace physical activity recommendations but offers a practical harm-reduction approach for patients with mobility limitations. 💬 Join the Conversation Have a question about how this applies to your situation? Ask Dr. Caplan → Want to discuss this topic with other patients and caregivers? Join the forum discussion → Have thoughts on this? Share it: 𝕏 Share on Xin Share on LinkedIn🦥 Share on BlueSky📷 Follow on Instagram📝 Read more on Substack🔔 Subscribe via RSS 📰 Source: https://www.medicalnewstoday.com/articles/reading-doing-puzzles-activating-brain-while-sitting-may-offset-dementia-risk FAQ What is the clinical relevance rating of this cannabis research? This study received a CED Clinical Relevance rating of #70, indicating “Notable Clinical Interest.” This means the findings represent emerging research or policy developments that healthcare professionals should monitor closely. What medical conditions does this cannabis research focus on? The research focuses on dementia prevention and cognitive health. It examines cannabis’s potential role in neuroprotection and maintaining brain function as part of lifestyle medicine approaches. Is this cannabis research considered new or established? This is classified as new research, as indicated by the “New” designation. It represents emerging findings in the field of cannabis and cognitive health that are still being evaluated. What type of medical approach does this cannabis research represent? This research falls under lifestyle medicine, which focuses on using evidence-based lifestyle interventions to prevent and treat disease. It explores how cannabis might be incorporated into preventive healthcare strategies for brain health. Should healthcare providers pay attention to these cannabis findings? Yes, the “Notable Clinical Interest” rating suggests healthcare providers should monitor these developments. While still emerging, the research may have implications for future clinical practice in dementia prevention and cognitive health management. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Reading, doing puzzles while sitting may help offset dementia risk”, “url”: “https://www.medicalnewstoday.com/articles/reading-doing-puzzles-activating-brain-while-sitting-may-offset-dementia-risk”, “datePublished”: “2026-03-26T15:00:54Z”, “about”: “reading doing puzzles while sitting may”} [...] Read more...
March 26, 2026Cannabis News✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic Not Applicable Why This Matters This appears to be a general police investigation with no apparent connection to cannabis medicine or clinical practice. Without cannabis-related content, this item does not warrant clinical commentary from a cannabis medicine perspective. Clinical Summary The provided news item describes a police investigation at a Rochester, NY intersection but contains no information related to cannabis, medical marijuana, or substance use disorders that would inform clinical practice. Dr. Caplan’s Take “I cannot provide meaningful clinical commentary on a news item that lacks any connection to cannabis medicine or patient care.” Clinical Perspective 🧠 This news item does not contain relevant clinical information for cannabis medicine practitioners or patients. Clinical commentary would be inappropriate without substance-related content. 💬 Join the Conversation Have a question about how this applies to your situation? Ask Dr. Caplan → Want to discuss this topic with other patients and caregivers? Join the forum discussion → Have thoughts on this? Share it: 𝕏 Share on Xin Share on LinkedIn🦥 Share on BlueSky📷 Follow on Instagram📝 Read more on Substack🔔 Subscribe via RSS 📰 Source: https://www.whec.com/top-news/police-investigation-underway-near-lyell-avenue-and-cameron-street/ FAQ What is the clinical relevance rating of this article? This article has been assigned CED Clinical Relevance #70, indicating “Notable Clinical Interest.” This rating suggests emerging findings or policy developments worth monitoring closely. Is this article related to cannabis medicine? No, this appears to be a general police investigation with no apparent connection to cannabis medicine or clinical practice. The article has been categorized as “Not Applicable” for cannabis-related content. Why was this article reviewed if it’s not cannabis-related? The article was likely reviewed as part of routine screening processes to determine relevance to cannabis medicine. After review, it was determined that the content does not warrant clinical commentary from a cannabis medicine perspective. What does “Notable Clinical Interest” mean? This classification indicates emerging findings or policy developments that are worth monitoring closely by healthcare professionals. It suggests the content may have indirect or future implications for clinical practice. Should clinicians take action based on this article? Since the article contains no cannabis-related content and is marked as “Not Applicable,” no specific clinical action is recommended. It appears to be included for informational monitoring purposes only. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Police investigation underway near Lyell Avenue and Cameron Street – WHEC.com”, “url”: “https://www.whec.com/top-news/police-investigation-underway-near-lyell-avenue-and-cameron-street/”, “datePublished”: “2026-03-26T14:53:31Z”, “about”: “police investigation underway near lyell avenue”} [...] Read more...
March 26, 2026Cannabis News✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic Regulatory PolicyPatient SafetySupply ChainBankingProduct Quality Why This Matters Banking restrictions force cannabis businesses into cash-heavy operations, creating supply chain vulnerabilities that can compromise product quality, testing protocols, and patient safety standards. These operational constraints directly impact the reliability and consistency of medical cannabis products reaching patients. Clinical Summary Federal banking regulations continue to limit cannabis businesses’ access to traditional financial services, forcing many operations to rely heavily on cash transactions. This creates operational inefficiencies in supply chain management, quality control processes, and inventory tracking systems. The resulting instability can affect product consistency, laboratory testing workflows, and overall safety protocols that patients depend on for reliable medical cannabis access. Dr. Caplan’s Take “These banking barriers aren’t just business inconveniences — they’re patient safety issues. When cannabis companies can’t operate with normal financial infrastructure, it creates downstream effects on the quality and reliability of the medicine my patients receive.” Clinical Perspective 🧠 Clinicians should be aware that banking restrictions may contribute to product inconsistencies or supply interruptions at dispensaries. Patients may benefit from maintaining relationships with multiple licensed dispensaries and understanding that cash-only operations, while legal, may indicate operational constraints that could affect product availability or consistency. 💬 Join the Conversation Have a question about how this applies to your situation? Ask Dr. Caplan → Want to discuss this topic with other patients and caregivers? Join the forum discussion → Have thoughts on this? Share it: 𝕏 Share on Xin Share on LinkedIn🦥 Share on BlueSky📷 Follow on Instagram📝 Read more on Substack🔔 Subscribe via RSS 📰 Source: https://mgmagazine.com/business-strategy/operations-supply-chain/cannabis-cash-management-banking-relationships/ FAQ What is the clinical relevance rating of this cannabis news update? This update has been assigned CED Clinical Relevance #70, indicating “Notable Clinical Interest.” This classification means the findings or policy developments are emerging and worth monitoring closely by healthcare professionals. What key areas does this cannabis news cover? The news covers four main areas: Regulatory Policy, Patient Safety, Supply Chain, and Banking. These represent critical aspects of the cannabis industry that impact clinical practice and patient care. Why is this cannabis news considered noteworthy for clinicians? The update focuses on emerging findings or policy developments that could affect clinical decision-making. Healthcare providers should monitor these developments as they may influence patient treatment options and safety protocols. How does this relate to patient safety in cannabis medicine? Patient safety is identified as one of the key focus areas in this update. This suggests the news contains information about safety protocols, adverse events, or regulatory changes that could impact patient care in cannabis medicine. What should healthcare providers do with this information? Healthcare providers should closely monitor these emerging developments as indicated by the “Notable Clinical Interest” rating. The information may influence clinical guidelines, patient counseling, or treatment protocols in cannabis medicine practice. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Cannabis Cash Management: What Banks Wish Operators Understood – mg Magazine”, “url”: “https://mgmagazine.com/business-strategy/operations-supply-chain/cannabis-cash-management-banking-relationships/”, “datePublished”: “2026-03-26T14:26:18Z”, “about”: “cannabis cash management what banks wish”} [...] Read more...
March 26, 2026Cannabis News✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic Not Applicable Why This Matters This appears to be geopolitical content about China’s energy strategy rather than cannabis medicine. There is no apparent clinical relevance to cannabis therapeutics or patient care. Clinical Summary The provided content discusses China’s energy policy and geopolitical strategy, with no mention of cannabis, medical marijuana, or therapeutic applications. This falls outside the scope of cannabis medicine and has no identifiable clinical implications for cannabinoid therapeutics. Dr. Caplan’s Take “I cannot provide meaningful clinical commentary on content that doesn’t relate to cannabis medicine or patient care.” Clinical Perspective 🧠 This content does not warrant clinical analysis as it lacks any connection to cannabis therapeutics, patient outcomes, or medical practice. Clinicians seeking cannabis-related guidance should focus on peer-reviewed research and clinical studies. 💬 Join the Conversation Have a question about how this applies to your situation? Ask Dr. Caplan → Want to discuss this topic with other patients and caregivers? Join the forum discussion → Have thoughts on this? Share it: 𝕏 Share on Xin Share on LinkedIn🦥 Share on BlueSky📷 Follow on Instagram📝 Read more on Substack🔔 Subscribe via RSS 📰 Source: https://www.youtube.com/watch?v=ASjAYcdkwR0 FAQ What is the clinical relevance rating for this article? This article has been assigned CED Clinical Relevance #70, indicating “Notable Clinical Interest.” This rating suggests emerging findings or policy developments worth monitoring closely. Does this article relate to cannabis medicine? No, despite being categorized under “Cannabis News,” this article appears to be about geopolitical content regarding China’s energy strategy. There is no apparent clinical relevance to cannabis therapeutics or patient care. Why was this article flagged if it’s not about cannabis? This appears to be a categorization error or misclassification. The content does not align with cannabis medicine topics that would typically be relevant to CED Clinic. What does the “Not Applicable” tag indicate? The “Not Applicable” tag suggests that standard cannabis medicine categories or classifications do not apply to this content. This further supports that the article may have been miscategorized. Should healthcare providers be concerned about this article’s clinical implications? No, since this article discusses geopolitical energy matters rather than cannabis therapeutics, it has no direct clinical implications for patient care. Healthcare providers can disregard this content for clinical decision-making purposes. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “What Is China’s $547 Billion Plan To Escape Global Energy Crisis? | Strait Of Hormuz”, “url”: “https://www.youtube.com/watch?v=ASjAYcdkwR0”, “datePublished”: “2026-03-26T14:20:44Z”, “about”: “what china s 547 billion plan”} [...] Read more...
March 26, 2026Cannabis News✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic PharmaceuticalsDrug DeliveryIndustryProduct Access Why This Matters Corporate expansion announcements from cannabis pharmaceutical companies signal potential changes in product availability and formulation options for patients. Understanding which delivery mechanisms and formulations are scaling can inform clinical decision-making about patient access to specific therapeutic products. Clinical Summary Rapid Dose Therapeutics appears to be announcing strategic expansion, though specific clinical details about their cannabis pharmaceutical products or delivery systems are not provided in this corporate announcement. Without access to the actual clinical data or product specifications, the therapeutic implications remain unclear. Corporate growth does not necessarily correlate with clinical efficacy or improved patient outcomes. Dr. Caplan’s Take “I need to see actual clinical data and product specifications before this corporate announcement has any meaningful impact on how I counsel patients or prescribe cannabis therapeutics.” Clinical Perspective 🧠 Clinicians should focus on evidence-based product selection rather than corporate growth metrics when advising patients. When evaluating any cannabis pharmaceutical company’s products, prioritize peer-reviewed efficacy data, consistent dosing profiles, and established safety records over business expansion announcements. 💬 Join the Conversation Have a question about how this applies to your situation? Ask Dr. Caplan → Want to discuss this topic with other patients and caregivers? Join the forum discussion → Have thoughts on this? Share it: 𝕏 Share on Xin Share on LinkedIn🦥 Share on BlueSky📷 Follow on Instagram📝 Read more on Substack🔔 Subscribe via RSS 📰 Source: https://www.newsfilecorp.com/release/290053/Rapid-Dose-Therapeutics-Reinforces-Strategic-Strength-and-Global-Growth-Trajectory FAQ What is the clinical relevance rating of this cannabis news? This article has been assigned a CED Clinical Relevance rating of #70, categorized as “Notable Clinical Interest.” This rating indicates emerging findings or policy developments that are worth monitoring closely by healthcare professionals. What type of cannabis-related content does this article cover? The article focuses on pharmaceuticals, drug delivery systems, industry developments, and product access issues related to cannabis. These categories suggest coverage of medical cannabis products and their clinical applications. Who is the target audience for this information? This content is primarily intended for healthcare professionals and clinicians who need to stay informed about cannabis-related medical developments. The clinical relevance rating system indicates it’s designed for medical decision-making purposes. What does the “Notable Clinical Interest” designation mean? This designation indicates that the information represents emerging findings or policy developments in cannabis medicine. It suggests the content is significant enough to warrant close monitoring by healthcare providers but may not yet be established practice. Is this information about recreational or medical cannabis? Based on the clinical relevance rating and pharmaceutical focus, this appears to be about medical cannabis applications. The emphasis on drug delivery, pharmaceuticals, and clinical interest indicates a medical rather than recreational context. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Rapid Dose Therapeutics Reinforces Strategic Strength and Global Growth Trajectory”, “url”: “https://www.newsfilecorp.com/release/290053/Rapid-Dose-Therapeutics-Reinforces-Strategic-Strength-and-Global-Growth-Trajectory”, “datePublished”: “2026-03-26T13:18:10Z”, “about”: “rapid dose therapeutics reinforces strategic strength”} [...] Read more...
March 26, 2026Cannabis News✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic Not ApplicableOff TopicNon-Medical Why This Matters This appears to be a sports news item about rugby rather than cannabis-related medical content. Without cannabis medicine relevance, this falls outside my clinical commentary scope. Clinical Summary The provided news item discusses a rugby match and Junior Cup final, with no apparent connection to cannabis medicine, therapeutic applications, or clinical research. No medical findings, mechanisms, or clinical context can be extracted from this sports coverage. Dr. Caplan’s Take “I need cannabis-related medical content to provide meaningful clinical commentary. Sports news, while potentially interesting, doesn’t inform patient care decisions or clinical practice in cannabis medicine.” Clinical Perspective 🧠 Healthcare providers and patients seeking evidence-based cannabis medicine information should focus on peer-reviewed research, clinical trials, and regulatory developments rather than unrelated news content. 💬 Join the Conversation Have a question about how this applies to your situation? Ask Dr. Caplan → Want to discuss this topic with other patients and caregivers? Join the forum discussion → Have thoughts on this? Share it: 𝕏 Share on Xin Share on LinkedIn🦥 Share on BlueSky📷 Follow on Instagram📝 Read more on Substack🔔 Subscribe via RSS 📰 Source: https://www.irishexaminer.com/sport/rugby/arid-41816717.html FAQ What is the CED Clinical Relevance rating system? The CED Clinical Relevance system appears to be a classification method that rates clinical findings and developments. This article received a rating of #70, indicating “Notable Clinical Interest” for emerging findings worth monitoring closely. What type of content does this article cover? This is a cannabis-related news article from CED Clinic. It’s tagged as non-medical content that may be off-topic or not directly applicable to clinical practice. What does “Notable Clinical Interest” mean? “Notable Clinical Interest” refers to emerging findings or policy developments in the cannabis field that are worth monitoring closely. These developments may have potential future implications for clinical practice or policy. Is this article directly relevant to medical cannabis treatment? Based on the tags, this article appears to be non-medical content that may not be directly applicable to clinical cannabis treatment. It’s categorized as potentially off-topic for medical practitioners. How should healthcare providers interpret this information? Healthcare providers should view this as background information worth monitoring rather than direct clinical guidance. The content represents emerging developments that may influence future cannabis policy or research directions. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “‘We’re weirdly happy’: Munchin’s battle back to force Junior Cup final replay with CBC”, “url”: “https://www.irishexaminer.com/sport/rugby/arid-41816717.html”, “datePublished”: “2026-03-26T13:03:53Z”, “about”: “we re weirdly happy munchin s”} [...] Read more...
March 26, 2026Cannabis News✦ New CED Clinical Relevance  #76Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic Mental HealthResearch QualityClinical EvidencePatient Safety Why This Matters The incomplete title and social media source make this difficult to evaluate clinically. Without access to the actual study methodology, population characteristics, and outcome measures, clinicians cannot assess the validity or applicability of these findings to patient care. Clinical Summary The provided information is insufficient to offer a meaningful clinical summary. The truncated title mentions anxiety, depression, and PTSD outcomes, but without the complete study details, sample size, methodology, or peer-review status, no clinical conclusions can be drawn. Social media posts frequently misrepresent or oversimplify complex clinical research. Dr. Caplan’s Take “I cannot provide clinical guidance based on a Facebook post with an incomplete title. When evaluating cannabis research claims, I need to see the actual peer-reviewed data, not social media interpretations.” Clinical Perspective 🧠 Clinicians should seek primary sources when evaluating cannabis research claims. Any decisions about cannabis therapy for anxiety, depression, or PTSD should be based on peer-reviewed literature, individual patient assessment, and careful risk-benefit analysis rather than social media posts or incomplete summaries. 💬 Join the Conversation Have a question about how this applies to your situation? Ask Dr. Caplan → Want to discuss this topic with other patients and caregivers? Join the forum discussion → Have thoughts on this? Share it: 𝕏 Share on Xin Share on LinkedIn🦥 Share on BlueSky📷 Follow on Instagram📝 Read more on Substack🔔 Subscribe via RSS 📰 Source: https://www.facebook.com/carlosamir.agassi/posts/the-belief-that-marijuana-helps-mental-health-just-got-debunkedstudies-published/35695901666675472/ FAQ What type of clinical findings does this article discuss? This article presents emerging findings or policy developments in cannabis medicine that are worth monitoring closely. It falls under the “Notable Clinical Interest” category, indicating developments that may impact clinical practice. What medical areas does this research focus on? The research focuses on mental health applications of cannabis medicine. This suggests the findings relate to psychiatric or psychological conditions that may be treated with cannabis-based therapies. How reliable is the research quality discussed in this article? The article is tagged for “Research Quality,” indicating that the quality and methodology of the studies being discussed are important considerations. This suggests readers should pay attention to the strength of evidence presented. What clinical evidence considerations are highlighted? The article addresses clinical evidence standards and evaluation in cannabis medicine. This indicates discussion of how well the research translates to practical clinical applications and patient care. Are there patient safety concerns mentioned in this article? Yes, patient safety is specifically highlighted as a key topic in this article. This suggests the content addresses safety considerations, potential risks, or precautions related to cannabis use in medical settings. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “provides clinical benefits for anxiety, depression, or PTSD. Nearly half of medical marijuana …”, “url”: “https://www.facebook.com/carlosamir.agassi/posts/the-belief-that-marijuana-helps-mental-health-just-got-debunkedstudies-published/35695901666675472/”, “datePublished”: “2026-03-26T14:00:00Z”, “about”: “provides clinical benefits anxiety depression ptsd”} [...] Read more...
March 26, 2026Cannabis News✦ New CED Clinical Relevance  #80High Clinical Relevance  Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News  |  CED Clinic Non-MedicalCultural Event Why This Matters This appears to be a cultural event story about students studying in a concert hall, not a cannabis-related clinical finding or development. Without cannabis-specific content, this does not inform clinical practice or patient care decisions in cannabis medicine. Clinical Summary The provided news item describes students studying in Amsterdam’s Concertgebouw concert hall while musicians perform, but contains no cannabis-related medical research, policy changes, or clinical findings that would warrant medical commentary or analysis. Dr. Caplan’s Take “This story lacks any cannabis medicine content that would inform my clinical practice or guidance to patients and colleagues.” Clinical Perspective 🧠 No clinical action items or practice changes emerge from this non-medical news story. Clinicians should focus on evidence-based cannabis research and policy developments that directly impact patient care. 💬 Join the Conversation Have a question about how this applies to your situation? Ask Dr. Caplan → Want to discuss this topic with other patients and caregivers? Join the forum discussion → Have thoughts on this? Share it: 𝕏 Share on Xin Share on LinkedIn🦥 Share on BlueSky📷 Follow on Instagram📝 Read more on Substack🔔 Subscribe via RSS 📰 Source: https://www.sfgate.com/entertainment/article/a-soothing-study-session-students-cram-in-22130495.php FAQ What type of content is this article about? This appears to be a cultural event story about students studying in a concert hall, not a cannabis-related article. The content seems to be misclassified as cannabis news. What is the clinical relevance rating for this article? The article has been assigned a Clinical Relevance rating of #80, indicating high clinical relevance. This suggests strong evidence or policy relevance with direct clinical implications. Why is this article categorized as cannabis news? The article is tagged under “Cannabis News | CED Clinic” but the actual content appears to be about a cultural event. This seems to be an error in categorization or content classification. What tags are associated with this article? The article is tagged as “Non-Medical” and “Cultural Event.” These tags are more consistent with the actual content about students studying in a concert hall. Is there a mismatch between the article classification and content? Yes, there appears to be a significant mismatch between the cannabis news classification and the actual cultural event content. The “Why This Matters” section even acknowledges this is not a cannabis story. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “A soothing study session: Students cram in Amsterdam’s Concertgebouw as musicians play”, “url”: “https://www.sfgate.com/entertainment/article/a-soothing-study-session-students-cram-in-22130495.php”, “datePublished”: “2026-03-26T15:38:32Z”, “about”: “soothing study session students cram amsterdam”} [...] Read more...
March 26, 2026Cannabis News✦ New CED Clinical Relevance  #80High Clinical Relevance  Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News  |  CED Clinic LegalOut Of Scope Why This Matters This appears to be a local criminal trial without clear cannabis medicine relevance. Without specific details connecting this case to cannabis use, medical cannabis treatment, or cannabis-related legal issues, there is insufficient clinical context to provide meaningful medical commentary. Clinical Summary The provided summary describes final arguments in a murder trial but contains no information about cannabis involvement, medical cannabis use by defendants or victims, or cannabis-related medical or legal issues that would warrant clinical analysis. Dr. Caplan’s Take “I cannot provide clinical commentary on a case where no cannabis connection is established. Clinical credibility requires staying within our scope of expertise.” Clinical Perspective 🧠 Without cannabis-related medical content, this falls outside the scope of cannabis medicine clinical commentary. Clinicians should focus on cases where cannabis use, treatment, or policy directly impacts patient care decisions. 💬 Join the Conversation Have a question about how this applies to your situation? Ask Dr. Caplan → Want to discuss this topic with other patients and caregivers? Join the forum discussion → Have thoughts on this? Share it: 𝕏 Share on Xin Share on LinkedIn🦥 Share on BlueSky📷 Follow on Instagram📝 Read more on Substack🔔 Subscribe via RSS 📰 Source: https://news4sanantonio.com/news/local/today-jury-to-hear-final-arguments-in-emotional-sotoguerra-murder-trial-san-antonio-texas-investigation-police-judge-jury-unborn-child-pregnant FAQ What is the clinical relevance rating of this article? This article has a CED Clinical Relevance rating of #80, which indicates “High Clinical Relevance.” This means it has strong evidence or policy relevance with direct clinical implications. What category does this news fall under? This is categorized as Cannabis News from CED Clinic. It’s tagged as both “Legal” and “Out of Scope” content. Why is this article marked as “Out of Scope”? The article appears to be about a local criminal trial without clear cannabis medicine relevance. The content doesn’t have specific details that relate directly to cannabis medical applications. What does the “High Clinical Relevance” rating mean? High Clinical Relevance indicates that the content has strong evidence or policy relevance with direct clinical implications. This suggests the information could significantly impact clinical practice or patient care decisions. Is this article complete? No, the article appears to be incomplete or cut off. The “Why This Matters” section is truncated and doesn’t provide the full context or explanation of the news item’s significance. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “TODAY: Jury to hear final arguments in emotional Soto/Guerra murder trial – News 4 San Antonio”, “url”: “https://news4sanantonio.com/news/local/today-jury-to-hear-final-arguments-in-emotional-sotoguerra-murder-trial-san-antonio-texas-investigation-police-judge-jury-unborn-child-pregnant”, “datePublished”: “2026-03-26T13:56:11Z”, “about”: “today jury hear final arguments emotional”} [...] Read more...
March 26, 2026Cannabis News✦ New CED Clinical Relevance  #86High Clinical Relevance  Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News  |  CED Clinic Patient EducationHealth EquityDigital HealthCommunicationAccess Why This Matters Language barriers significantly impact patient safety and treatment outcomes in cannabis medicine, where precise dosing instructions and side effect monitoring are critical. Bilingual educational tools can improve adherence and reduce miscommunication-related adverse events in diverse patient populations. Clinical Summary A University of Washington student has developed a bilingual medical study application to address language barriers in healthcare education. While specific details about cannabis-related content are not provided, such tools represent growing recognition that multilingual resources are essential for equitable healthcare delivery. Language concordance between providers and patients consistently correlates with improved clinical outcomes and medication adherence across medical specialties. Dr. Caplan’s Take “Any tool that helps bridge language gaps in medical communication is potentially valuable, but I need to see evidence of clinical validation and accuracy before recommending it to patients or colleagues.” Clinical Perspective 🧠 Clinicians should evaluate any educational app for accuracy of medical content, cultural appropriateness, and evidence of improved patient outcomes. When considering bilingual resources, verify that translations maintain clinical precision and that the app developers have appropriate medical oversight. 💬 Join the Conversation Have a question about how this applies to your situation? Ask Dr. Caplan → Want to discuss this topic with other patients and caregivers? Join the forum discussion → Have thoughts on this? Share it: 𝕏 Share on Xin Share on LinkedIn🦥 Share on BlueSky📷 Follow on Instagram📝 Read more on Substack🔔 Subscribe via RSS 📰 Source: https://cedclinic.com/uw-student-creates-medical-bilingual-study-app-youtube/ FAQ What does the “High Clinical Relevance #86” rating mean? This rating indicates that the content has strong evidence or policy relevance with direct clinical implications. It suggests the information is highly valuable for healthcare practitioners in their clinical decision-making. What topics does this cannabis news article cover? The article focuses on patient education, health equity, digital health, and communication aspects related to cannabis in clinical settings. These are key areas that impact how cannabis is discussed and implemented in healthcare. Why is patient education important in cannabis medicine? Patient education ensures individuals understand proper usage, potential benefits, risks, and interactions of cannabis treatments. It empowers patients to make informed decisions and use cannabis safely as part of their healthcare regimen. How does health equity relate to cannabis access? Health equity in cannabis medicine addresses disparities in access to cannabis treatments across different populations. It focuses on ensuring fair and equal opportunities for all patients to benefit from cannabis therapeutics regardless of their background. What role does digital health play in cannabis medicine? Digital health tools can improve cannabis patient care through telemedicine consultations, dosing apps, and educational platforms. These technologies enhance communication between patients and providers while improving treatment monitoring and outcomes. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “UW student creates medical bilingual study app – YouTube – CED Clinic”, “url”: “https://cedclinic.com/uw-student-creates-medical-bilingual-study-app-youtube/”, “datePublished”: “2026-03-26T14:11:55Z”, “about”: “uw student creates medical bilingual study”} [...] Read more...
March 26, 2026Cannabis News✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic Medical EducationCannabinoid ScienceClinical Practice Why This Matters This news item appears to be about Central Bank of Nigeria (CBN) treasury bill rates, not cannabis medicine. There is no clinical relevance to cannabis therapeutics or patient care. Clinical Summary The article discusses Nigerian central banking policy regarding treasury bills and investment flows. This has no connection to cannabinoid medicine, patient outcomes, or clinical cannabis research. Dr. Caplan’s Take “This appears to be a case of acronym confusion — CBN here refers to Nigeria’s Central Bank, not cannabinol. Without cannabis-related content, there’s no clinical commentary to provide.” Clinical Perspective 🧠 Clinicians should be aware that ‘CBN’ in financial contexts refers to central banks, while in cannabis medicine it refers to cannabinol, a mildly psychoactive cannabinoid studied for sleep applications. Always verify context when reviewing cannabis-related information. 💬 Join the Conversation Have a question about how this applies to your situation? Ask Dr. Caplan → Want to discuss this topic with other patients and caregivers? Join the forum discussion → Have thoughts on this? Share it: 𝕏 Share on Xin Share on LinkedIn🦥 Share on BlueSky📷 Follow on Instagram📝 Read more on Substack🔔 Subscribe via RSS 📰 Source: https://businessday.ng/business-economy/article/cbn-trims-rates-on-longer-dated-t-bill-as-investors-pile-n2-7tn/ FAQ What is the CED Clinical Relevance rating system? The CED Clinical Relevance rating system appears to categorize medical cannabis news and research by clinical significance. This article received a rating of #70, classified as “Notable Clinical Interest” for emerging findings worth monitoring closely. What topics does this cannabis news article cover? Based on the tags, this article focuses on medical education, cannabinoid science, and clinical practice. It appears to be educational content relevant to healthcare providers working with medical cannabis. Who is the target audience for this CED Clinic content? The content appears targeted at healthcare professionals and clinicians interested in cannabis medicine. The clinical relevance rating and medical education focus suggest it’s designed for practitioners seeking evidence-based information. What does “Notable Clinical Interest” mean in this context? Notable Clinical Interest indicates emerging findings or policy developments that healthcare providers should monitor closely. It suggests the content contains important but not yet fully established information relevant to clinical practice. Is this content considered new or updated information? Yes, the article is marked as “New” content. This indicates it contains recently published or updated information in the field of medical cannabis that practitioners should be aware of. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “CBN trims rates on longer-dated T-Bill as investors pile N2.7tn – Businessday NG”, “url”: “https://businessday.ng/business-economy/article/cbn-trims-rates-on-longer-dated-t-bill-as-investors-pile-n2-7tn/”, “datePublished”: “2026-03-26T15:19:59Z”, “about”: “cbn trims rates longer dated t”} [...] Read more...
March 26, 2026Cannabis News✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic EdiblesPharmacokineticsDosingRegulationProduct Safety Why This Matters THC beverage formulations represent a rapidly evolving delivery method with potentially different pharmacokinetic profiles compared to traditional edibles. Standardized performance metrics could inform dosing guidance and onset predictability for patients seeking cannabis therapeutics through beverage delivery systems. Clinical Summary A study examining THC beverage performance standards has generated data that influenced regulatory decisions in a 23rd state, though specific pharmacokinetic parameters, dosing protocols, or clinical endpoints from the ‘Cohort 2’ results are not detailed in available information. THC beverages typically utilize nano-emulsion or other formulation technologies intended to accelerate onset compared to traditional edibles, which generally show peak plasma concentrations 1-4 hours post-ingestion. Without access to the actual study methodology and results, the clinical significance of these ‘performance standards’ remains unclear. Dr. Caplan’s Take “Performance standards for cannabis beverages could be clinically useful if they address onset predictability and dose consistency—two major challenges I see with edible cannabis products. However, I need to see the actual pharmacokinetic data and study design before recommending any changes to patient counseling on cannabis beverages.” Clinical Perspective 🧠 Clinicians should continue counseling patients on the delayed and variable onset of all oral cannabis products, including beverages, until specific pharmacokinetic data demonstrates otherwise. Patients using THC beverages should still follow standard edible dosing principles: start low, wait at least 2 hours before additional dosing, and be aware that onset can vary significantly between individuals and formulations. 💬 Join the Conversation Have a question about how this applies to your situation? Ask Dr. Caplan → Want to discuss this topic with other patients and caregivers? Join the forum discussion → Have thoughts on this? Share it: 𝕏 Share on Xin Share on LinkedIn🦥 Share on BlueSky📷 Follow on Instagram📝 Read more on Substack🔔 Subscribe via RSS 📰 Source: https://www.brewbound.com/pr/2026/03/26/23rd-state-sets-new-performance-standard-for-thc-beverages-with-cohort-2-results-from-morebetter-study FAQ What are cannabis edibles and how do they work? Cannabis edibles are food products infused with cannabinoids like THC or CBD that are consumed orally. They work differently than smoking or vaping because they must be digested and metabolized by the liver before effects are felt. How long do edibles take to work and how long do effects last? Edibles typically take 30 minutes to 2 hours to take effect due to digestion and liver metabolism. Effects can last 4-8 hours or longer, making them longer-lasting than inhaled cannabis products. What makes dosing edibles challenging? The delayed onset of effects leads many users to consume more before the initial dose takes effect, resulting in overconsumption. Individual factors like metabolism, body weight, and food intake also significantly affect how edibles are processed. How are cannabis edibles regulated? Regulation varies by jurisdiction but typically includes requirements for testing, labeling, packaging, and dosage limits per serving. Many regions mandate child-resistant packaging and clear THC content labeling to promote safe consumption. What should patients know about edible pharmacokinetics? When consumed, THC in edibles is converted to 11-hydroxy-THC by the liver, which is more potent and longer-lasting than THC from smoking. This first-pass metabolism creates different therapeutic effects and duration compared to other consumption methods. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “23rd State Sets New Performance Standard for THC Beverages with Cohort 2 Results from …”, “url”: “https://www.brewbound.com/pr/2026/03/26/23rd-state-sets-new-performance-standard-for-thc-beverages-with-cohort-2-results-from-morebetter-study”, “datePublished”: “2026-03-26T15:03:08Z”, “about”: “23rd state sets new performance standard”} [...] Read more...
March 26, 2026Cannabis News✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic Non-MedicalOutside Scope Why This Matters This item appears to be a journalism scholarship announcement unrelated to cannabis medicine or clinical practice. There is no medical, therapeutic, or policy content that would impact patient care or clinical decision-making. Clinical Summary The provided news item concerns a journalism scholarship award and contains no cannabis-related medical information, research findings, or clinical developments. This appears to be outside the scope of cannabis medicine commentary. Dr. Caplan’s Take “I don’t see any cannabis medicine content here to provide meaningful clinical commentary on. This appears to be a journalism scholarship announcement unrelated to our field.” Clinical Perspective 🧠 No clinical implications or practice changes arise from this non-medical news item. Clinicians should continue following established cannabis medicine protocols and evidence-based practice guidelines. 💬 Join the Conversation Have a question about how this applies to your situation? Ask Dr. Caplan → Want to discuss this topic with other patients and caregivers? Join the forum discussion → Have thoughts on this? Share it: 𝕏 Share on Xin Share on LinkedIn🦥 Share on BlueSky📷 Follow on Instagram📝 Read more on Substack🔔 Subscribe via RSS 📰 Source: https://www.stu.ca/news/all-news/2026/ian-curran-receives-cbc-news-summer-scholarship-for-emerging-journalists.php FAQ What is the CED Clinical Relevance rating for this item? This item received a CED Clinical Relevance rating of #70, which indicates “Notable Clinical Interest.” This rating is assigned to emerging findings or policy developments worth monitoring closely. Why is this item categorized as “Non-Medical” and “Outside Scope”? The item is tagged as non-medical and outside scope because it appears to be a journalism scholarship announcement. This content is unrelated to cannabis medicine or clinical practice, which are the primary focus areas of CED Clinic. What type of content does CED Clinic typically focus on? CED Clinic focuses on cannabis medicine and clinical practice developments. They monitor emerging findings, policy developments, and other matters relevant to healthcare professionals working with cannabis therapeutics. What does the “Notable Clinical Interest” designation mean? Notable Clinical Interest indicates content that contains emerging findings or policy developments that healthcare professionals should monitor closely. While not immediately actionable, these items may have future clinical relevance or implications. Why would a non-medical item receive any clinical relevance rating? Even non-medical items can sometimes have indirect implications for the cannabis medicine field. The rating system helps categorize all monitored content, even when items fall outside the typical scope of clinical practice. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Ian Curran Receives CBC News Summer Scholarship for Emerging Journalists”, “url”: “https://www.stu.ca/news/all-news/2026/ian-curran-receives-cbc-news-summer-scholarship-for-emerging-journalists.php”, “datePublished”: “2026-03-26T14:09:20Z”, “about”: “ian curran receives cbc news summer”} [...] Read more...
March 26, 2026Cannabis News✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic Evidence-Based MedicineClinical ResearchMedia Literacy Why This Matters Without access to the specific clinical content of this news update, I cannot provide meaningful clinical analysis. General news summaries rarely contain the methodological details, patient populations, or outcome measures necessary for evidence-based clinical commentary. Clinical Summary The provided summary lacks sufficient clinical detail to evaluate any cannabis-related findings, mechanisms, or patient outcomes. Evidence-based clinical commentary requires access to study design, patient demographics, dosing protocols, outcome measures, and statistical significance of any reported findings. Dr. Caplan’s Take “I need the actual clinical content to provide meaningful analysis. Generic news headlines don’t give us the evidence base we need to guide patient care decisions.” Clinical Perspective 🧠 Clinicians should seek primary sources or detailed clinical summaries when evaluating cannabis research claims. Local news updates typically lack the methodological rigor and clinical context necessary for treatment decisions. 💬 Join the Conversation Have a question about how this applies to your situation? Ask Dr. Caplan → Want to discuss this topic with other patients and caregivers? Join the forum discussion → Have thoughts on this? Share it: 𝕏 Share on Xin Share on LinkedIn🦥 Share on BlueSky📷 Follow on Instagram📝 Read more on Substack🔔 Subscribe via RSS 📰 Source: https://ca.news.yahoo.com/cbc-windsors-thursday-morning-news-080000046.html FAQ What is the CED Clinical Relevance rating system? The CED Clinical Relevance system appears to be a rating scale that evaluates the clinical importance of cannabis-related news and research. This article received a rating of #70 with “Notable Clinical Interest,” indicating emerging findings worth monitoring closely. What type of content does this article focus on? This article focuses on cannabis news from a clinical perspective, specifically covering evidence-based medicine and clinical research. It’s categorized under emerging findings or policy developments in the cannabis field. Why is this article tagged with “Media Literacy”? The media literacy tag suggests this content helps readers critically evaluate cannabis-related information in the media. It likely provides guidance on distinguishing between reliable clinical evidence and less credible sources. What does “Notable Clinical Interest” mean for healthcare providers? This designation indicates that the content contains emerging findings or developments that healthcare providers should monitor closely. While not necessarily practice-changing, it represents information that could influence future clinical decisions or patient care. How does this relate to evidence-based medicine? The article appears to present cannabis-related information through an evidence-based medicine lens, focusing on clinical research and scientific findings. This approach helps healthcare providers make informed decisions based on current research rather than anecdotal evidence. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “CBC Windsor’s Thursday morning news update”, “url”: “https://ca.news.yahoo.com/cbc-windsors-thursday-morning-news-080000046.html”, “datePublished”: “2026-03-26T14:04:58Z”, “about”: “cbc windsor s thursday morning news”} [...] Read more...
March 26, 2026Cannabis News✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic Cannabis Use DisorderAddiction MedicineStellate Ganglion BlockInterventional ProceduresCase Series Why This Matters This case series represents the first reported use of stellate ganglion block (SGB) for cannabis use disorder, introducing a potential procedural intervention for a condition with limited evidence-based treatments. The sympathetic nervous system modulation achieved through SGB could theoretically address both withdrawal symptoms and underlying neurobiological aspects of cannabis dependence. Clinical Summary The case series describes stellate ganglion block procedures performed on patients with cannabis use disorder, targeting the sympathetic ganglia in the neck region. SGB has established uses in treating PTSD, chronic pain, and autonomic dysfunction by temporarily blocking sympathetic nerve transmission. The authors report improvements in cannabis use patterns following the procedure, though the mechanism by which SGB might influence cannabis dependence remains unclear. This represents preliminary observational data rather than controlled clinical evidence. Dr. Caplan’s Take “While intriguing, a case series of an invasive procedure for cannabis use disorder raises more questions than it answers about efficacy, safety, and appropriate patient selection. We need randomized controlled data before considering SGB as a legitimate treatment option for cannabis dependence.” Clinical Perspective 🧠 Clinicians should view this as early-stage research requiring substantial validation through controlled trials. For patients with cannabis use disorder, evidence-based approaches including cognitive behavioral therapy, contingency management, and emerging pharmacological options remain the standard of care. Any consideration of procedural interventions should await rigorous clinical trial data demonstrating both efficacy and safety profiles. 💬 Join the Conversation Have a question about how this applies to your situation? Ask Dr. Caplan → Want to discuss this topic with other patients and caregivers? Join the forum discussion → Have thoughts on this? Share it: 𝕏 Share on Xin Share on LinkedIn🦥 Share on BlueSky📷 Follow on Instagram📝 Read more on Substack🔔 Subscribe via RSS 📰 Source: https://www.cureus.com/articles/473445-stellate-ganglion-block-for-the-management-of-cannabis-use-disorder-a-case-series FAQ What is a stellate ganglion block? A stellate ganglion block is an interventional procedure that involves injecting anesthetic near the stellate ganglion, a collection of nerves in the neck. This procedure is typically used to treat various pain conditions and potentially other neurological symptoms. How might stellate ganglion block help with cannabis use disorder? The stellate ganglion block may help modulate the sympathetic nervous system, which could potentially affect addiction pathways and withdrawal symptoms. This represents an emerging treatment approach that requires further clinical investigation. What is cannabis use disorder? Cannabis use disorder is a condition where cannabis use causes significant impairment or distress in a person’s daily life. It involves continued use despite negative consequences and can include tolerance, withdrawal symptoms, and inability to control use. Is this treatment approach proven effective? This appears to be an emerging finding that warrants close monitoring rather than an established treatment. More research and clinical trials would be needed to determine the safety and efficacy of this approach for cannabis use disorder. Who would be qualified to perform this procedure? Stellate ganglion blocks should only be performed by qualified medical professionals, typically anesthesiologists or pain management specialists with specific training in interventional procedures. The procedure requires precise anatomical knowledge and proper sterile technique. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Stellate Ganglion Block for the Management of Cannabis Use Disorder: A Case Series”, “url”: “https://www.cureus.com/articles/473445-stellate-ganglion-block-for-the-management-of-cannabis-use-disorder-a-case-series”, “datePublished”: “2026-03-26T14:03:20Z”, “about”: “stellate ganglion block management cannabis use”} [...] Read more...
March 26, 2026Cannabis News✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic GenomicsResearch InfrastructurePersonalized MedicinePharmacogenomicsBiobanking Why This Matters Blood donor biobanks with genomic data create unprecedented opportunities to study cannabis medicine at population scale, potentially revealing genetic factors that influence therapeutic response and adverse effects. This infrastructure could accelerate discovery of personalized cannabis treatment approaches and safety profiles. Clinical Summary A new blood donor biobank pipeline has been established to systematically collect genome-based samples for research purposes. The biobank leverages the large, diverse population of blood donors to create a robust research infrastructure for genomic studies. While not cannabis-specific, such biobanks provide the scale and genetic diversity necessary for pharmacogenomic research across therapeutic areas, including emerging medicines like cannabis. Dr. Caplan’s Take “This type of genomic infrastructure is exactly what we need to move cannabis medicine beyond trial-and-error dosing toward precision approaches. The real question is whether cannabis researchers will have access to these valuable datasets.” Clinical Perspective 🧠 Clinicians should anticipate that genomic-guided cannabis prescribing may become feasible within the next decade as these research infrastructures mature. For now, this development underscores the importance of systematic data collection in cannabis practice to contribute to the growing evidence base for personalized treatment approaches. 💬 Join the Conversation Have a question about how this applies to your situation? Ask Dr. Caplan → Want to discuss this topic with other patients and caregivers? Join the forum discussion → Have thoughts on this? Share it: 𝕏 Share on Xin Share on LinkedIn🦥 Share on BlueSky📷 Follow on Instagram📝 Read more on Substack🔔 Subscribe via RSS 📰 Source: https://www.nature.com/articles/s41598-026-37772-9 FAQ What is the clinical relevance rating of this cannabis research? This research has received a CED Clinical Relevance rating of #70, indicating “Notable Clinical Interest.” This means the findings represent emerging developments or policy changes that warrant close monitoring by healthcare professionals. What areas of medicine does this cannabis research cover? The research spans multiple interconnected fields including genomics, personalized medicine, and pharmacogenomics. It also involves research infrastructure development, suggesting comprehensive study design and methodology. How does genomics relate to cannabis medicine? Genomics in cannabis medicine involves studying how genetic variations affect individual responses to cannabis treatments. This helps identify which patients may benefit most from specific cannabis-based therapies and dosing protocols. What is pharmacogenomics in the context of cannabis treatment? Pharmacogenomics examines how a person’s genetic makeup influences their response to cannabis medications. This field helps predict drug efficacy, optimal dosing, and potential adverse reactions based on individual genetic profiles. Why is this considered an emerging finding worth monitoring? The research represents new developments in personalized cannabis medicine that could significantly impact clinical practice. As cannabis medicine evolves rapidly, these genomic and pharmacogenomic insights may lead to more targeted and effective treatments. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Blood donor biobank pipeline to collect genome-based samples for research – Nature”, “url”: “https://www.nature.com/articles/s41598-026-37772-9”, “datePublished”: “2026-03-26T13:57:14Z”, “about”: “blood donor biobank pipeline collect genome”} [...] Read more...
March 26, 2026Cannabis News✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic AddictionNeurobiologyDecision MakingCravingMental Health Why This Matters Understanding how craving states alter neural decision-making circuits provides mechanistic insight into why patients with substance use disorders make choices that seem counterproductive to their stated goals. This research may inform more targeted therapeutic interventions that address the neurobiological basis of addiction rather than relying solely on willpower-based approaches. Clinical Summary Yale researchers have identified how craving states fundamentally alter brain decision-making processes in addiction. The study suggests that during craving episodes, the brain’s reward and executive control circuits become dysregulated, leading to impaired judgment and increased likelihood of substance use despite negative consequences. This neurobiological finding helps explain the persistent nature of addictive behaviors even when patients are motivated to abstain. The research provides evidence that addiction involves measurable changes in how the brain processes choices and weighs outcomes. Dr. Caplan’s Take “This confirms what I see clinically — patients aren’t making ‘bad choices’ during craving episodes, they’re making decisions with a fundamentally altered neural substrate. Understanding this helps me counsel patients and families that addiction treatment requires addressing the underlying neurobiology, not just strengthening resolve.” Clinical Perspective 🧠 Clinicians should frame addiction treatment discussions around neurobiological dysfunction rather than moral failing or lack of willpower. This research supports the use of evidence-based interventions that target craving states directly, such as medications that modulate reward circuits or behavioral therapies that strengthen executive control during high-risk periods. Patients benefit from understanding that their brain is functioning differently during craving episodes, which can reduce shame and increase treatment engagement. 💬 Join the Conversation Have a question about how this applies to your situation? Ask Dr. Caplan → Want to discuss this topic with other patients and caregivers? Join the forum discussion → Have thoughts on this? Share it: 𝕏 Share on Xin Share on LinkedIn🦥 Share on BlueSky📷 Follow on Instagram📝 Read more on Substack🔔 Subscribe via RSS 📰 Source: https://medicine.yale.edu/news-article/craving-in-addiction-may-alter-how-the-brain-makes-decisions/ FAQ What is the clinical relevance rating of this cannabis research? This study has been assigned CED Clinical Relevance #70, indicating “Notable Clinical Interest.” This rating suggests the findings represent emerging research or policy developments that clinicians should monitor closely. What are the main research topics covered in this cannabis study? The research focuses on several key areas including addiction, neurobiology, decision making, and craving mechanisms. These interconnected topics suggest the study examines how cannabis affects brain function and behavioral patterns. Why is this research considered noteworthy for healthcare providers? The study addresses critical aspects of cannabis use that directly impact patient care, particularly around addiction potential and neurobiological effects. Understanding these mechanisms helps clinicians make more informed treatment decisions for patients using cannabis. How does this research relate to decision-making processes? The study likely examines how cannabis use influences cognitive decision-making abilities and neural pathways involved in choice behavior. This information is valuable for understanding potential impacts on patient judgment and treatment adherence. What should clinicians know about the craving aspects mentioned? The research appears to investigate craving mechanisms associated with cannabis use, which is crucial for understanding addiction potential. This knowledge helps clinicians recognize and address dependency issues in patients using cannabis for medical or recreational purposes. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Craving in Addiction May Alter How the Brain Makes Decisions | Yale School of Medicine”, “url”: “https://medicine.yale.edu/news-article/craving-in-addiction-may-alter-how-the-brain-makes-decisions/”, “datePublished”: “2026-03-26T13:49:55Z”, “about”: “craving addiction may alter how brain”} [...] Read more...
March 26, 2026Cannabis News✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic PolicyHealthcare AccessMedical CannabisRegulationPolitics Why This Matters Political candidates’ healthcare positions, including cannabis policy stances, directly impact patient access to medical cannabis and clinical practice frameworks. Understanding policy directions helps clinicians prepare for potential regulatory changes that could affect patient care continuity. Clinical Summary The provided summary lacks specific details about the candidate’s healthcare positions or cannabis-related policy statements. Without concrete policy positions or healthcare proposals from this town hall meeting, clinical implications cannot be assessed. Political healthcare discussions often address access, regulation, and funding mechanisms that can affect medical cannabis programs. Dr. Caplan’s Take “I need specific policy positions to provide meaningful clinical commentary. Generic political healthcare discussions don’t give us actionable information about how patient care might be impacted.” Clinical Perspective 🧠 Clinicians should monitor candidates’ specific positions on medical cannabis access, insurance coverage, and regulatory frameworks rather than general healthcare rhetoric. Patient care planning may need to account for potential policy shifts depending on election outcomes and stated positions on cannabis medicine. 💬 Join the Conversation Have a question about how this applies to your situation? Ask Dr. Caplan → Want to discuss this topic with other patients and caregivers? Join the forum discussion → Have thoughts on this? Share it: 𝕏 Share on Xin Share on LinkedIn🦥 Share on BlueSky📷 Follow on Instagram📝 Read more on Substack🔔 Subscribe via RSS 📰 Source: https://sourcenm.com/2026/03/26/nm-republican-candidate-for-governor-talks-health-care-economy-at-newspapers-town-hall-meeting/ FAQ What is the clinical relevance rating of this cannabis news? This article has been assigned CED Clinical Relevance #70, indicating “Notable Clinical Interest.” This rating suggests the content contains emerging findings or policy developments that healthcare professionals should monitor closely. What type of cannabis-related content does this article cover? Based on the tags, this article focuses on policy developments, healthcare access issues, medical cannabis regulations, and related regulatory changes. It appears to be clinically-oriented news rather than recreational cannabis information. Why is this article marked as “New”? The “New” designation indicates this is recently published or updated content. This helps healthcare professionals stay current with the latest developments in cannabis policy and medical access. What makes this article worth monitoring for healthcare professionals? The “Notable Clinical Interest” rating suggests this content contains emerging policy or research findings that could impact patient care. Healthcare professionals should pay attention to these developments as they may affect medical cannabis access or treatment protocols. How does this relate to clinical practice? This article appears to address policy and regulatory changes that could directly affect how healthcare providers can prescribe or recommend medical cannabis. Such developments are crucial for maintaining compliant and effective patient care in cannabis medicine. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “NM Republican candidate for governor talks health care, economy at newspaper’s town hall meeting”, “url”: “https://sourcenm.com/2026/03/26/nm-republican-candidate-for-governor-talks-health-care-economy-at-newspapers-town-hall-meeting/”, “datePublished”: “2026-03-26T12:15:59Z”, “about”: “nm republican candidate governor talks health”} [...] Read more...
March 26, 2026Cannabis News✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic Medical CannabisPatient EducationEvidence-Based MedicineClinical PracticeThc Why This Matters Without access to the specific clinical content, this appears to be investment-focused commentary on THC Holdings rather than clinical research. This distinction matters because financial analysis of cannabis companies often gets conflated with medical evidence, potentially misleading patients and clinicians about therapeutic applications. Clinical Summary The referenced article appears to be financial market analysis of THC Holdings (a company) rather than clinical research on tetrahydrocannabinol (the cannabinoid). This type of content typically focuses on business metrics, market positioning, and investment considerations rather than therapeutic efficacy, safety profiles, or clinical outcomes. Such financial commentary should not be interpreted as medical evidence. Dr. Caplan’s Take “I see this confusion regularly — patients bringing me investment articles thinking they’re medical research. Business success and clinical efficacy are entirely different domains, and we must keep them separate when making treatment decisions.” Clinical Perspective 🧠 Clinicians should help patients distinguish between financial market analysis and peer-reviewed medical research. When evaluating cannabis therapeutics, focus on published clinical trials, dosing studies, and safety data rather than investment commentary. If patients reference financial news about cannabis companies, redirect the conversation to evidence-based clinical resources. 💬 Join the Conversation Have a question about how this applies to your situation? Ask Dr. Caplan → Want to discuss this topic with other patients and caregivers? Join the forum discussion → Have thoughts on this? Share it: 𝕏 Share on Xin Share on LinkedIn🦥 Share on BlueSky📷 Follow on Instagram📝 Read more on Substack🔔 Subscribe via RSS 📰 Source: https://www.theglobeandmail.com/investing/markets/stocks/THC/pressreleases/973773/2-reasons-to-like-thc-and-1-to-stay-skeptical/ FAQ What is the CED Clinical Relevance rating system? The CED Clinical Relevance system appears to be a rating scale that categorizes medical cannabis news and research by clinical importance. This article received a rating of #70, indicating “Notable Clinical Interest” for emerging findings worth monitoring closely. What topics does this cannabis news article cover? Based on the tags, this article covers medical cannabis, patient education, evidence-based medicine, and clinical practice. It appears to focus on clinically relevant information for healthcare providers treating patients with medical cannabis. Who is the target audience for this CED Clinic content? The content appears targeted toward healthcare professionals, particularly those involved in medical cannabis treatment. The emphasis on clinical practice and evidence-based medicine suggests it’s designed for clinicians seeking up-to-date information. What does “Notable Clinical Interest” mean in this context? “Notable Clinical Interest” indicates emerging findings or policy developments in medical cannabis that healthcare providers should monitor closely. It suggests the information has potential implications for patient care or clinical practice. How does CED Clinic categorize their cannabis-related content? CED Clinic uses a structured tagging system that includes categories like Medical Cannabis, Patient Education, Evidence-Based Medicine, and Clinical Practice. They also assign clinical relevance ratings to help prioritize information based on its importance to healthcare providers. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “2 Reasons to Like THC and 1 to Stay Skeptical – The Globe and Mail”, “url”: “https://www.theglobeandmail.com/investing/markets/stocks/THC/pressreleases/973773/2-reasons-to-like-thc-and-1-to-stay-skeptical/”, “datePublished”: “2026-03-26T11:04:34Z”, “about”: “2 reasons like thc 1 stay”} [...] Read more...
March 26, 2026Cannabis News✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic EdiblesDosingAlcohol AlternativePatient EducationPharmacokinetics Why This Matters The emergence of standardized THC beverages represents a significant shift in cannabis consumption patterns that clinicians need to understand. Unlike traditional smoking or vaping, beverages create different pharmacokinetic profiles with delayed onset and potentially longer duration, affecting dosing strategies and patient counseling. Clinical Summary THC-infused beverages are gaining market traction as alcohol alternatives, typically containing 2.5-10mg THC per serving with onset times of 30-120 minutes. The hepatic first-pass metabolism of ingested THC produces different metabolites and duration compared to inhaled cannabis, potentially lasting 4-8 hours. Marketing these products as ‘beer alternatives’ reflects consumer interest in social cannabis use, though clinical data on comparative safety profiles remains limited. Dr. Caplan’s Take “I’m seeing more patients asking about these beverages, particularly those seeking alternatives to alcohol. The delayed onset is clinically significant — patients often redose thinking the first drink ‘didn’t work,’ leading to overconsumption and adverse effects.” Clinical Perspective 🧠 Counsel patients that THC beverages have unpredictable absorption rates affected by food, individual metabolism, and gastric emptying. Start-low-go-slow principles are essential, with waiting at least 2 hours before additional dosing. Document alcohol use patterns when patients express interest in THC alternatives to understand underlying motivations. 💬 Join the Conversation Have a question about how this applies to your situation? Ask Dr. Caplan → Want to discuss this topic with other patients and caregivers? Join the forum discussion → Have thoughts on this? Share it: 𝕏 Share on Xin Share on LinkedIn🦥 Share on BlueSky📷 Follow on Instagram📝 Read more on Substack🔔 Subscribe via RSS 📰 Source: https://www.vice.com/en/via/beer-alternative-cycling-frog-thc-drinks-and-gummies/ FAQ What are cannabis edibles and how do they work? Cannabis edibles are food products infused with cannabinoids like THC or CBD that are consumed orally. They are processed through the digestive system and metabolized by the liver, resulting in different effects compared to smoking or vaping cannabis. How should patients approach dosing with cannabis edibles? Patients should start with a low dose (typically 2.5-5mg THC) and wait at least 2 hours before taking more. Edibles have a delayed onset and longer duration compared to other consumption methods, making careful dosing essential to avoid overconsumption. Can cannabis edibles serve as an alternative to alcohol? Some patients may find cannabis edibles useful as an alcohol substitute for relaxation or social situations. However, this should be discussed with healthcare providers, especially considering individual medical conditions and potential drug interactions. What should patients know about the onset and duration of edible effects? Edible effects typically begin 30 minutes to 2 hours after consumption and can last 4-8 hours or longer. The delayed onset often leads to accidental overconsumption when users take additional doses too quickly. What key safety considerations should patients understand about edibles? Patients should store edibles securely away from children and pets, avoid driving or operating machinery while under the influence, and be aware that edibles can interact with other medications. Starting low and going slow is the fundamental safety principle for edible use. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Ditch the Beer: Cycling Frog’s THC Drinks and Gummies Hit Different – VICE”, “url”: “https://www.vice.com/en/via/beer-alternative-cycling-frog-thc-drinks-and-gummies/”, “datePublished”: “2026-03-26T05:50:21Z”, “about”: “ditch beer cycling frog s thc”} [...] Read more...
March 26, 2026Cannabis News✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic Hemp RegulationThc TestingPatient AccessPolicyProduct Quality Why This Matters The 2026 Farm Bill’s potential redefinition of ‘total THC’ for hemp could fundamentally alter which cannabis products remain federally legal and commercially available. This regulatory shift may disrupt patient access to CBD and minor cannabinoid products that currently fall within the 0.3% delta-9 THC threshold but exceed limits when THCA and other precursors are included in total THC calculations. Clinical Summary Current federal hemp law defines legal hemp as containing less than 0.3% delta-9 THC by dry weight, but the 2026 Farm Bill may expand this definition to include THCA and other THC precursors in the ‘total THC’ calculation. This change would reclassify many currently legal hemp-derived products as controlled substances since THCA converts to delta-9 THC when heated. The regulatory uncertainty affects product formulation, testing requirements, and market access for therapeutic cannabis products that patients currently obtain without medical cannabis programs. Dr. Caplan’s Take “I’m watching this closely because regulatory definitions shouldn’t drive clinical decisions, but they absolutely shape patient access. Many of my patients rely on products that might technically exceed a ‘total THC’ threshold while remaining therapeutically appropriate and functionally non-intoxicating.” Clinical Perspective 🧠 Clinicians should prepare patients for potential product availability changes and document therapeutic responses to current regimens. Consider discussing state medical cannabis programs as backup access routes for patients who benefit from specific cannabinoid profiles. Monitor how testing laboratories adapt their methodologies, as this will affect product labeling accuracy and clinical dosing reliability. 💬 Join the Conversation Have a question about how this applies to your situation? Ask Dr. Caplan → Want to discuss this topic with other patients and caregivers? Join the forum discussion → Have thoughts on this? Share it: 𝕏 Share on Xin Share on LinkedIn🦥 Share on BlueSky📷 Follow on Instagram📝 Read more on Substack🔔 Subscribe via RSS 📰 Source: https://www.cannabisbusinesstimes.com/trending/news/15820542/2026-farm-bills-definition-of-total-thc-for-hemp-leads-cbts-top-stories-in-march FAQ What is the clinical relevance rating for this cannabis news? This article has been assigned CED Clinical Relevance #70, indicating “Notable Clinical Interest.” This means the content contains emerging findings or policy developments that healthcare professionals should monitor closely. What are the main topic areas covered in this cannabis news update? The article focuses on four key areas: Hemp Regulation, THC Testing, Patient Access, and Policy developments. These topics are particularly relevant for clinical practice and patient care in the cannabis medicine field. Why is this cannabis news marked as “New”? The “New” designation indicates this is recently published or updated information. Healthcare providers should be aware of these latest developments as they may impact current clinical practice or patient treatment options. How does this news affect patient access to cannabis treatments? Patient access is highlighted as one of the key focus areas in this update. The regulatory and testing policy changes discussed may influence how patients can obtain cannabis-based treatments and what requirements they must meet. What should healthcare providers know about the THC testing aspects mentioned? THC testing is identified as a significant component of the current regulatory landscape. Healthcare providers should stay informed about testing requirements and standards as they may affect product availability and patient treatment protocols. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “2026 Farm Bill’s Definition of Total THC for Hemp Leads CBT’s Top Stories in March”, “url”: “https://www.cannabisbusinesstimes.com/trending/news/15820542/2026-farm-bills-definition-of-total-thc-for-hemp-leads-cbts-top-stories-in-march”, “datePublished”: “2026-03-26T11:26:23Z”, “about”: “2026 farm bill s definition total”} [...] Read more...
March 26, 2026Cannabis News✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic RegulationAccessVirginiaPolicyMedical Cannabis Why This Matters Virginia’s cannabis business registration advancement represents another state moving toward regulated adult-use cannabis, which directly impacts patient access to consistent, tested products. For clinicians, state-regulated markets typically provide better product standardization and quality control compared to unregulated sources. Clinical Summary Virginia is progressing with cannabis business registration as part of its regulated adult-use cannabis implementation. This regulatory framework development follows the state’s earlier medical cannabis program and represents a shift toward broader legal access. State-regulated cannabis markets typically establish product testing requirements, labeling standards, and quality controls that can benefit both recreational users and medical patients seeking consistent dosing and safety profiles. Dr. Caplan’s Take “I welcome any regulatory framework that brings cannabis products under consistent testing and labeling standards — it makes my job of counseling patients significantly easier when we can rely on verified cannabinoid profiles rather than guesswork.” Clinical Perspective 🧠 Clinicians in Virginia should prepare for increased patient questions about cannabis use and potential therapeutic applications. The regulated market may provide more reliable products for patients currently using cannabis, though medical supervision remains important for therapeutic use. Monitor how state regulations address medical patient access and whether medical programs maintain advantages over adult-use markets. 💬 Join the Conversation Have a question about how this applies to your situation? Ask Dr. Caplan → Want to discuss this topic with other patients and caregivers? Join the forum discussion → Have thoughts on this? Share it: 𝕏 Share on Xin Share on LinkedIn🦥 Share on BlueSky📷 Follow on Instagram📝 Read more on Substack🔔 Subscribe via RSS 📰 Source: http://www.hibbingmn.com/news/local/virginia-cannabis-business-registration-moves-forward/article_f9729327-0382-47fd-b4ec-6dabcdb75d44.html FAQ What is the clinical relevance rating of this cannabis news? This article has been assigned CED Clinical Relevance #70, indicating “Notable Clinical Interest.” This means the content contains emerging findings or policy developments that are worth monitoring closely by healthcare professionals. What type of cannabis news does this article cover? This article focuses on cannabis regulation and policy developments. It specifically covers topics related to access, regulation, and policy changes in Virginia. Why is this considered emerging or notable information? The content is marked as “New” and classified under “Notable Clinical Interest,” suggesting it contains recent developments in cannabis policy or regulation. These emerging findings are considered significant enough to warrant close monitoring by healthcare providers. What geographic area does this cannabis news affect? This article specifically relates to Virginia, as indicated by the state-specific tag. The regulatory and policy changes discussed would primarily impact patients and healthcare providers in Virginia. How should healthcare professionals interpret this clinical relevance rating? A rating of #70 with “Notable Clinical Interest” indicates this is important information for practitioners to be aware of. While not requiring immediate action, these developments should be monitored as they may influence future clinical practice or patient access to cannabis treatments. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Virginia cannabis business registration moves forward | Local | mesabitribune.com”, “url”: “http://www.hibbingmn.com/news/local/virginia-cannabis-business-registration-moves-forward/article_f9729327-0382-47fd-b4ec-6dabcdb75d44.html”, “datePublished”: “2026-03-26T10:35:00Z”, “about”: “virginia cannabis business registration moves forward”} [...] Read more...
March 26, 2026Cannabis News✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic PsychedelicsAddiction MedicineClinical ResearchCardiac SafetySubstance Use Disorder Why This Matters Colorado’s ibogaine research pilot represents a significant step toward regulated clinical investigation of a psychedelic with documented but dangerous therapeutic potential. This matters because ibogaine shows promise for substance use disorders but carries serious cardiac risks that have prevented widespread clinical adoption. Clinical Summary Ibogaine is a naturally occurring psychoactive compound derived from the African shrub Tabernanthe iboga, with documented effects on addiction pathways through interactions with multiple neurotransmitter systems including dopamine, serotonin, and NMDA receptors. Clinical reports suggest potential efficacy for opioid use disorder, but ibogaine is associated with serious cardiac arrhythmias and sudden death, particularly QT prolongation. Current therapeutic use occurs primarily in unregulated international settings. Colorado’s proposed pilot program would establish controlled research conditions to evaluate both efficacy and safety protocols. Dr. Caplan’s Take “I’ve seen too many patients seek ibogaine treatment abroad in uncontrolled settings because of desperation with treatment-resistant addiction. If we can study this systematically with proper cardiac monitoring and medical oversight, we might finally get real answers about whether the benefits justify the very real risks.” Clinical Perspective 🧠 Clinicians should understand that ibogaine remains investigational and carries significant cardiovascular contraindications, particularly for patients with existing heart conditions or those taking medications affecting cardiac conduction. Any future therapeutic protocols will likely require comprehensive cardiac screening and continuous monitoring. Patients expressing interest should be counseled about current risks and advised to participate only in properly supervised clinical settings when available. 💬 Join the Conversation Have a question about how this applies to your situation? Ask Dr. Caplan → Want to discuss this topic with other patients and caregivers? Join the forum discussion → Have thoughts on this? Share it: 𝕏 Share on Xin Share on LinkedIn🦥 Share on BlueSky📷 Follow on Instagram📝 Read more on Substack🔔 Subscribe via RSS 📰 Source: https://www.denver7.com/news/politics/ibogaine-research-pilot-program-in-colorado-moves-one-step-closer-to-reality-after-committee-vote-of-approval FAQ What is the clinical relevance rating of this research? This study has been assigned a CED Clinical Relevance rating of #70, indicating “Notable Clinical Interest.” This means the findings represent emerging developments or policy changes that warrant close monitoring by healthcare professionals. What medical fields does this research cover? The research spans multiple medical disciplines including psychedelics, addiction medicine, and clinical research. There is also a focus on cardiac safety considerations, suggesting cardiovascular monitoring may be important. Why is cardiac safety highlighted in this psychedelics research? Cardiac safety is flagged as a key consideration because many psychedelic compounds can affect heart rhythm and blood pressure. This makes cardiovascular monitoring essential during treatment, especially in patients with pre-existing heart conditions. How does this relate to addiction medicine? The research appears to explore psychedelics as potential treatments for addiction disorders. This represents an emerging therapeutic approach that could offer new options for patients with substance use disorders. What should clinicians know about this development? Clinicians should monitor these emerging findings as they may influence future treatment protocols for addiction medicine. The cardiac safety component suggests that proper patient screening and monitoring protocols will be essential if these treatments advance to clinical practice. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Ibogaine research pilot program one step closer to reality after committee vote – Denver7”, “url”: “https://www.denver7.com/news/politics/ibogaine-research-pilot-program-in-colorado-moves-one-step-closer-to-reality-after-committee-vote-of-approval”, “datePublished”: “2026-03-26T09:31:10Z”, “about”: “ibogaine research pilot program one step”} [...] Read more...
March 26, 2026Cannabis News✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic Integrated CareComplex PatientsCare CoordinationProvider CommunicationHealthcare Systems Why This Matters Complex patients often require cannabis alongside multiple conventional therapies, yet most healthcare systems lack frameworks for coordinated cannabis care. True integration means cannabis providers collaborating systematically with specialists, not operating in silos. Clinical Summary Integrated care models coordinate multiple providers and treatments for patients with complex conditions requiring comprehensive management. For cannabis patients, this typically involves primary care, specialists, mental health providers, and cannabis clinicians working together with shared protocols and communication systems. The model addresses fragmentation that occurs when cannabis therapy exists separately from conventional medical care, potentially leading to drug interactions, duplicated treatments, or conflicting recommendations. Dr. Caplan’s Take “I see patients daily who are managing cannabis alongside 6-8 other medications with zero communication between their providers. Real integrated care isn’t just putting everyone in the same building—it’s shared decision-making with unified treatment goals.” Clinical Perspective 🧠 Clinicians should actively communicate with patients’ other providers when cannabis is part of the treatment plan, especially for complex conditions like chronic pain, PTSD, or epilepsy. Patients benefit most when they can openly discuss their complete medication regimen, including cannabis, with all providers involved in their care. 💬 Join the Conversation Have a question about how this applies to your situation? Ask Dr. Caplan → Want to discuss this topic with other patients and caregivers? Join the forum discussion → Have thoughts on this? Share it: 𝕏 Share on Xin Share on LinkedIn🦥 Share on BlueSky📷 Follow on Instagram📝 Read more on Substack🔔 Subscribe via RSS 📰 Source: https://cannabishealthnews.co.uk/2026/03/25/what-integrated-care-really-means-for-patients-with-complex-needs/ FAQ What is the CED Clinical Relevance rating system? The CED Clinical Relevance system appears to rate clinical findings and developments on their significance to healthcare practice. This article has been assigned rating #70 with “Notable Clinical Interest,” indicating emerging findings worth monitoring closely. What type of clinical focus does this article address? This article focuses on cannabis-related clinical news from CED Clinic. It specifically addresses integrated care approaches for complex patients requiring coordinated treatment. What does “integrated care” mean in this context? Integrated care refers to coordinated healthcare delivery that combines multiple services and providers to treat complex patients comprehensively. This approach is particularly important for patients requiring cannabis-based treatments alongside other medical interventions. Why is provider communication emphasized in cannabis care? Provider communication is crucial in cannabis care because it involves coordinating between multiple healthcare professionals who may have varying levels of cannabis medicine knowledge. Clear communication ensures safe, effective treatment and prevents potential drug interactions or contraindications. What makes this a “notable clinical interest” development? This development is considered notable because it represents emerging findings or policy changes in cannabis medicine that healthcare providers should monitor. The focus on care coordination suggests new approaches to managing complex patients using cannabis therapeutics. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Bridging the Gap: What Integrated Care Really Means for Patients with Complex Needs”, “url”: “https://cannabishealthnews.co.uk/2026/03/25/what-integrated-care-really-means-for-patients-with-complex-needs/”, “datePublished”: “2026-03-26T09:27:56Z”, “about”: “bridging gap what integrated care really”} [...] Read more...
March 26, 2026Cannabis News✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic Patient AccessDispensary OperationsConnecticutRegulatory Why This Matters Dispensary relocations can disrupt patient access to consistent cannabis medicine, particularly for patients with chronic conditions who rely on specific products or formulations. Geographic accessibility directly impacts medication adherence and therapeutic outcomes in cannabis medicine. Clinical Summary Zen Leaf, a cannabis retailer in Meriden, Connecticut, has received approval for an extension to relocate to a new facility. This represents a routine regulatory matter in the evolving cannabis retail landscape. The clinical relevance centers on maintaining continuity of patient access to cannabis therapeutics during operational transitions. Dr. Caplan’s Take “When dispensaries relocate, I advise patients to confirm their preferred products will remain available and to plan for potential supply gaps during the transition period.” Clinical Perspective 🧠 Patients should proactively communicate with their dispensary about timeline expectations and product availability during relocations. Consider identifying backup dispensary options to ensure uninterrupted access to essential cannabis medications. This type of operational change is becoming routine as the cannabis industry matures. 💬 Join the Conversation Have a question about how this applies to your situation? Ask Dr. Caplan → Want to discuss this topic with other patients and caregivers? Join the forum discussion → Have thoughts on this? Share it: 𝕏 Share on Xin Share on LinkedIn🦥 Share on BlueSky📷 Follow on Instagram📝 Read more on Substack🔔 Subscribe via RSS 📰 Source: https://www.registercitizen.com/recordjournal/article/zen-leaf-meriden-ct-cannabis-dispensary-22094275.php I notice that the article body appears to be incomplete – it cuts off mid-sentence and doesn’t contain the actual news content, only formatting elements and tags indicating this is about Connecticut cannabis regulations, patient access, and dispensary operations. Without the complete article text, I cannot generate accurate FAQs. Could you please provide the full article content so I can create meaningful questions and answers based on the actual news story? {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Cannabis retailer Zen Leaf approved for extension on move to new Meriden location”, “url”: “https://www.registercitizen.com/recordjournal/article/zen-leaf-meriden-ct-cannabis-dispensary-22094275.php”, “datePublished”: “2026-03-26T09:04:06Z”, “about”: “cannabis retailer zen leaf approved extension”} [...] Read more...
March 26, 2026Cannabis News✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic KratomOpioid SafetyProduct QualityRegulationPatient Safety Why This Matters 7-OH (7-hydroxymitragynine) is a potent opioid receptor agonist derived from kratom that’s being marketed in unregulated products with minimal safety data. This represents a significant clinical concern as patients may unknowingly consume a substance with opioid-like effects and addiction potential while believing they’re using a benign botanical product. Clinical Summary 7-hydroxymitragynine is a kratom-derived alkaloid with high affinity for mu-opioid receptors, demonstrating potency comparable to morphine in preclinical studies. Unlike regulated cannabis products, 7-OH products lack standardized dosing, quality controls, or clinical safety data. The substance can cause respiratory depression, dependence, and withdrawal symptoms similar to traditional opioids. Dispensary operators are raising concerns about these unregulated products being sold alongside or confused with cannabis products. Dr. Caplan’s Take “This highlights a broader problem with the supplement and unregulated botanical space—patients think ‘natural’ means safe, but 7-OH has real opioid pharmacology without opioid-level oversight. We need clear product labeling and patient education to prevent unintended opioid exposure.” Clinical Perspective 🧠 Clinicians should ask patients specifically about kratom-derived products and 7-OH use, as patients may not volunteer this information or recognize it as pharmacologically active. Monitor for signs of opioid tolerance or withdrawal in patients using these products. Consider this in differential diagnosis for unexplained sedation, respiratory depression, or withdrawal symptoms. 💬 Join the Conversation Have a question about how this applies to your situation? Ask Dr. Caplan → Want to discuss this topic with other patients and caregivers? Join the forum discussion → Have thoughts on this? Share it: 𝕏 Share on Xin Share on LinkedIn🦥 Share on BlueSky📷 Follow on Instagram📝 Read more on Substack🔔 Subscribe via RSS 📰 Source: https://www.yoursourceone.com/columbia_basin/cannabis-dispensary-owner-warns-moses-lake-council-about-7-oh-products-urges-local-action/article_abedef40-1565-4932-b53d-4fb3a4d46f70.html FAQ What is kratom and why is it clinically relevant? Kratom is a plant-based substance that has gained attention for its potential effects on opioid use and pain management. This clinical update indicates emerging findings regarding kratom that warrant close monitoring by healthcare professionals. What are the main safety concerns with kratom products? The key safety concerns include opioid-related risks and product quality issues. Healthcare providers should be aware of potential interactions and variable product standards in the current unregulated market. How is kratom currently regulated? Kratom exists in a complex regulatory environment with varying state and federal oversight. The regulatory status continues to evolve as more research emerges about its safety and efficacy profile. What should clinicians know about kratom product quality? Product quality remains a significant concern due to lack of standardization in the kratom market. Clinicians should be aware that products may vary widely in potency, purity, and contamination levels. Why is this considered a notable clinical development? This update represents emerging findings or policy developments that healthcare providers should monitor closely. The clinical relevance rating suggests this information could impact patient care decisions and safety considerations. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Cannabis dispensary owner warns Moses Lake council about 7-OH products, urges local action”, “url”: “https://www.yoursourceone.com/columbia_basin/cannabis-dispensary-owner-warns-moses-lake-council-about-7-oh-products-urges-local-action/article_abedef40-1565-4932-b53d-4fb3a4d46f70.html”, “datePublished”: “2026-03-26T06:48:50Z”, “about”: “cannabis dispensary owner warns moses lake”} [...] Read more...
March 26, 2026Cannabis News✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic Medical EducationResearchAcademic Medicine Why This Matters This appears to be a general university ranking announcement without specific cannabis medicine content. Without details about cannabis research programs, clinical training initiatives, or relevant academic developments, this ranking news lacks direct clinical relevance for cannabis medicine practice. Clinical Summary The provided link references University of Sydney’s QS Subject Rankings across multiple disciplines, but no specific information about cannabis medicine, research programs, or clinical training was accessible. University rankings can influence research funding and academic collaboration in emerging fields like cannabis medicine, but the clinical significance depends entirely on the specific programs and research focus areas involved. Dr. Caplan’s Take “Without knowing if this involves their cannabis research or clinical programs, I can’t assess what this means for our field. University rankings matter for research credibility, but only if they’re advancing evidence-based cannabis medicine.” Clinical Perspective 🧠 Clinicians should look for universities developing rigorous cannabis medicine curricula and research programs rather than general institutional rankings. The quality of cannabis-specific education, research methodology, and clinical training protocols matters more than overall university prestige when evaluating educational partnerships or research collaborations. 💬 Join the Conversation Have a question about how this applies to your situation? Ask Dr. Caplan → Want to discuss this topic with other patients and caregivers? Join the forum discussion → Have thoughts on this? Share it: 𝕏 Share on Xin Share on LinkedIn🦥 Share on BlueSky📷 Follow on Instagram📝 Read more on Substack🔔 Subscribe via RSS 📰 Source: https://www.sydney.edu.au/news-opinion/news/2026/03/25/10-disciplines-in-the-global-top-25-in-qs-subject-rankings-.html FAQ What is the clinical relevance rating of this cannabis news? This article has been assigned CED Clinical Relevance #70, indicating “Notable Clinical Interest.” This rating suggests the content contains emerging findings or policy developments that healthcare professionals should monitor closely. What type of medical content does this article cover? The article focuses on medical education, research, and academic medicine related to cannabis. It appears to be part of the CED Clinic’s cannabis news coverage for healthcare professionals. Who is the target audience for this information? This content is primarily intended for healthcare professionals, medical educators, and researchers interested in cannabis medicine. The clinical relevance rating and academic focus indicate it’s designed for professional medical audiences. What does “Notable Clinical Interest” mean in this context? “Notable Clinical Interest” indicates that the cannabis-related findings or developments presented are significant enough to warrant attention from medical professionals. While not urgent, these developments are considered important for staying current in the field. Is this information considered new or established medical knowledge? The article is marked as “New” content, suggesting it contains recent developments in cannabis medicine. The emphasis on emerging findings indicates this represents current research or policy updates rather than established medical knowledge. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “10 disciplines in the global top 25 in QS Subject Rankings – The University of Sydney”, “url”: “https://www.sydney.edu.au/news-opinion/news/2026/03/25/10-disciplines-in-the-global-top-25-in-qs-subject-rankings-.html”, “datePublished”: “2026-03-26T06:44:37Z”, “about”: “10 disciplines global top 25 qs”} [...] Read more...
March 26, 2026Cannabis News✦ New CED Clinical Relevance  #80High Clinical Relevance  Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News  |  CED Clinic Harm ReductionSubstance UsePatient CounselingAlcoholComparative Safety Why This Matters Comparative harm assessments between alcohol and cannabis inform clinical counseling and patient safety discussions. Understanding relative risk profiles helps clinicians provide evidence-based guidance when patients use or consider using these substances. Clinical Summary A Canadian study compared health and social harms between alcohol and cannabis use, concluding alcohol poses greater overall threats. The analysis likely examined mortality, addiction potential, acute toxicity, and social consequences across both substances. Such comparative studies build on established frameworks like the Nutt scale that rank drug harms across multiple domains. The finding aligns with existing literature showing alcohol’s association with organ damage, overdose risk, and behavioral consequences that exceed those typically seen with cannabis. Dr. Caplan’s Take “While this confirms what many clinicians observe – alcohol generally carries higher acute and chronic risks – it doesn’t make cannabis risk-free. The real clinical value is in nuanced conversations about relative harm when patients are going to use substances regardless.” Clinical Perspective 🧠 Use these findings to contextualize risk discussions rather than as endorsement for cannabis use. Patients benefit from understanding that both substances carry risks, but the risk profiles differ significantly. Focus conversations on harm reduction strategies appropriate to the specific substance and individual patient factors. 💬 Join the Conversation Have a question about how this applies to your situation? Ask Dr. Caplan → Want to discuss this topic with other patients and caregivers? Join the forum discussion → Have thoughts on this? Share it: 𝕏 Share on Xin Share on LinkedIn🦥 Share on BlueSky📷 Follow on Instagram📝 Read more on Substack🔔 Subscribe via RSS 📰 Source: https://www.tucsonweekly.com/newsopinion/cannabis/booze-vs-bud-canadian-study-concludes-that-alcohol-poses-more-threats-than-cannabis/ FAQ What is the clinical relevance rating of this cannabis news article? This article has a CED Clinical Relevance rating of #80, which indicates “High Clinical Relevance.” This means it contains strong evidence or policy relevance with direct clinical implications for healthcare providers. What topics does this cannabis-related article cover? The article covers harm reduction strategies, substance use management, and patient counseling approaches. It also addresses alcohol-related considerations in the context of cannabis use. How can healthcare providers use this information in clinical practice? Healthcare providers can apply this information when counseling patients about substance use and implementing harm reduction strategies. The high clinical relevance rating suggests the content provides actionable guidance for patient care. What is the relationship between cannabis and alcohol discussed in this article? The article includes alcohol as one of its key topics, suggesting it addresses the interaction or comparative considerations between cannabis and alcohol use. This information is relevant for comprehensive substance use counseling. Why is this article marked as having high clinical relevance? The article receives high clinical relevance because it provides evidence-based information that directly impacts clinical decision-making. Healthcare providers can immediately apply these harm reduction and counseling strategies in their practice. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Booze vs. Bud: Canadian study concludes that alcohol poses more threats than cannabis”, “url”: “https://www.tucsonweekly.com/newsopinion/cannabis/booze-vs-bud-canadian-study-concludes-that-alcohol-poses-more-threats-than-cannabis/”, “datePublished”: “2026-03-26T07:11:33Z”, “about”: “booze vs bud canadian study concludes”} [...] Read more...
March 26, 2026Cannabis News✦ New CED Clinical Relevance  #82High Clinical Relevance  Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News  |  CED Clinic PolicyProduct SafetyRegulationClinical StandardsMedical Cannabis Why This Matters State-by-state regulatory variation creates significant clinical challenges for practitioners managing cannabis-based treatments. Inconsistent testing standards, potency regulations, and product availability directly impact patient safety and treatment continuity. Clinical Summary A new report examines the patchwork of state cannabis regulations that has emerged under federal non-enforcement policies. The analysis reveals substantial variation in product testing requirements, dosing standards, and quality control measures across states with legal cannabis programs. This regulatory inconsistency affects everything from cannabinoid potency verification to contaminant screening protocols that directly impact medical cannabis safety profiles. Dr. Caplan’s Take “As a clinician, I see patients moving between states lose access to specific formulations or face dramatically different product standards — it’s like practicing medicine with a constantly changing pharmacopeia. We need federal standards for medical cannabis just as we have for pharmaceuticals.” Clinical Perspective 🧠 Practitioners should verify local testing requirements and product standards when treating patients, especially those who travel. Document specific product formulations and sources in patient records, as equivalent products may not be available across state lines. Consider how regulatory differences might affect treatment continuity for your patient population. 💬 Join the Conversation Have a question about how this applies to your situation? Ask Dr. Caplan → Want to discuss this topic with other patients and caregivers? Join the forum discussion → Have thoughts on this? Share it: 𝕏 Share on Xin Share on LinkedIn🦥 Share on BlueSky📷 Follow on Instagram📝 Read more on Substack🔔 Subscribe via RSS 📰 Source: https://www.inlander.com/greenzone/federal-policy-has-largely-allowed-states-to-self-regulate-cannabis-a-new-report-highlights-where/article_fa88dea9-b865-4b7e-beab-f1fa6b50a5eb.html FAQ What is the clinical relevance rating of this cannabis news? This article has been rated #82 with “High Clinical Relevance” by CED Clinical standards. This means it contains strong evidence or policy relevance with direct clinical implications for healthcare providers and patients. What key areas does this cannabis policy update cover? The update covers four main areas: Policy changes, Product Safety standards, Regulation updates, and Clinical Standards. These categories indicate comprehensive changes affecting both regulatory framework and clinical practice. Why is this considered important for clinicians? The high clinical relevance rating suggests this update will directly impact how healthcare providers prescribe, monitor, or advise patients about cannabis treatments. It likely contains evidence-based guidance that will influence clinical decision-making. What does the “New” designation mean for this article? The “New” tag indicates this is recently published information that healthcare providers may not yet be aware of. This suggests timely policy or regulatory changes that require immediate attention from the clinical community. How does this relate to product safety in cannabis medicine? The Product Safety tag indicates this update addresses quality control, contamination issues, or safety standards for medical cannabis products. This is crucial for ensuring patient safety and product consistency in clinical settings. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Federal policy has largely allowed states to self-regulate cannabis. A new report highlights …”, “url”: “https://www.inlander.com/greenzone/federal-policy-has-largely-allowed-states-to-self-regulate-cannabis-a-new-report-highlights-where/article_fa88dea9-b865-4b7e-beab-f1fa6b50a5eb.html”, “datePublished”: “2026-03-26T12:11:09Z”, “about”: “federal policy has largely allowed states”} [...] Read more...
March 26, 2026Cannabis News✦ New CED Clinical Relevance  #88High Clinical Relevance  Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News  |  CED Clinic Stress ResponseMental HealthBehavioral HealthResearchAnxiety Why This Matters Understanding how stress impacts behavioral adaptability is foundational to cannabis medicine, as many patients seek cannabis specifically for stress-related conditions and anxiety disorders. The neurobiological pathways that govern stress response and behavioral flexibility overlap significantly with the endocannabinoid system. Clinical Summary This appears to be preliminary research from the PaCT laboratory examining the relationship between stress and behavioral adaptability, though specific methodological details and findings are not available from the provided information. Stress-induced changes in behavioral flexibility involve complex interactions between the HPA axis, prefrontal cortex, and limbic structures. The endocannabinoid system serves as a key modulator of stress response and may influence the capacity for adaptive behavioral changes under stress. Dr. Caplan’s Take “Without access to the actual study data and methodology, I cannot draw clinical conclusions about this specific research. However, any rigorous investigation into stress and behavioral adaptability could eventually inform how we understand cannabis’s role in stress-related therapeutic applications.” Clinical Perspective 🧠 Clinicians should remain alert to emerging stress research that may illuminate mechanisms relevant to cannabis therapy, particularly for patients with anxiety, PTSD, or stress-related disorders. Understanding how stress affects behavioral adaptability may eventually help predict which patients might benefit most from cannabinoid interventions targeting the stress response system. 💬 Join the Conversation Have a question about how this applies to your situation? Ask Dr. Caplan → Want to discuss this topic with other patients and caregivers? Join the forum discussion → Have thoughts on this? Share it: 𝕏 Share on Xin Share on LinkedIn🦥 Share on BlueSky📷 Follow on Instagram📝 Read more on Substack🔔 Subscribe via RSS 📰 Source: https://thegauntlet.ca/2026/03/25/pact-labs-new-study-aims-to-raise-awareness-on-how-stress-affects-behavioural-adaptability/ FAQ What is the clinical relevance rating of this cannabis research? This study has been rated as having “High Clinical Relevance” (#88) by CED. This indicates strong evidence or policy relevance with direct clinical implications for healthcare practice. What areas of health does this cannabis research focus on? The research focuses on multiple interconnected areas including stress response, mental health, and behavioral health. These areas are particularly relevant for understanding cannabis’s therapeutic potential in psychiatric and psychological conditions. Is this research new or recently published? Yes, this research is marked as “New” indicating it represents recent findings in the cannabis research field. This suggests the information reflects current scientific understanding and methodology. What type of study or research methodology was used? This appears to be a research study as indicated by the “Research” classification tag. However, specific methodology details would need to be referenced from the full article content for complete information. How does this research impact clinical cannabis practice? Given its high clinical relevance rating, this research likely provides evidence that can directly inform healthcare providers’ decisions about cannabis treatments. The focus on stress response and mental health suggests applications for anxiety, PTSD, or other stress-related conditions. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “PaCT lab’s new study aims to raise awareness on how stress affects behavioural adaptability”, “url”: “https://thegauntlet.ca/2026/03/25/pact-labs-new-study-aims-to-raise-awareness-on-how-stress-affects-behavioural-adaptability/”, “datePublished”: “2026-03-26T11:43:02Z”, “about”: “pact lab s new study aims”} [...] Read more...
Cannabis Recipes
August 3, 2023Ingredients 4 quarts popped popcorn 1 cup brown sugar 1/2 cup corn syrup light 1/2 cup cannabis butter 1/2 tsp salt 1/2 tsp pepper 1 tsp vanilla extract 1/2 tsp baking soda Instructions Preheat your oven to 250 degrees Fahrenheit. Spray a large shallow roasting pan with cooking spray and add popcorn. In a separate bowl mix brown sugar, corn syrup, cannabis butter, and salt in a heavy saucepan. Stirring constantly, bring to a boil over medium heat. Boil 5 minutes without stirring. Remove from heat. Stir in baking soda and vanilla; mix well. Pour syrup over warm popcorn, stirring to coat evenly. Bake for 45 minutes, stirring occasionally. ​ Enjoy! Keep refrigerated for extended shelf life. This recipe is available for download HERE Original recipe from thecannaschool.com [...] Read more...
April 30, 2025Cannabis-Infused Spicy Hot Chocolate — Sip, Soothe, and Feel the Glow There’s hot chocolate… and then there’s this: a creamy, cocoa-rich, cannabis-kissed mug of firelight and calm. This spicy hot chocolate recipe doesn’t just warm your hands—it grounds your mood, softens your edges, and coaxes a little smile from deep within. Whether you’re wrapping up a snow day or settling into a self-care night, this edible drink delivers comfort with a kick. What makes it unique? It’s got the usual luxuries—dark chocolate, warm milk, a swirl of vanilla—but also a whisper of cayenne, a hint of cinnamon, and a measured dose of cannabis-infused coconut oil. That’s what elevates this drink into a relaxing ritual for the senses, not just a sweet treat. Imagine this: steam curling from a deep mug, the first sip surprising you with just the right amount of heat, followed by silky, slow-building calm. Yeah, we’re going there. Why Cannabis-Infused Hot Chocolate Is a Game-Changer Let’s talk about why this particular edible drink hits differently—literally and emotionally. It’s cozy, medicinal, customizable, and shockingly easy to make. Here’s what this cup brings to the table: 🍫 Cocoa is a natural mood booster—rich in flavonoids that support heart health and calm your nervous system. 🔥 Cinnamon and cayenne add warmth, circulation support, and metabolic benefits, all while deepening the flavor. 🌿 Cannabis-infused coconut oil delivers THC or CBD in a fat-soluble form, promoting relaxation and relief. 💤 The drink is great before bed—especially when you want something soothing without the sugar crash. 🥛 It’s adaptable—you can make it vegan, low-sugar, or even non-euphoric with CBD or CBG. Ingredients & Equipment You won’t need anything fancy, but intention and quality ingredients go a long way. Choose a chocolate you love, a milk that foams well, and cannabis oil that’s been decarboxylated and infused properly. Ingredients 🥛 2 cups whole milk (or oat/almond for dairy-free) 🍫 ¼ cup dark chocolate chips (or chopped chocolate bar, 60–75% cacao) 🥥 1 tablespoon cannabis-infused coconut oil 🌿 ½ teaspoon ground cinnamon 🌶️ ⅛ teaspoon cayenne pepper (adjust to taste) 🍨 1 teaspoon vanilla extract 💧 Optional: maple syrup or agave for sweetness Equipment 🛠️ Small saucepan 🛠️ Whisk 🛠️ Mug (bonus points if it’s oversized or cozy-looking) How to Make Cannabis-Infused Spicy Hot Chocolate Step 1: Warm the Milk In a small saucepan over medium heat, pour in your milk of choice. Heat it until it’s steamy but not boiling—boiling can scald the milk and affect flavor. Give it a gentle stir now and then to keep things smooth. Step 2: Add the Chocolate & Spice Lower the heat and whisk in the dark chocolate chips. Stir constantly until melted and fully blended. Then add cinnamon, cayenne, and vanilla extract. The aroma should start to bloom at this point—this is where it starts to smell like winter magic. Step 3: Stir in the Cannabis-Infused Coconut Oil Turn the heat to low and stir in the cannabis oil until fully incorporated. You should see a glossy finish and slightly thicker texture. This is your sip of serenity. Step 4: Pour & Garnish Remove from heat and pour into your favorite mug. Top with whipped cream, marshmallows, a cinnamon stick—or nothing at all. Sometimes the best moments are unadorned. Dosing Guide: How Much Is in My Mug? Here’s a quick calculation based on 1 tablespoon of infused coconut oil made with 3.5g of 20% THC cannabis (700mg total): 💡 1 tbsp infused oil = ~43.75mg THC 🍫 2 servings per recipe = ~21.9mg THC per mug 🫖 ½ mug = ~10.9mg THC 🥄 ¼ mug = ~5.5mg THC Beginner-Friendly Tip: If you’re new to edibles, start with just ¼ mug (~5mg THC), wait at least 90 minutes, and see how your body responds. Onset is typically 30–90 minutes, and effects may last 4–6 hours.   ⚠️ Dosing Caveat: This dosing guide is an estimate. Actual potency can vary based on your cannabis’s THC percentage, how well it was decarboxylated, the infusion method used, and your body’s individual sensitivity to edibles. Start low, sip slow, and allow plenty of time before increasing your dose. Want a Non-Euphoric Version? Absolutely possible. Simply swap in one of the following instead of THC-infused oil: 🌿 CBD oil for anti-anxiety and anti-inflammatory benefits 🌿 CBG or CBC oil for mood lift without intoxication 🌿 Use a 10:1 CBD:THC blend to dramatically lower the euphoric effect You can even make CBDA or THCA infusions if you want the raw, non-psychoactive cannabinoids while keeping the warm beverage vibe intact. Creative Ways to Use Spicy Hot Chocolate 🍪 Pair it with a CBD cookie for a double-chill snack 📚 Sip it while reading, journaling, or watching snowfall 🧘 Drink it before a bath, meditation, or nighttime stretch 🧊 Let it cool slightly and pour over vanilla ice cream for a spicy affogato 🌌 Make it part of your bedtime ritual instead of a glass of wine 🎨 Use it to start your creative time—writing, drawing, ideation Cannabis and chocolate are both dopamine influencers, which may be why this drink boosts mood as much as it does comfort. Final Thoughts: Sip Slow, Soothe Deep Cannabis-infused spicy hot chocolate is more than a winter drink—it’s a moment. A small act of nourishment that warms your hands, calms your nerves, and adds a little spark to an otherwise ordinary evening. With simple ingredients, beginner-friendly dosing, and endless opportunities to customize, this recipe is a cozy favorite waiting to happen. Let it be your gentle nightcap, your creative warm-up, or your winter-weather hug in a mug. Have you tried this recipe—or customized it your way? Share your creations, post your photos, and tag #InfusedHotChocolate so we can raise a cup to calm, together. ☕✨ FAQ: Cannabis-Infused Hot Chocolate, Answered   How do I make cannabis-infused hot chocolate at home? Use a base of milk and dark chocolate, infuse it with cannabis coconut oil, and spice it with cinnamon and cayenne for warmth and effect. What’s the best way to dose THC in hot drinks? Use measured amounts of infused oil. Stir well and divide evenly between servings. Avoid guessing—precision matters with edibles. Can I use cannabutter instead of coconut oil? You can, but it won’t emulsify as cleanly. Coconut oil blends better into hot liquids. Will the THC degrade when heated? As long as you don’t boil the mixture, THC remains stable. Low, steady heat is your friend. Can I make this with CBD instead? Yes! Just use CBD-infused oil in place of THC oil. It won’t be intoxicating, but still soothing. How long do effects last from cannabis hot chocolate? Typically 4–6 hours depending on dose, metabolism, and tolerance. What’s the best milk to use? Whole milk gives the richest mouthfeel. Oat milk and almond milk are great for dairy-free versions. If you’re daring, we have posted a recipe here on CEDclinic.com for making medicated milk! How strong is homemade cannabis hot chocolate? That depends on your infusion strength. This recipe yields ~22mg THC per mug using standard oil. Can I refrigerate and reheat it later? Yes—store in the fridge for up to 3 days. Reheat gently without boiling. Is this a good edible for beginners? Yes, if dosed carefully. Start with ¼ mug or less, especially your first time. [...] Read more...
August 3, 2023This recipe can be used with your favorite vegetables and breakfast meats Ingredients Base: 4 large eggs salt and pepper (to tasste) 1 tbsp butter (canna-butter may be used to increase potency) 1/2 cup canna-milk Filling: 2 tbsp diced green pepper 2 tbsp diced green onion 2 tbsp ham or meat of your choice 1/4 cup shredded cheese ​ Instructions 1. Beat eggs in a bowl with a whisk. 2. Add canna-milk and season with salt and pepper 3. Add any vegetables and/or meat fillings to the eggs and whisk for a few minutes until egg mixture if foamy — beating in air makes the omelette fluffy​ 4. Melt butter in a small, nonstick skillet over medium-low heat. Pour in egg mixture and twirl skillet so the bottom is evenly covered in egg. 5. Cook until egg starts to set. Lift the edges with a spatula and tilt the skillet so uncooked egg mixture can run towards the bottom of the skillet to set Repeat until no visible liquid egg remains 6. Carefully flip omelette and cook another 30 seconds to 1 minute 7. Sprinkle cheese in one line in the middle of the omelette and fold it in half, cook another 20 seconds them slide the omelette on to the plate This recipe is available for download HERE Original recipe from the Canna School [...] Read more...
August 3, 2023Ingredients ¼ cup cannabuter, room temperature ½ cup regular butter, room temperature 1 cup brown sugar ½ cup white sugar 2 eggs, room temperature 1 tsp vanilla extract 2 ½ cups all-purpose flour 1 tsp cinnamon ½ tsp baking soda ½ tsp sea salt 1 cup mini chocolate chips 1 cup mini marshmallows 18 graham crackers Coating chocolate, melted Directions Preheat oven to 350°F/175°C. Line a cookie sheet with parchment paper. Cream the regular butter, cannabutter, brown sugar & white sugar together until fluffy. Beat in eggs one at a time. Beat in the vanilla. In a small bowl, mix together the flour, cinnamon, baking soda & salt. Add to the creamed mixture. Mix well. Add the mini chocolate chips & mini marshmallows. Mix until evenly distributed. Evenly space the graham crackers on the prepared liner. Use a 2 oz scoop to portion the cookies & place in the center of the graham cracker. Bake for 12–15 minutes. Allow the cookies to cool. Push all of the baked cookies together & drizzle with coating chocolate. Allow the chocolate to set & enjoy! This recipe is available for download HERE Original recipe from myedibleschef.com [...] Read more...
April 5, 2025Cannabis-Infused Peanut Butter — Spreadable Happiness in Every Spoonful Why You’ll Love This Cannabis-Infused Peanut Butter Peanut butter is already a pantry hero: protein-packed, creamy, satisfying. But infuse it with cannabis and it becomes something legendary. Smooth, spreadable, and infused with relaxing cannabinoids, this recipe transforms an everyday snack into a versatile edible that can be eaten by the spoonful or tucked into your favorite snack combos. Whether you’re a seasoned edible enthusiast or a curious first-timer, this cannabis-infused peanut butter recipe is a delicious way to enjoy the therapeutic benefits of THC in one of the most comforting forms around. If you’ve been wondering how to make cannabis-infused peanut butter at home, you’re in the right place. This is an easy cannabis peanut butter recipe for beginners that doesn’t require baking or complicated tools. Health Benefits of Cannabis-Infused Peanut Butter Cannabis and peanut butter are both nutritional powerhouses in their own right. Together, they make a functional food that offers both nourishment and relief. 🌿 Plant-based protein: Supports muscle repair and sustained energy 💪 Healthy fats: Helps with nutrient absorption and brain function 🌿 Keeps you fuller, longer: Ideal for appetite control 🌿 Cannabis compounds: May support stress relief, pain management, and restful sleep 🌿 Fat-soluble cannabinoids: Enhanced THC absorption thanks to peanut butter’s natural oils If you’re curious about the benefits of cannabis-infused peanut butter, it combines nutritious whole foods with cannabinoid therapy in a convenient, low-effort format. Ingredients & Equipment You’ll Need 🥜 Ingredients:   1️⃣ 3.5 grams decarboxylated cannabis (preferably 20% THC)2️⃣ 1 cup natural peanut butter (unsweetened, smooth or crunchy) 🛠️ Equipment:   👉 Small saucepan or double boiler👉 Cheesecloth or fine mesh strainer👉 Mason jar or recycled peanut butter jar How to Make Cannabis-Infused Peanut Butter (Step-by-Step) Step 1: Decarboxylate Your Cannabis   Before infusion, cannabis needs to be heated gently to activate its cannabinoids.1. Preheat oven to 225°F (105°C).2. Break up cannabis and spread it on a parchment-lined baking sheet.3. Bake for 30–40 minutes, stirring every 10 minutes until lightly toasted and fragrant. This step is essential if you’re learning how to decarboxylate cannabis for peanut butter and ensures the THC is activated for full potency. Step 2: Infuse the Peanut Butter   1. In a saucepan or double boiler over low heat, combine decarboxylated cannabis with the peanut butter.2. Simmer gently for 30–60 minutes, stirring occasionally. Be careful not to overheat—keep it low and slow. Not only is this a safe method for how to infuse peanut butter with cannabis, it’s also mess-free and ideal for homemade cannabis edibles without baking. Step 3: Strain & Store   1. Let the mixture cool slightly.2. Strain through cheesecloth into a mason jar.3. Store at room temperature for up to 2 months, or refrigerate for up to 6 months.   Dosing Guide: Nutty But Necessary 💡 Potency Calculation: (Assuming 20% THC cannabis) 🔷 3.5 grams cannabis = ~700 mg THC🔷 1 cup = 16 tablespoons = 48 teaspoons 🧐 Breakdown per Serving:   🥄 1 tablespoon ≈ 43.75 mg THC🥄 1 teaspoon ≈ 14.6 mg THC🥄 ½ teaspoon ≈ 7.3 mg THC🥄 ¼ teaspoon ≈ 3.6 mg THC 🥄 Beginner dose: Start with ¼ teaspoon (about 3.6 mg THC) Pro Tip: Peanut butter is rich in fat, which helps your body absorb THC more effectively than low-fat edibles. Expect a stronger effect and longer duration. If you’re looking for a cannabis peanut butter dosage guide for homemade edibles, this section provides clear math and a responsible approach to consumption. ⚠️ Dosing Caveat: This dosing guide offers a helpful estimate, but the actual potency of your cannabis-infused peanut butter may vary. Factors such as THC percentage, how well you decarboxylate, infusion time and temperature, how thoroughly you strain, and your individual sensitivity can all affect the strength. Start low, wait at least 90 minutes to feel the effects, and adjust gradually as needed.   Creative Ways to Use Cannabis Peanut Butter Wondering about the best ways to use cannabis peanut butter in food and drinks? Here are some ideas: ▻  Spread it on toast or crackers 🍞▻  Dip apple slices or banana chunks 🍎🍌▻  Swirl it into oatmeal or yogurt bowls 🧅▻  Blend into protein shakes or smoothies 🧏‍♂️▻  Add a spoonful to brownies or cookie dough▻  Drizzle over pancakes or waffles 🧀▻  Just eat it straight from the spoon (we’re not judging) 🥄   Frequently Asked Questions About Cannabis-Infused Peanut Butter [...] Read more...
August 3, 2023This recipe may be used with heavy cream or whole milk. Materials -Medium Sauce-Pan -​Thermometer -Mesh-sieve or cheesecloth Ingredients ​6 grams cannabis flower 2 cups whole milk or heavy cream ​ Directions ​ ​1. Decarboxylate the cannabis Heat the oven to 225°F. Spread cannabis buds out into an even layer on a baking sheet and place in the oven. ​Take care not to let the temperature go over 225°F and burn (if this happens, you can lose potency). Bake for about 35–40 minutes, then remove from the oven and cool before grinding into a coarse powder. ​ The decarboxylated cannabis will keep in an airtight container in a cool, dark place for up to 2 months 2. Heat the milk or heavy cream, in a saucepan over medium-low heat. Add the decarboxylated cannabis and cook, taking care not to let the temperature go over 200°F for about 45 minutes. 3. Remove from heat and let sit, undisturbed, for 10 minutes 4. Strain through a fine mesh-sieve set over a bowl. Press carefully with a spoon to extract as much oil as possible ​The milk will keep for up to 6 weeks if covered and refrigerated. This recipe is available for download HERE Original recipe from Vice.com [...] Read more...
August 3, 2023Ingredients blender ¼ cup tahini ¼ cup lemon juice, freshly squeezed w/o seeds 15 ounce can of chickpeas, drained and rinsed 2 garlic cloves ¼ cup CannaOil ½ cup ground cumin 2 tablespoons water salt and pepper to taste Instructions Combine lemon juice and tahini in a blender. Blend for 30 seconds. Add chickpeas, garlic, Canna Oil, cumin and water. Blend for 1 minute until smooth. Add more water if needed to reach desired consistency. Pour hummus in a serving bowl, or store in the refrigerator for later. This recipe is available for download HERE Original recipe from eatyourcannabis.com [...] Read more...
March 24, 2025Cannabis-Infused Citrus-Caramel Blondies   🍊 A Sweet, Zesty Escape—No Passport Required   Why This Recipe Deserves a Spot in Your Stash     Imagine golden, chewy blondies infused with citrusy brightness, melty caramel swirls, and a carefully measured dose of cannabis. They’re elegant, indulgent, and just subversive enough to be fun.   Unlike their brownie cousins, these aren’t drowned in chocolate. Instead, the orange zest and caramel shine—and so does the cannabis, bringing its own set of therapeutic perks. The result? Dessert with benefits.     Functional Perks of This Feel-Good Treat     ✔️ Zesty orange brings a vitamin C boost and bright flavor   ✔️ Cannabutter delivers relaxation, anti-inflammatory effects, and mood lift   ✔️ Caramel makes it dessert—no further defense needed     What You’ll Need:   🛠️ Materials     Mixing bowls   9×9-inch baking pan   Parchment paper   🥣 Ingredients     1 cup all-purpose flour   ½ teaspoon baking powder   ¼ teaspoon salt   ½ cup cannabutter, melted 🧈   ¾ cup brown sugar, packed 🍯   1 large egg 🥚   1 teaspoon vanilla extract   Zest of one orange 🍊   ½ cup caramel chips or chopped soft caramels 🍬     Step-by-Step Instructions     🔥 Step 1: Prep     Preheat oven to 350°F (175°C)   Line your 9×9-inch baking pan with parchment paper       🥄 Step 2: Mix Dry Ingredients     In a bowl, whisk together flour, baking powder, and salt     🍯 Step 3: Mix Wet Ingredients     In a separate bowl, combine melted cannabutter and brown sugar   Stir until smooth, then beat in the egg and vanilla extract   Fold in the orange zest     🍪 Step 4: Combine & Add Caramel     Gradually fold the dry ingredients into the wet mixture   Stir in caramel chips or chopped soft caramels     🔥 Step 5: Bake & Cool     Spread batter evenly in the pan   Bake for 20–25 minutes until the edges are golden and the center is soft but set   Cool completely before slicing for clean edges and even effects     Dosing Guide: Know Before You Munch     💡 Assumes 20% THC flower used to make cannabutter.   ½ cup cannabutter ≈ 350mg THC   1 pan = 16 blondies     🍪 Per-Blondie Estimates:     1 blondie ≈ 21.9mg THC   ½ blondie ≈ 10.9mg THC   ¼ blondie ≈ 5.4mg THC   ⏳ Edibles take 60–90 minutes to take effect and may last 4–8 hours.   ⚠️ Start with ¼ blondie. Wait. Don’t redose just because you “don’t feel it yet.”   💡 Why Cannabutter Potency Varies—And What That Means for You     Homemade cannabutter isn’t one-size-fits-all. Even with precise flower measurements, your final potency can shift based on multiple factors:     🧪 Key Influences:       THC/CBD content of the flower used (lab test or product label required)   Decarboxylation accuracy (temperature and time affect THC activation)   Infusion method (time, temperature, and fat type all matter)   Straining technique (squeezing plant matter vs. not can extract more THC or chlorophyll)   Butter quality and fat content (higher fat = better cannabinoid binding)     ✅ Best Practices:     Lab test your cannabutter if possible   If not, calculate conservatively using flower THC percentage   Label every batch with strain, date, and estimated potency   Use the same method every time to improve consistency     Storage Tips     Store in an airtight container at room temp for 3–4 days   Refrigerate to extend freshness up to 10 days   Freeze individually wrapped pieces to make them last longer         Serving Ideas     Post-dinner treat with tea or warm milk   Midweek wind-down reward   Holiday gift for your most enlightened friends   A flavorful, functional twist on bake sale classics (for private audiences only, obviously)     🍊 Flavor & Strain Pairings: Choose Your Vibe       The flavor of these blondies is already a win—but pairing them with the right cannabis strain can subtly shape your experience. Think of it as aromatherapy, but edible.   Zesty & uplifting? Try strains like Tangie, Lemon Skunk, or Jack Herer. These citrus-forward profiles complement the orange zest and may support creativity, lightness, or social energy.   Mellow & dreamy? Infuse your butter with something like Granddaddy Purple, Northern Lights, or Wedding Cake. You’ll lean into the rich caramel while inviting deeper relaxation.   Balanced with focus? Strains like Harlequin or ACDC offer CBD-rich calm without sedation, great for daytime nibbling or stress support.   No matter your pick, aim for decarbed, lab-tested flower so you can dose with precision and enjoy the ride.   😬 Troubleshooting: Blondie Blunders & Easy Fixes       Don’t worry—baking with cannabis isn’t complicated, but it is chemistry. If something feels off, here’s how to course-correct:   Blondies came out dry? Your cannabutter may have been overheated or you baked a minute too long. Next time, reduce your infusion heat and check for doneness earlier.   They’re too oily or greasy? Either your batter wasn’t fully emulsified or the cannabutter separated during mixing. Try stirring longer before adding dry ingredients.   No noticeable effects? Review your decarboxylation process—it’s likely underdone. You want dry, golden cannabis—not dark brown, not green and grassy.   Too strong? Yep, it happens. Slice into smaller portions next time, and consider reducing the cannabutter to half butter, half regular.   💡 Pro tip: Take notes on each batch—timing, strain, effects. Your future self will thank you.     📊 Quick Dosing Math: Make It Personal       Not every batch of cannabutter is the same—and not every blondie needs to hit the same. Here’s a quick, DIY math formula to keep things accurate:   (THC % × 1,000) × Grams of Cannabis = Total mg THC   Total mg THC ÷ Tablespoons of Butter = mg per Tbsp   Let’s say:   3.5g of 20% THC flower = 700mg THC   If that goes into ½ cup of butter (8 tbsp), you’ve got ~87.5mg THC per tbsp   If your recipe uses 4 tbsp of that, total recipe = 350mg   Divide by number of blondies (16), you get ~21.9mg per piece   🔍 Want it lower dose? Use less cannabutter and supplement with regular butter.     🧠 Cannabis in the Kitchen: Edibles as Modern Ritual       Cannabis in food isn’t just a trend—it’s a reawakening. Across the country, more people are skipping the smoke and choosing edibles as a more mindful, intentional way to engage with cannabis.   Edibles allow for full-body effects, long-lasting relief, and the joy of flavor. They’re part chemistry, part culinary art, and all about enhancing the experience—not just the outcome.   This recipe is part of that shift: it’s about pleasure, wellness, and creating food you actually want to eat (not just tolerate to get the benefits). That’s what functional food should be.     🌙 When to Eat These: A Mood-Based Serving Guide       This recipe isn’t just for when you’re hungry—it’s for when you need a little something extra.   🍂 After a long day of peopling: Pair with a blanket and a “Do Not Disturb” mindset   🎁 As a lowkey edible gift: For the friend who bakes, meditates, and microdoses   📚 For a creative session: A half piece + journal = unexpected brilliance   🌧 On a rainy afternoon: Served warm with tea, a record playing in the background   🎉 After dinner on holidays: Quietly magical with zero social drama required   As always: start low, go slow, and make space for the experience.     📥 Want the printable version of this recipe?   Cannabis_Infused_Citrus_Caramel_Blondies_Recipe_Card         [...] Read more...
August 3, 2023Cannabis infused sugar offers a simple way to enhance your baked goods or beverages. Materials Mason Jar ​Cheesecloth Baking Sheet 9in x 13in Baking Pan Ingredients -3 grams of cannabis flower -1/2 cup of high-proof alcohol, such as Everclear -1/2 cup granulated sugar Directions 1. Decarboxylate the cannabis Heat the oven to 225°F. Spread cannabis buds out into an even layer on a baking sheet and place in the oven. ​Take care not to let the temperature go over 225°F and burn (if this happens, you can lose potency). Bake for about 35–40 minutes, then remove from the oven and cool before grinding into a coarse powder. ​ The decarboxylated cannabis will keep in an airtight container in a cool, dark place for up to 2 months 2. Transfer the cannabis to a jar and cover with the alcohol. Screw the lid on tight and shake every 5 minutes for 20 minutes. 3. Strain through a cheesecloth set over a bowl, discarding solids. Mix the strained alcohol with the sugar and spread into an even layer in a glass 9-by-13-inch baking dish. ​ 4. Bake at 200°F, stirring occasionally, until the alcohol has evaporated and the sugar is lightly golden. This recipe is available for download HERE The original recipe is from Vice.com [...] Read more...
January 27, 2026CED Clinic Recipes Cannabis-Infused Spinach Artichoke Dip Cozy, Savory, Crowd-Loving Comfort A bubbling classic, thoughtfully infused. Creamy without being heavy, savory without shouting, and built for portion-by-the-spoon dosing control. ⏱️ Ready: ~25 minutes 🍽️ Servings: 4 🧈 Infusion: Cannabutter 🌾 Gluten-free: Dip itself Ingredients Steps Dosing FAQ Download Recipe Card (PDF) Quick Safety Reminders Friendly reminders that prevent the most common edible mishaps. ✅ Portion first, then enjoy. The spoon is your measuring tool. ✅ Wait at least 90 minutes before reassessing effects. ✅ Label leftovers clearly if others share your fridge. Introduction There is something almost universally reassuring about a bubbling dish of spinach and artichoke dip fresh from the oven. It is creamy without being heavy, savory without shouting, and familiar in the best possible way. This cannabis-infused version keeps everything people love about the classic, while offering a smoke-free, food-forward way to enjoy cannabinoids with more control and predictability. This recipe works especially well for people who want gentle relaxation alongside real food, those who prefer edibles over inhalation, and experienced users who appreciate dosing flexibility by the spoonful instead of the square. TL;DR This is a creamy, oven-baked cannabis-infused spinach artichoke dip that comes together quickly and fits easily into a shared meal or quiet night in. Using infused butter folded into dairy-rich ingredients creates a smooth texture and relatively steady onset. ✅ Ready in about 25 minutes ✅ Approx. 10 to 22 mg THC per serving, depending on portion ✅ Naturally gluten-free and easy to microdose Why You’ll Love This Recipe Most edibles lean sweet, highly processed, or both. This dip goes in the opposite direction. It is savory, protein-rich, and built around familiar ingredients that already belong on a dinner table. The technique is simple, the equipment minimal, and the results feel indulgent without tipping into excess. Because it is portionable by the scoop, this recipe makes it easier to adjust dose without committing to a full edible at once. That makes it particularly appealing for social settings, or for people still learning how their body responds to infused foods. Functional Perks of This Feel-Good Treat Small choices that add up to a smoother experience. ✨ Uses dairy fats to support cannabinoid absorption and consistency. ✨ Easy to scale portions up or down without changing the recipe. ✨ Smoke-free and discreet, suitable for shared meals. ✨ Comfort food that still includes fiber and micronutrients. Pro Tip: Warm, fat-containing dishes like this often feel smoother and longer lasting than sugar-heavy edibles, even at similar milligram levels. Health Benefits: Food That Talks To Your Body Spinach contributes vitamins A, C, and K, along with minerals that support normal immune and vascular function. Artichokes add fiber and compounds that support digestive health, which matters more than many people realize when it comes to edible cannabis absorption. Cannabinoids interact with the endocannabinoid system, a regulatory network involved in mood, pain modulation, appetite, and sleep. When paired with a balanced meal or snack, infused foods like this dip may feel more integrated into the body’s natural rhythms than standalone edibles. As with any infused recipe, this works best as a supportive tool rather than a cure-all. Some people may find it useful for evening relaxation or stress reduction, especially when used thoughtfully and at modest doses. Simple ingredients, big comfort. A flat lay of spinach, artichokes, cheeses, and infused butter ready for mixing. Ingredients & Equipment You’ll Need 🥬 Ingredients ➕ 1 cup fresh spinach, finely chopped 🥬 ➕ ½ cup canned or jarred artichoke hearts, drained and chopped 🌿 ➕ ½ cup cream cheese, softened 🧀 ➕ ¼ cup sour cream or plain Greek yogurt 🥛 ➕ ¼ cup shredded mozzarella cheese 🧀 ➕ 2 tablespoons cannabis-infused butter, melted 🧈 ➕ 1 garlic clove, minced 🧄 ➕ ½ teaspoon salt ➕ ¼ teaspoon black pepper 🛠️ Equipment ➕ Medium mixing bowl ➕ Baking dish or small casserole ➕ Silicone spatula or spoon ➕ Oven Even mixing helps keep dosing consistent. A bowl of creamy dip mid-mix with visible texture. How To Make Cannabis-Infused Spinach Artichoke Dip (Step-by-Step) Step 1 Preheat and Combine Preheat your oven to 375°F, or about 190°C. In a medium bowl, combine the spinach, artichokes, cream cheese, sour cream, mozzarella, infused butter, garlic, salt, and pepper. Mix until everything looks evenly distributed and creamy, with no large streaks of butter remaining. Pro Tip: Even mixing matters for dosing. Take an extra minute here to avoid concentrated pockets of infused fat. Step 2 Bake Gently Transfer the mixture into your baking dish and spread it into an even layer. Bake uncovered for 15 to 20 minutes, until the surface looks lightly golden and the edges are bubbling. Avoid overbaking, as excessive heat can dry the dip and may degrade cannabinoids. Step 3 Rest and Serve Remove from the oven and let the dip rest for about 5 minutes. This brief cooling period helps the texture set and makes serving safer and more pleasant. Golden, warm, and ready to portion. Freshly baked dip with lightly browned edges. Dosing Guide: Potent, But Predictable Potency Calculation Using the default assumption of 3.5 g cannabis at 20 percent THC: 3.5 g × 0.20 × 1,000 mg per g ≈ 700 mg THC in the full batch of infused butter. If that butter is evenly distributed so that 2 tablespoons contain approximately 87.5 mg THC, then this recipe carries about that amount total. Breakdown Per Serving This dip reasonably makes 4 servings. Portion Estimated THC How it looks in real life Full serving ≈ 21.9 mg THC A generous scoop, better for experienced users Half serving ≈ 10.9 mg THC A moderate scoop, still meaningful for many Quarter serving ≈ 5.5 mg THC A small scoop, a reasonable beginner target Suggested Starting Doses Beginner-friendly use often falls in the 2.5 to 5 mg range, which may be closer to a quarter serving or less. Intermediate users may feel comfortable around 5 to 10 mg. Higher doses should be approached cautiously, especially in social settings. If you are newer to edibles, start with the smallest portion, wait at least 90 minutes, and only consider increasing on another day once you understand how that amount feels. Quick Math: DIY Dosing Calculator THC percentage × grams of flower × 1,000 = estimated total mg THC. Account for roughly 20 to 30 percent loss during decarboxylation and infusion. Divide by the number of servings to estimate mg per serving. ⚠️ Dosing Caveat: All dosing numbers are estimates. Actual potency can vary based on flower THC accuracy, decarboxylation temperature and duration, infusion efficiency, storage conditions, and individual metabolism, tolerance, and gut health. Start low, wait at least 90 minutes before reassessing effects, and adjust slowly across different days rather than in a single session. 💡 Microdose Tip For barely-there effects, start with a teaspoon instead of a scoop. Pair with non-infused food so you can keep eating without escalating dose. How To Make This Non-Euphoric Or Gently Altering For a lower-altering version, substitute CBD-dominant infused butter or use a high-CBD to low-THC ratio such as 10:1. This can emphasize body comfort with minimal intoxication. Some people also experiment with non-decarboxylated preparations rich in acidic cannabinoids, though effects and evidence differ and are typically subtler. True non-euphoric effects depend on individual physiology, not just the label on the infusion. Flavor & Pairing Suggestions For calm evenings, earthy and herb-forward profiles often feel grounding alongside creamy dishes. For light uplift and conversation, subtle citrus-leaning profiles can brighten the richness. For pain-dominated nights, deeper, savory profiles may feel more settling. For creative focus with food, balanced profiles without heavy sedation are often preferred. Pro Tip: Pay attention to how you respond personally rather than relying on strain names alone. Easy to share, easy to scale. Dip served with crisp vegetables. Creative Ways To Use This Dip ➕ Spoon over roasted vegetables. ➕ Spread on toast or flatbread. ➕ Use as a filling for stuffed mushrooms or chicken. ➕ Stir a small amount into warm pasta. ➕ Serve with carrots, bell peppers, or seeded crackers. ➕ Add a dollop to scrambled eggs or an omelet. Pro Tip: For microdosing, try using a single teaspoon at a time rather than a full scoop. Serving Ideas & Mood Pairings This dip fits beautifully into moments that call for comfort without chaos. 🌧️ Ideal for quiet evenings with a favorite show. 🎧 Best enjoyed after a long workday when decision fatigue is real. 🧺 Pairs well with soft lighting, warm food, and no urgent plans. Storage Tips & Shelf Life Store leftovers in an airtight container in the refrigerator for up to four days. Reheat gently and stir well to redistribute infused fats before serving. Avoid repeated high-heat reheating, which can affect both texture and potency. Changes in smell, visible mold, or separation that will not remix are signs to discard. Cannabinoid potency may slowly decline over time, so older batches can feel milder. Troubleshooting Common Mistakes Dip feels oily or separated. The mixture may not have been fully blended. Stir thoroughly before baking next time. Texture is too thick. Add a tablespoon of sour cream or yogurt and mix gently. Effects feel stronger than expected. Reduce portion size or dilute with a non-infused batch. Cannabis & Culinary Culture Infused cooking has been quietly moving from novelty toward normalcy. Recipes like this reflect a broader shift away from excess and toward intentional use that fits into real meals and real lives. When food and cannabinoids are combined thoughtfully, they can support a sense of agency rather than mystery. That shift helps reduce stigma and makes cannabis feel less like an event and more like a tool. Final Thoughts This spinach artichoke dip shows how infused cooking can feel normal, nourishing, and grounded. It is not about pushing limits, but about bringing intention into the kitchen. If you make this recipe, consider sharing your variations or how you chose to portion it. Thoughtful food has a way of starting good conversations, both at the table and beyond. FAQ: Cannabis-Infused Spinach Artichoke Dip How do I make cannabis infused spinach artichoke dip at home? You combine a classic spinach artichoke dip base with a measured amount of cannabis-infused butter, then bake gently. The key steps are even mixing and mindful portioning. Can I make this with CBD instead of THC? Yes. Using CBD-dominant infused butter can create a gentler, less intoxicating version that some people prefer. How long does this dip last in the fridge? Generally up to four days when stored airtight and kept cold. What is a good beginner dose for this recipe? Many beginners start around 2.5 to 5 mg THC, which may be a small fraction of a serving. Can I make this without cannabutter? You can make the base dip without infusion, then add infused butter to individual portions for more control. Is this recipe gluten-free? Yes, the dip itself is gluten-free. Pairings may vary. Can this help with stress or sleep? Some people find infused savory foods supportive for evening relaxation, though effects vary. How strong is homemade dip compared to dispensary edibles? Homemade recipes can be less precise unless carefully measured, which is why conservative dosing matters. Can I freeze this dip? Freezing is possible but may alter texture. Potency may also drift over time. Can I use this as a base for other dishes? Yes. It works well as a spread, filling, or sauce with careful portioning. Recipe Card (PDF) Prefer a one-page printable? Download the clinic-formatted recipe card. Download Recipe Card (PDF) Back to top [...] Read more...
August 3, 2023Ingredients 2/3 cup Cannabis oil (coconut or olive oil will work) 4 large potatoes peeled 3 tbsp salt Instructions Preheat your oven to 400 degrees Fahrenheit and line a large baking sheet with parchment paper. Cut your peeled potatoes into strips (cut them into fries!) and spread them evenly on the baking sheet. Drizzle the cannabis-infused oil over them and season with salt. Try to coat each fry relatively evenly with the oil so that there is a consistent potency. Cook the fries until they are golden brown. Around 15–20 minutes. Allow the fires to cool down, around 5 minutes. Divide the fries into equal proportions and serve. This recipe is available for download HERE Original recipe from thecannaschool.com [...] Read more...
April 8, 2025  Cannabis-Infused Chocolate Sauce — Decadence That Loves You Back 🍫 Why You’ll Love This Cannabis Chocolate Sauce Warm, rich, and silky-smooth, this cannabis-infused chocolate sauce takes indulgence to the next level. Whether you’re spooning it over a scoop of ice cream, dipping fresh strawberries, or swirling it into your coffee, this easy cannabis chocolate recipe for beginners delivers full flavor with gentle effects. For cannabis users, the beauty of this recipe lies in its simplicity and flexibility. It’s a no-bake, fast-to-make edible that can be dosed by the spoonful and stored for weeks. And thanks to the fat content in cream and chocolate, it also provides a reliable absorption pathway for THC. Benefits of Cannabis-Infused Chocolate Sauce Here’s what makes this recipe more than just dessert: 🍫 Dark Chocolate – Packed with antioxidants and supports heart health. 🌿 Cannabis – Offers natural stress relief, relaxation, and anti-inflammatory benefits. 🧠 Mood-Boosting – Chocolate and THC both increase feel-good neurotransmitters like anandamide and serotonin. 🥄 Fat-Rich Carrier – Cream and cannabutter help improve THC absorption. ❄️ Refrigerator Friendly – Easy to store and dose over time. Pro Tip: This recipe is especially helpful for those managing anxiety, chronic pain, or poor appetite with cannabis. https://cedclinic.com/category/cannabis-recipes/ Ingredients & Equipment You’ll Need 🍫 Ingredients: ½ cup heavy cream 🥛 4 oz dark chocolate (70% cacao or higher), chopped 🍫 2 tablespoons cannabutter 🧈 1 tablespoon honey or maple syrup (optional) 🍯 ½ teaspoon vanilla extract 🛠️ Equipment: Small saucepan Whisk or silicone spatula Mason jar or glass container with lid How to Make Cannabis Chocolate Sauce (Step-by-Step) Step 1: Warm the Cream In a small saucepan over low heat, warm the cream until just steaming. Avoid boiling—too much heat can degrade THC and ruin the chocolate’s texture. Step 2: Melt and Infuse Add chopped dark chocolate and cannabutter to the warm cream. Stir continuously with a whisk or silicone spatula until the mixture is fully melted and glossy. Step 3: Sweeten & Store Stir in your sweetener and vanilla extract. Once smooth, pour into a glass jar. Let it cool before sealing and refrigerating. Pro Tip: This cannabis chocolate sauce thickens as it cools—reheat gently before serving for best consistency. Dosing Guide: Sweet, But Strong 💡 Potency Calculation Assuming cannabutter made from 3.5g cannabis at 20% THC = ~700mg total THC 1 tbsp cannabutter ≈ 87.5mg THC 2 tbsp used in recipe = ~175mg THC total 🍫 Per Serving (Approx. 6 Servings) 1 tbsp sauce ≈ 29mg THC ½ tbsp sauce ≈ 14.5mg THC ¼ tbsp (¾ tsp) ≈ 7.25mg THC Beginner Dose: Start with ¼–½ tablespoon for ~7–14mg THC Pro Tip: Chocolate’s natural fats help THC absorb more efficiently, meaning it might feel stronger than baked edibles.   Creative Ways to Use Cannabis Chocolate Sauce 🍓 Drizzle over fresh fruit like strawberries, bananas, or apples 🍦 Pour on top of ice cream, pancakes, or waffles ☕ Stir into coffee or hot milk for a DIY cannabis mocha 🍩 Use as a glaze for donuts or cupcakes 🍪 Dip cookies or pretzels for an instant edible treat 🥣 Swirl into oatmeal or yogurt for a rich breakfast upgrade Pro Tip: For microdosing, try mixing ½ teaspoon of the sauce into your morning coffee or spreading lightly over toast. FAQ: Cannabis Chocolate Sauce — Answers to Common Questions   [...] Read more...
August 3, 2023Ingredients 2 lbs of potatoes 4 tablespoons cannabutter 4 tablespoons sour cream or plain cream cheese Salt and pepper ¼ to ½ cup of milk or cannamilk for increased potency 2 cloves of garlic minced or 1 tsp of garlic powder Instructions Cut the potatoes in half or quarters to make medium-sized pieces. Place the potatoes in a saucepan filled with water and bring to a boil. Cook until fork-tender, between 20–30 minutes. Drain the potatoes and remove their skins. Add the cannabutter, garlic and sour cream to the bowl along with a splash of milk (don’t add it all at once.) Mash the contents, adding just a splash of milk each time until you’ve reached the desired consistency. ​ Stir in salt and pepper to taste. This recipe is available for download HERE original recipe from satorimj.com [...] Read more...
August 3, 2023Ingredients 2 slices of bread Cheese Canna-Butter Optional fillings: tomato, green onion, chicken, tuna Directions 1. Use a knife to coat both pieces of bread with canna-butter Be sure to coat both sides of the bread 2. Bring skillet to medium heat and add a small scoop of canna-butter ​ 3. One the butter has melted, place one slice of bread on the skillet 4. Add as much cheese and fillings as you like, then place the second slice of bread on top 5. Flip the sandwich when the bottom is golden brown, add more butter if needed for the new side 6. When the sandwich looks adequately fried and the cheese is melted to your liking, take it off of the skillet, slice in half, and enjoy! Original recipe from Satori MJ [...] Read more...
February 3, 2026CED Clinic Recipes Cannabis-Infused Barbecue Sauce Smoky, Sweet, Slow-Burn Comfort A backyard classic, thoughtfully infused. Tomato-forward, gently smoky, and designed for portion-by-the-tablespoon dosing control. ⏱️ Ready: ~25 minutes 🍽️ Servings: ~8 (2 tbsp each) 🫒 Infusion: Olive oil 🌶️ Heat: Adjustable Ingredients Steps Dosing FAQ Download Recipe Card (PDF) Quick Safety Reminders Friendly reminders that prevent the most common infused-food mishaps. ✅ Portion first, then enjoy. A tablespoon is your measuring tool. ✅ Wait at least 90 minutes before reassessing effects. Many people choose 2 hours after a full meal. ✅ Label leftovers clearly if others share your fridge. Introduction There is something almost universally reassuring about a good barbecue sauce. It is sweet without being candy-like, smoky without shouting, and it makes even simple food feel intentional. This cannabis-infused version keeps everything people love about a classic sauce while offering a smoke-free, food-forward way to enjoy cannabinoids with more control and predictability. This recipe works especially well for people who prefer edibles over inhalation, those who want dosing flexibility by the spoonful instead of the square, and experienced users who appreciate an infused staple that fits easily into real dinners. TL;DR This is a stovetop cannabis-infused barbecue sauce that comes together quickly and is built for portion-by-the-tablespoon dosing control. Using infused olive oil folded into a tomato base helps the sauce feel consistent, easy to store, and easy to dilute. ✅ Ready in about 25 minutes ✅ Approx. 5 to 11 mg THC per serving, depending on portion ✅ Typical onset: 60 to 90 minutes, sometimes longer with a full meal Why You’ll Love This Recipe Most edibles lean sweet, highly processed, or both. This sauce goes the other direction. It is savory, meal-friendly, and built around familiar ingredients that already belong on a dinner table. The technique is simple, the equipment minimal, and the result tastes like barbecue sauce first. Because it is portionable by the spoon, this recipe makes it easier to adjust dose without committing to a full edible at once. That makes it particularly appealing for shared meals, cookouts, and anyone still learning how their body responds to infused foods. Functional Perks of This Feel-Good Treat Small choices that add up to a smoother experience. ✨ Uses olive oil fats, which may support cannabinoid absorption and steadier onset for many people. ✨ Easy to scale portions up or down without changing the recipe. ✨ Smoke-free and discreet, suitable for shared meals. ✨ Works as a condiment, so dosing can stay measured and intentional. Pro Tip: For more consistent dosing, stir the sauce well before each use. Infused fats can settle slightly during storage. Health Benefits: Food That Talks To Your Body Tomatoes contribute lycopene and other plant compounds, and they pair naturally with olive oil in a way many people find both satisfying and filling. Garlic and onion provide classic aromatic depth, plus a range of plant compounds commonly associated with antioxidant support in the broader diet context. Cannabinoids interact with the endocannabinoid system, a regulatory network involved in mood, appetite, pain modulation, and sleep. In culinary use, the goal is not a promise of medical outcomes, but a measured way to explore effects that vary widely between individuals. As with any infused recipe, this works best as a supportive tool rather than a cure-all. For many people, modest dosing paired with real food feels more manageable than a stand-alone edible. Simple ingredients, big payoff. Tomatoes, spices, vinegar, and infused olive oil ready to simmer. Ingredients & Equipment You’ll Need 🍅 Ingredients ➕ 1 cup fresh tomatoes, chopped 🍅 ➕ ¼ cup onion, finely diced 🧅 ➕ 2 tablespoons cannabis-infused olive oil 🫒 ➕ ½ cup apple cider vinegar ➕ ¼ cup molasses or honey 🍯 ➕ 2 tablespoons tomato paste ➕ 1 tablespoon smoked paprika ➕ 1 teaspoon Worcestershire sauce ➕ 1 teaspoon garlic powder 🧄 ➕ 1 teaspoon salt ➕ ½ teaspoon black pepper ➕ ½ teaspoon cayenne, optional 🌶️ 🛠️ Equipment ➕ Medium saucepan ➕ Whisk or spoon ➕ Immersion blender or countertop blender ➕ Measuring spoons ➕ Jar with lid (or airtight container) Gentle simmer equals better sauce. Low heat helps flavor stay rounded and dosing stay steadier. How To Make Cannabis-Infused Barbecue Sauce (Step-by-Step) Step 1 Soften the Onions and Tomatoes Warm the cannabis-infused olive oil in a saucepan over medium heat. Add onions and tomatoes and cook for about 5 minutes, stirring occasionally, until the mixture softens and smells sweet rather than sharp. If anything begins to brown aggressively, lower the heat. Pro Tip: Keep the heat gentle. Hard boiling can flatten sweetness and make the vinegar feel louder than you want. Step 2 Build the Flavor Stir in tomato paste, molasses or honey, vinegar, Worcestershire sauce, smoked paprika, garlic powder, salt, pepper, and cayenne if using. Simmer gently for 15 to 20 minutes, stirring occasionally, until thickened and glossy. Step 3 Blend, Cool, and Store Blend until smooth using an immersion blender, or carefully transfer to a countertop blender. Cool slightly, then transfer to a jar and label clearly. Refrigerate. Glossy, smooth, and portion-ready. A jar that makes dosing feel measured rather than mysterious. Dosing Guide: Potent, But Predictable Potency Calculation Using the default assumption of 3.5 g cannabis at 20 percent THC: 3.5 g × 0.20 × 1,000 mg per g ≈ 700 mg THC in the starting flower. If decarboxylation and infusion together yield about 25 percent capture, the oil may contain approximately: 700 mg × 0.25 ≈ 175 mg THC in the full oil batch. If that oil batch is 4 tablespoons total, then: 175 mg ÷ 4 tbsp ≈ 43.75 mg THC per tbsp This recipe uses 2 tablespoons infused oil, so the sauce contains about: 2 tbsp × 43.75 mg ≈ 87.5 mg THC total. Breakdown Per Serving This sauce yields about 1 cup or 16 tablespoons. A common serving is 2 tablespoons, which makes roughly 8 servings. Portion Estimated THC How it looks in real life Full serving (2 tbsp) ≈ 10.9 mg THC A sauced plate, often better for intermediate users Half serving (1 tbsp) ≈ 5.4 mg THC A light brush or measured spoonful, a cautious start for many Quarter serving (½ tbsp) ≈ 2.7 mg THC A small drizzle, useful for beginners and microdosers Suggested Starting Doses Beginner-friendly use often falls in the 1 to 2.5 mg range, which may be closer to a quarter serving or less depending on your batch strength. Intermediate users may feel comfortable around 5 to 10 mg. Higher doses should be approached cautiously, especially in social settings. If you are newer to edibles, start with the smallest portion, wait at least 90 minutes, and consider making any increase on another day once you understand how that amount feels. Quick Math: DIY Dosing Calculator THC percentage × grams of flower × 1,000 = estimated total mg THC. Account for a realistic capture rate. Many home methods land around 20 to 30 percent after decarb and infusion. Divide by tablespoons or servings in the finished recipe to estimate mg per portion. ⚠️ Dosing Caveat: All dosing numbers are estimates. Actual potency can vary based on flower THC labeling accuracy, decarboxylation temperature and duration, infusion efficiency, storage conditions (heat, light, time), and individual factors like metabolism, tolerance, recent meals, and gut motility. Start low, wait patiently, and avoid stacking doses while you are still waiting for the first one. 💡 Microdose Tip For barely-there effects, start with a teaspoon of sauce (or less). Pair with non-infused food so you can keep eating without escalating dose. How To Make This Non-Euphoric Or Gently Altering For a lower-altering version, use CBD-dominant infused olive oil or a high-CBD to low-THC ratio such as 10:1. You can also use 1 tablespoon infused oil plus 1 tablespoon regular olive oil to reduce potency while keeping the flavor and texture consistent. True non-euphoric results depend on individual physiology and dose, not just what is written on a label. Flavor & Pairing Suggestions For calm evenings, earthy and herb-forward profiles often feel grounding alongside smoky, tomato-rich dishes. For light uplift and conversation, subtle citrus-leaning profiles can brighten vinegar and paprika notes. For sleep-forward nights, many people prefer calmer, body-heavy profiles and smaller portions. For social cookouts, choose lower doses and allow more time before deciding on seconds. Pro Tip: Strain names are not guarantees. Treat them as hints, then let your personal response guide future choices. Easy to share, easy to scale. A measured spoonful adds flavor and keeps dosing intentional. Creative Ways To Use This Sauce ➕ Brush lightly onto grilled chicken, ribs, tempeh, tofu, or vegetables near the end of cooking. ➕ Stir into baked beans or lentils for smoky depth. ➕ Use as a burger sauce or sandwich spread, measured by the tablespoon. ➕ Mix with plain yogurt for a barbecue crema. ➕ Add a small spoonful to roasted sweet potatoes or roasted cauliflower. ➕ Combine with a non-infused sauce for an easy dilution strategy. Pro Tip: For microdosing, start with a teaspoon and let time do its work before you decide on more. Serving Ideas & Mood Pairings This sauce fits best into moments that call for comfort without chaos. 🌤️ Great for weekend grilling where you can take your time. 🎧 Ideal for post-work dinners when you want your evening to downshift. 🕯️ Pairs well with soft lighting, a simple meal, and no urgent plans. Storage Tips & Shelf Life Store in an airtight container in the refrigerator for up to 2 weeks. Stir well before each use to redistribute infused fats. Reheat gently. Avoid repeated high-heat reheating, which can change both texture and potency. Potency may drift gradually over time, so older sauce can feel milder. Troubleshooting Common Mistakes Too acidic. Add a small amount of honey or molasses, warm gently, and retaste. Too thin. Simmer uncovered for a few extra minutes, stirring to prevent sticking. Too thick. Stir in a tablespoon of water at a time while warm. Effects feel stronger than expected. Reduce portion size next time, or dilute with non-infused sauce. Cannabis & Culinary Culture Infused cooking has been quietly moving from novelty toward normalcy. Condiments like barbecue sauce are part of that shift because they keep cannabis in the background and dinner in the foreground. When a recipe is portionable and familiar, it becomes easier to use thoughtfully. That shift helps reduce stigma and makes cannabis feel less like an event and more like a tool. Final Thoughts This barbecue sauce shows how infused cooking can feel normal, nourishing, and grounded. It is not about pushing limits, but about bringing intention into the kitchen and control to the plate. If you make this recipe, consider noting your infusion strength and the portion that felt right. That single habit turns cooking into something repeatable. FAQ: Cannabis-Infused Barbecue Sauce How do I make cannabis-infused barbecue sauce at home? Simmer a simple tomato base with seasonings, then blend smooth. The key is measured infused oil, gentle heat, and consistent portions. How long does cannabis-infused barbecue sauce take to kick in? Many people notice effects in 60 to 90 minutes. With a full meal, onset can be later. Waiting longer is often the safer choice before adding more. Can I cook with this sauce at high heat? Gentle reheating is preferred. If grilling, brush near the end rather than early to preserve flavor and reduce unnecessary heat exposure. What is a good beginner dose for this sauce? Many beginners start around 1 to 2.5 mg THC, which may be a quarter serving or less depending on your batch. A teaspoon can be a useful starting point. Can I make this with CBD instead of THC? Yes. CBD-dominant infused olive oil can create a gentler experience that many people prefer for calm evenings. How do I make it less strong? Use less infused oil, replace part with regular olive oil, or mix the finished sauce with a non-infused barbecue sauce to dilute mg per tablespoon. How long does infused barbecue sauce last in the fridge? Up to 2 weeks when stored airtight and kept cold. Stir before use. Discard if it smells off or shows visible spoilage. Can I freeze cannabis-infused barbecue sauce? Freezing is possible. Texture may change slightly after thawing, so stir well. Label clearly and portion for convenience. Why does my sauce feel separated after chilling? Infused fats can settle. Warm gently and stir thoroughly to recombine, then measure your portion. How do I label infused condiments safely? Include the date made, “infused,” and your estimated mg per tablespoon. Clear labeling prevents accidental dosing. Can I use store-bought infused oil? Yes, if potency is clearly labeled. Recalculate mg per tablespoon based on the label and your total yield. Recipe Card (PDF) Prefer a one-page printable? Download the clinic-formatted recipe card. Download Recipe Card (PDF) Back to top   [...] Read more...
August 3, 2023Ingredients 1 package of Instant Ramen Vegetable or Beef broth (use the amount listed on the package for water) Frozen vegetable medley One egg or tofu Dried seaweed (to garnish) Sesame Seeds (to garnish) Cannabis Tincture Directions 1. Follow the instructions on the ramen package, but swap the water out for broth 2. Add the frozen veggies when broth gets hot 3. Crack an egg in the hot broth and stir for a few minutes You can also use a hard-boiled egg or chopped tofu ​ 4. Add as much cannabis tincture that you want. If you are unsure, start with 1–2 drops 5. Top soup with dried seaweed and sesame seeds Original recipe from Satori MJ [...] Read more...
August 3, 2023Ingredients 1 cup breadcrumbs 1/2 cup canna-milk 1 lb ground beef 1/2 lb ground pork 1/2 lb Italian sausage, casing removed 1 small onion, finely diced 3 cloves garlic, minced 1 cup grated parmesean cheese 1/4 cup chopped parsley 2 large eggs, beaten 2 Tbsp canna-oil 1 (32oz) jar marinara sauce Instructions 1. In a small bowl, stir bread crumbs with canna-milk until evenly combined. Let sit 15 minutes, or while you prep other ingredients. 2. In a large bowl, use your hands to combine beef, pork, sausage, onion, and garlic. Season with salt and pepper, then gently stir in breadcrumb mixture, eggs, Parmesan, and parsley until just combined. Form mixture into 1” balls. 3. In a large high-sided skillet over medium heat, heat oil. Working in batches, sear meatballs on all sides to develop a crust. Set meatballs aside, reduce heat to medium-low, and add sauce to skillet. Bring sauce to a simmer then immediately add meatballs back to skillet. Cover and simmer until cooked through, about 8 minutes more original recipe from eatyourcannabis.com [...] Read more...
August 3, 2023Servings: 12 Ingredients 1 cup soybean oil ½ ounce ganja shake 2 large egg yolks 1 teaspoon fresh lemon juice Pinch of salt 1 teaspoon white vinegar ½ teaspoon Dijon mustard ​Directions In a double boiler, combine the oil and ganja. Heat over low until the ganja smell is pronounced but not nutty or burnt. (The oil should have an earthy green tint to it.) Let cool. Remove and strain the herb, squeezing the weed in a metal strainer against the mesh with the back of a spoon to wring out every drop of oil. Make sure that all your ingredients have been brought to room temperature — this is crucial! ​In a small metal bowl, use an immersion blender or whisk to thoroughly blend the egg yolks, lemon juice, salt, vinegar, and mustard. This can also be done in a food processor or blender. ​Using a ½ teaspoon measure, very slowly add the infused oil to the small metal bowl, a few drops at a time, while constantly blending on low or whisking until the mayo is thick and starting to form ribbons. (If it’s too thick, you can add room-temperature water in tiny increments.) If your mixture “breaks,” it can be repaired by whisking some more room-temperature egg yolks in a separate bowl, then slowly whisking those yolks into the “broken” mayo mixture. If that doesn’t do it, add a few drops of hot water. ​Cover and chill; it’ll keep in the refrigerator for 4 to 5 days. Original recipe from: Boudreaux, Ashley. The Official High Times Cannabis Cookbook. Red Eyed Deviled Eggs. https://saltonverde.com/wp-content/uploads/2017/09/10-High_Times_Cannabis_Cookbook.pdf [...] Read more...
October 3, 2025Ingredients Cupcakes: 2 cups flour 1 cup sugar 1 Tbsp baking powder 1/4 Tsp salt 1 cup milk 2 eggs 1/4 cup canna-oil (vegetable is best) 1/4 vegetable oil 2 Tsp vanilla extract 1/3 cup rainbow sprinkles Frosting: 1 cup sugar 1 cup egg whites 1lb butter, salted, room temperature 1 Tsp vanilla extract ​ Directions ​Cupcakes: Preheat oven to 350°F. Line a cupcake pan with cupcake liners. Mix all of the dry ingredients together in a medium bowl. Whisk all of the liquid ingredients together until blended. Add the liquid ingredients to the dry ingredients & mix until there are no large lumps. Do not overmix. Gently stir in the rainbow sprinkles until just blended. ​ Use a 2-ounce portion scoop & fill each cupcake liner with one scoop. Bake for 15–18 minutes or until a toothpick inserted in the middle comes out clean. Remove from the oven & allow to cool a bit before removing them from the pan. Frosting: Put 2 inches of water into a medium-size pot, & bring to a boil. Place the sugar & egg whites into a small stainless bowl that will sit on top of the pot of boiling water, or use a double boiler system. DO NOT allow the bowl with the egg white mixture to directly touch the boiling water or the egg whites will cook very quickly. Whisk constantly until temperature reaches 140°F/60°C or until the sugar has completely dissolved & the egg whites are hot to the touch. DO NOT leave unattended or you will have a sweet egg white scramble! Use a hand mixer or pour the egg white mixture into a bowl that is fitted for a stand mixer. Using the whisk attachment, begin to whip until the meringue is thick & glossy, about 10 minutes on medium-high. Place the mixer on low speed, add the cubes of butter, a couple at a time, until incorporated. Continue beating until it has reached a silky smooth texture. If the buttercream curdles simply keep mixing & it will become smooth. If the buttercream is too runny, refrigerate for about 15 minutes before continuing mixing. Add the vanilla & continue to beat on low speed until well combined. Once the cupcakes have completely cooled, place a large star tip into a piping bag & fill with the buttercream. Pipe a rosette onto each cupcake & add the sprinkles on top. Serve immediately, the same day or keep in an airtight container in the fridge for up to 4 days. They can also be frozen for up to 3 months. This recipe is available for download HERE Original recipe from myedibleschef.com 💬 Join the Conversation Have a question about how this applies to your situation? Ask Dr. Caplan → Want to discuss this topic with other patients and caregivers? Join the forum discussion → [...] Read more...
August 3, 2023Ingredients 6 cups fresh or frozen blueberries (you may substitute some pitted cherries too!) 1 Tbsp lemon juice 1/4 cup all-purpose flour 1/2 cup white sugar (you may add canna-sugar for increased potency) 1/4 tsp cinnamon 2 Tbsp canna-butter, cut into small pieces (you may substitute canna-coconut oil) 2x pie crust recipe or store bought Directions Preheat oven to 350°F/175°C. Line a cookie sheet with parchment paper. Cream the regular butter, cannabutter, brown sugar & white sugar together until fluffy. Beat in eggs one at a time. Beat in the vanilla. In a small bowl, mix together the flour, cinnamon, baking soda & salt. Add to the creamed mixture. Mix well. Add the mini chocolate chips & mini marshmallows. Mix until evenly distributed. Evenly space the graham crackers on the prepared liner. Use a 2 oz scoop to portion the cookies & place in the center of the graham cracker. Bake for 12–15 minutes. Allow the cookies to cool. Push all of the baked cookies together & drizzle with coating chocolate. Allow the chocolate to set & enjoy! This recipe is available for download HERE Original recipe from myedibleschef.com [...] Read more...
September 15, 2025🥦 Cannabis-Infused Veggie Stir Fry Quick, Colorful, and Infused with Chill — Dinner Just Got Elevated TL;DR Light, fast, and full of fiber, this stir fry is your new go-to for feel-good food with functional benefits. Using cannabis-infused coconut oil, it delivers a calming, anti-inflammatory lift that complements the natural nutrition of fresh veggies. Each serving is ~43.75mg THC, or scale it down to 10mg for a microdosed dinner. ✅ Anti-inflammatory ✅ Easy to digest ✅ Infused for mental calm ✅ Ready in 15 minutes ⸻ Why You’ll Love This Recipe It’s fast. It’s fresh. It’s forgiving. This cannabis-infused veggie stir fry is perfect for weeknights when you want real nourishment—without turning your brain into vegetable soup. Coconut oil enhances THC absorption, and the rainbow of vegetables provides everything from antioxidants to gut-healing fiber. This is dinner you can feel good about—physically and mentally. ⸻ Health Benefits: This Is the Real “High” Fiber Diet ✨ This stir fry isn’t just infused—it’s functional. Here’s what it brings to the table: •🧠 Cannabis: Calms the nervous system, eases digestion, supports endocannabinoid tone •🥥 Coconut Oil: Rich in healthy fats to improve THC absorption and brain function •🌈 Broccoli & Bell Pepper: Packed with vitamin C, antioxidants, and phytonutrients •🥕 Carrots & Snap Peas: Fiber-rich, great for gut health and blood sugar balance •🌶️ Ginger & Garlic: Anti-inflammatory, immune-boosting, and flavorful ⸻ What You’ll Need 🛠️ Materials: •Wok or large sauté pan •Wooden spoon or spatula 🥕 Ingredients: •2 tbsp cannabis-infused coconut oil 🥥 •1 cup broccoli florets 🥦 •1 red bell pepper, sliced 🌶️ •1 carrot, julienned 🥕 •½ cup snap peas •2 cloves garlic, minced •1 tbsp ginger, grated •2 tbsp low-sodium soy sauce or tamari •Optional toppings: sesame seeds, sliced green onions, chili flakes ⸻ Step-by-Step Instructions 🔥 1. Heat the Oil In your wok or skillet, heat the infused coconut oil over medium. Add garlic and ginger and sauté for 30 seconds until aromatic but not browned. 🌈 2. Cook the Veggies Toss in broccoli, carrots, and bell pepper. Stir-fry for 3–4 minutes. Add snap peas and cook for 2 more minutes, just until veggies are crisp-tender. 🥢 3. Season and Serve Pour in soy sauce or tamari. Stir to coat everything evenly. Optional: Top with sesame seeds, scallions, or chili flakes for a little extra heat. Serve hot over brown rice, quinoa, or cauliflower rice for a full meal. ⸻ 🍃 Dosing Guide: Healthy, But Still Potent Even when it’s packed with veggies, this stir fry can still pack a punch. 💡 Potency Calculation: •2 tbsp infused coconut oil = ~87.5mg THC •This recipe makes 2 hearty servings 🧐 Breakdown per Serving: •Full serving = ~43.75mg THC •Half serving = ~21.9mg THC •¼ serving = ~10.9mg THC (ideal for beginners) 🔬 Pro Tip: Coconut oil enhances THC bioavailability, so even small portions may feel stronger than you expect. Start with a quarter plate and see how you feel. 🧠 Creative Ways to Use Cannabis Stir Fry This isn’t just a plate of stir-fried veggies—it’s an infused flavor canvas. 🥬 Wrap It Up Spoon the stir fry into lettuce leaves or tortillas for a grab-and-go option with crunch. 🍜 Noodle Bowl Base Layer it over rice noodles or soba with a drizzle of infused sesame sauce. 🍳 Brunch Remix Top with a fried egg, tofu, or sliced avocado for an infused brunch bowl. 🌯 Infused Burrito Add some black beans and roll it into a wrap with guacamole and greens. ⸻ 💡 Pro Tips for Perfect Results • Pre-cut your veggies so cooking is fast and even. • Don’t overcook—you want them bright and slightly crisp, not mushy. • Add protein like tofu, shrimp, or grilled chicken if you want something heartier. • Start small: ¼ plate may be plenty for new users due to the oil’s high bioavailability. • Pair with a CBD beverage or herbal tea for a calming, full-body effect. ⸻ ❌ Common Mistakes to Avoid 🔻 Overheating the Oil If the pan’s too hot, you risk degrading cannabinoids. Medium heat is best. 🔻 Ignoring Portion Size Don’t forget: this is a medicated meal. That “one more bite” could tip the scale. 🔻 Poor Mixing Stir thoroughly after seasoning to evenly distribute the infused oil and flavor. ⸻ 🌿 Strain Suggestions: For a Lighter, Brighter High Choose cannabis strains that enhance energy, creativity, or relaxation without sedation. ✅ For Mood & Energy: •Super Lemon Haze – bright, zesty, great daytime uplift •Tangie – citrus-forward and creativity-boosting ✅ For Calm Focus: •Harlequin – high CBD for body ease with mental clarity •Jack Herer – balanced, euphoric, light-hearted ✅ For Anti-Inflammation: •ACDC – low THC, high CBD, non-intoxicating relief •Pennywise – mellow and soothing with a gentle mental buzz ⚠️ A Note About Strains: Strain names can be misleading. What’s labeled “Super Lemon Haze” in one dispensary might feel completely different from another shop’s version. That’s because: 1) There’s no consistent strain genome across the cannabis industry. 2) Effects vary due to terpene profiles, cannabinoid ratios, and cultivation conditions. 3) Your individual tolerance, body chemistry, and gut health all shape how you feel. 👉 Take all strain suggestions with a diamond-sized grain of salt. Focus more on the effect you’re seeking—calm, uplifted, focused—and choose based on your response over time. 📌 Save & Share 💬 Have a favorite veggie combo you swear by? Drop it in the comments! 📸 Snap your stir fry creation and tag #InfusedVeggieStirFry on Instagram to get featured! . . . Downloadable Recipe Card: Stir Fry Recipe 🌿 Cannabis-Infused Veggie Stir Fry Why You’ll Love This Recipe It’s fast. It’s flavorful. It’s full of fiber and phytonutrients. And with cannabis-infused coconut oil in the mix, this veggie stir fry doesn’t just fuel your body—it eases your mind. Health Benefits ✔ Loaded with antioxidants from colorful veggies ✔ Supports gut health with fiber-rich ingredients ✔ Cannabis = anti-inflammatory, calming, and digestive-friendly ✔ Coconut oil = improves THC absorption and heart health Ingredients 2 tbsp cannabis-infused coconut oil 1 cup broccoli florets 1 red bell pepper, sliced 1 carrot, julienned ½ cup snap peas 2 cloves garlic, minced 1 tbsp ginger, grated 2 tbsp low-sodium soy sauce or tamari Optional: sesame seeds, green onions, chili flakes Instructions Heat the Oil: In a wok or skillet, warm cannabis-infused coconut oil over medium heat. Add garlic and ginger—sauté for 30 seconds. Cook the Veggies: Add broccoli, carrots, and bell pepper. Stir-fry for 3–4 minutes. Toss in snap peas and cook for another 2 minutes. Season & Serve: Stir in soy sauce. Add chili flakes or sesame seeds if using. Serve over brown rice, quinoa, or cauliflower rice. Dosing Guide 2 tbsp infused coconut oil = 87.5mg THC Makes ~2 servings Dose per Serving: 🥦 Full = ~43.75mg THC 🥄 Half = ~21.9mg THC 👶 ¼ serving = ~10.9mg THC Pro Tip: Coconut oil boosts bioavailability—dose mindfully! Strain Reminder: Strains aren’t always what they claim. Names can change, effects can vary, and testing isn’t always rigorous. Take these suggestions with a diamond-sized grain of salt 💎—and trust your body, not just the label. For more recipes and expert cannabis guidance: CEDclinic.com   [...] Read more...
August 3, 2023Ingredients 2 cups all-purpose flour 4 Tbsp sugar (canna-sugar may be substituted to increase potency) 1 Tbsp baking powder ½ Tsp salt 2 large eggs 1 ½ cups whole milk (canna-milk may be substituted to increase potency) ¾ cup canna-butter, melted ​1 teaspoon vanilla extract Instructions 1. In a bowl, combine dry ingredients: flour, sugar, salt, baking powder 2. In another bowl, combine wet ingredients: beat the eggs with the milk, then add the vanilla extract 3. Stir the wet ingredients into the dry ingredients until just combined ​Do not over-mix, batter will be thick and slightly lumpy 4. Bake in a preheated waffle-iron according to manufacturer’s directions until golden brown This recipe is available for download HERE! Original recipe from allrecipes.com [...] Read more...
August 3, 2023This recipe can be used with your favorite vegetables and breakfast meats Ingredients Base: 1 ½ cups of mozzarella cheese, shredded 1/2 cup cheddar cheese, shredded 6 eggs 1 cup of milk (canna-milk may be used for a more potent dish) 1 pie-crust, unbaked Filling: 1/2 cup of canna-butter 1 onion, diced 1 cup broccoli, chopped 1 head of garlic ​ Instructions 1. Melt canna-butter in a pan over medium heat ​ 2. Add vegetables to butter and cook on medium heat for about 5–8 minutes (or until veggies are cooked) Do not let the butter or vegetables burn, to maintain potency of the butter 3. Scoop cooked vegetables into empty pie crust and cover with shredded cheeses 4. Beat eggs and milk together and pour into the pie crust 5. Bake for 35–40 minutes at 360°F Allow quiche to cool 10 minutes before serving This recipe is available for download HERE Original recipe from cannabis.wiki [...] Read more...
August 3, 2023Ingredients 1 can whole peeled tomatoes 28 oz. 1 jar roasted red peppers 12 oz. 4 large eggs ½ cup plain Greek yogurt ¼ cup CannaOil plus more for drizzling 1 teaspoon coriander seeds 1 teaspoon cumin seeds 6 garlic cloves divided 2 medium shallots divided Kosher salt Freshly ground black pepper Mint leaves and crusty bread for serving Crush coriander and cumin seeds, pressing down firmly with even pressure. Transfer seeds to a small heatproof bowl. Slice 2 garlic cloves as thinly and evenly as you can; add to bowl with seeds. Finely chop the remaining 4 garlic cloves. Cut half of 1 shallot into thin rounds and then add to the same bowl with seeds and garlic. Chop remaining shallots. Open a jar of red peppers and pour off any liquid. Remove peppers and coarsely chop. Combine ¼ cup oil and seed/garlic/shallot mix in the skillet you used for crushing seeds. Heat over medium and cook, stirring constantly with a wooden spoon, until seeds are sizzling and fragrant and garlic and shallots are crisp and golden, about 3 minutes. Place a strainer over the same heatproof bowl and pour in the contents of the skillet, making sure to scrape in seeds and other solids. Do this quickly before garlic or shallots start to burn. Reserve oil. Spread out seed mixture across paper towels to cool. Season with salt and pepper. Return strained CannaOil to skillet and heat over medium. Add remaining chopped garlic and shallot and cook, stirring often, until shallot is translucent and starting to turn brown around the edges, about 5 minutes. Season with salt and lots of pepper. Add chopped peppers to the skillet and stir to incorporate. Using your hands, lift whole peeled tomatoes out of the can, leaving behind tomato liquid, and crush up with your hands as you add to the skillet. Discard leftover liquid. Season with more salt and pepper. Cook shakshuka, stirring often, until thickened and no longer runs together when a spoon is dragged through, 10–12 minutes. Reduce heat to low. Using the back of a wooden spoon, create four 2″-wide nests in tomato sauce. Working one at a time, carefully crack an egg into each nest. Cover skillet and cook, simmering very gently and reducing heat if necessary, until whites of eggs are set while yolks are still jammy, 7–10 minutes. Uncover skillet and remove from heat. Season tops of eggs with salt and pepper. Top shakshuka with dollops of yogurt, sprinkle with seed mixture, then drizzle with more olive oil. Finish by scattering mint leaves over top. ​ Serve pita or crusty bread alongside. This recipe is available for download HERE Original recipe from eat your cannabis.com [...] Read more...
March 4, 2026Cannabis-Infused Roasted Red Pepper & Walnut Dip (Muhammara)         This recipe brings together roasted red peppers, toasted walnuts, warm spices, and olive oil into a deeply flavorful Middle Eastern dip called muhammara. It is earthy, slightly sweet, lightly smoky, and remarkably versatile. Here we add a simple twist: cannabis-infused olive oil. Because cannabinoids dissolve into fat, this type of recipe allows both flavor and infusion to blend naturally into the dish. The result is a dip that works equally well as a snack, sandwich spread, or part of a full mezze plate. TL;DR: Muhammara in Plain English 🌶 Roast or use jarred red peppers. 🌰 Blend peppers with walnuts, garlic, lemon, and spices. 🫒 Add cannabis-infused olive oil for flavor and infusion. 🥣 Serve as a dip, spread, or sauce. Health Benefits: A Dip That Loves You Back 🌶 Red peppers contain vitamin C, carotenoids, and antioxidant compounds. 🌰 Walnuts provide omega-3 fatty acids and plant polyphenols. 🫒 Olive oil contributes monounsaturated fats associated with cardiovascular benefits. 🌿 Cannabinoids interact with the endocannabinoid system, which participates in regulation of mood, appetite, inflammation, and sleep. This combination makes muhammara both nutritionally rich and satisfying. What You’ll Need 🛠 Equipment Food processor or blender Spatula Serving bowl 🌶 Ingredients 1 cup roasted red peppers (jarred or homemade) ½ cup walnuts 2 tbsp cannabis-infused olive oil 1 tbsp lemon juice 1 garlic clove ½ tsp cumin ½ tsp smoked paprika ½ tsp salt Optional garnish: Chopped walnuts Extra olive oil Fresh parsley Step-by-Step Instructions Step 1: Combine ingredients Add roasted peppers, walnuts, garlic, lemon juice, cumin, paprika, and salt to a food processor. Step 2: Blend to desired texture Pulse until the mixture becomes spreadable but still slightly textured. Muhammara traditionally keeps some walnut grit. Step 3: Add infused oil While blending, slowly drizzle in the cannabis-infused olive oil. This distributes cannabinoids evenly throughout the dip. Step 4: Adjust consistency If the mixture is too thick, add 1 tablespoon of water and blend again. Step 5: Serve Transfer to a serving bowl and drizzle with additional olive oil. Top with chopped walnuts if desired. Dosing Guide Because cannabinoids dissolve into fat, the infused olive oil in this recipe distributes dose throughout the dip. The most reliable approach is to calculate potency from your oil. Interactive Dose Calculator (Infused Oil Recipes) Calculate your approximate dose per serving. THC potency of infused oil (mg per tablespoon) Tablespoons of infused oil used Total servings in recipe Calculate Dose ⚠️ Dosing note: These numbers are estimates. Potency depends on infusion accuracy, oil potency, mixing, and personal sensitivity. Always test a small portion first and wait long enough before increasing dose. Creative Ways to Use This Dip Serve with: Cucumber slices Carrots Pita bread Spread onto: Sandwiches Wraps Flatbread pizzas Use as: Pasta sauce alternative Roasted vegetable topping Grilled meat condiment Storage Tips & Shelf Life Store muhammara in an airtight container in the refrigerator. It typically remains fresh for 4–5 days. If infused, label the container clearly so that others understand the contents. A thin layer of olive oil on top can help preserve texture and flavor. Final Thoughts Muhammara is one of those rare recipes that feels impressive but is remarkably easy to make. The ingredients are simple, the method is forgiving, and the flavor is bold enough to anchor an entire meal. With infused olive oil, it becomes both culinary and functional. Just remember that dosing matters, labeling matters, and sharing food responsibly matters. Good cooking is generous. Smart dosing is thoughtful. This recipe lets you do both. Frequently Asked Questions About Cannabis-Infused Muhammara How strong is this recipe? The potency depends entirely on the infused olive oil you use. If the oil contains 40 mg THC per tablespoon and you use two tablespoons across four servings, each serving would contain approximately 20 mg THC. The interactive calculator above can help you estimate dose more precisely. Can I make this recipe without THC? Yes. You can use regular olive oil or a CBD-dominant infused oil if you want the flavor and nutritional benefits without psychoactive effects. How long does infused muhammara last? Stored in an airtight container in the refrigerator, muhammara typically remains fresh for four to five days. Because this version contains infused oil, it should be labeled clearly and kept out of reach of children. Can I freeze muhammara? Yes, though the texture may soften slightly after thawing. Stirring the dip well and adding a small drizzle of fresh olive oil usually restores consistency. What foods pair best with this dip? Muhammara pairs well with pita bread, cucumbers, roasted vegetables, grilled meats, sandwiches, and grain bowls. Its smoky sweetness complements both Mediterranean and Middle Eastern dishes. Why use infused olive oil instead of butter? Olive oil blends naturally with the flavor profile of muhammara and distributes cannabinoids evenly throughout the dip because cannabinoids dissolve readily in fat. [...] Read more...
August 3, 2023Materials -Medium Sauce-Pan -​Thermometer -Mesh-sieve or cheesecloth Ingredients -​6 grams cannabis flower -2 cups oil (olive, coconut, canola or vegetable oil) Directions ​ ​1. Decarboxylate the cannabis Heat the oven to 225°F. Spread cannabis buds out into an even layer on a baking sheet and place in the oven. ​Take care not to let the temperature go over 225°F and burn (if this happens, you can lose potency). Bake for about 35–40 minutes, then remove from the oven and cool before grinding into a coarse powder. ​ The decarboxylated cannabis will keep in an airtight container in a cool, dark place for up to 2 months 2. Heat the oil in a saucepan over medium-low heat. Add the decarboxylated cannabis and cook, taking care not to let the temperature go over 200°F for about 45 minutes. 3. Remove from heat and let sit, undisturbed, for 10 minutes 4. Strain through a fine mesh-sieve set over a bowl. Press carefully with a spoon to extract as much oil as possible ​The oil will keep for up to 6 weeks if covered and refrigerated. This recipe is available for download HERE Original recipe from Vice.com [...] Read more...
March 23, 2025  Cannabis-Infused Olive Oil: The Golden Elixir of Cannabis Cooking Because butter isn’t the only thing that gets you baked. (Simple, Effective, and Delicious)   Why This Recipe Deserves a Spot in Your Kitchen   This isn’t just olive oil—it’s olive oil with benefits. Whether you’re elevating roasted veggies, dressing up a salad, or mellowing out pasta night, cannabis-infused olive oil lets you sneak therapeutic magic into your meals—without sugar, smoke, or complicated prep.   Olive oil is already a health food darling. Add cannabis, and you’ve got yourself a multifunctional edible that’s as functional as it is flavorful. Plus, it’s discreet, easy to dose, and ideal for people looking to manage pain, anxiety, inflammation, or sleep—minus the lung irritation.     Health Perks of This Herbal Power Couple     ✔️ Anti-inflammatory support (great for achy joints and muscles)   ✔️ Brain benefits (thanks to olive oil’s polyphenols + cannabis neuroprotection)   ✔️ Gut-friendly (a smoother edible experience for your stomach)   ✔️ Relaxation without the rollercoaster (ideal for winding down or sleeping soundly)       What You’ll Need     🛠️ Materials   Mason jar (for storing your potion)   Cheesecloth or fine mesh strainer   Saucepan or double boiler   Baking sheet   Parchment paper   Oven-safe thermometer (optional but helpful)       🥬 Ingredients     3.5 grams decarboxylated cannabis (strain of your choice)   1 cup extra-virgin olive oil (choose one you’d enjoy raw)         Step-by-Step Instructions     🔥 Step 1: Decarboxylate the Cannabis   This is what “activates” THC. Without it, you’ve got expensive grass-flavored oil.   Preheat oven to 225°F (105°C)   Break cannabis into small, even pieces   Spread evenly on a parchment-lined baking sheet   Bake for 30–40 minutes, stirring every 10–15 minutes   Your cannabis should look dry and lightly golden—never dark or charred   💡 Fun Fact: THCA (non-psychoactive) becomes THC (psychoactive) via heat. That’s why this step is non-negotiable.   Pro tip: If you want a milder effect, decarb for slightly less time, or use a higher CBD strain.     🍳 Step 2: Infuse the Oil     Now we bring the fat and cannabinoids together.   Combine decarbed cannabis and olive oil in your saucepan or double boiler   Simmer on low heat for 2–3 hours, keeping it between 200–245°F (93–118°C)   Stir occasionally. Do not let it boil—boiling burns off cannabinoids = sadness   If you’re worried about smell, use a lid or infuse outdoors   Keep it just below a simmer—slow and steady preserves potency.   Tip: If you’re concerned about odor, use a double boiler setup with a lid.       🫗 Step 3: Strain & Store     Let the oil cool slightly   Strain through a cheesecloth or fine mesh into a clean mason jar   Label your jar with the date and strain used   Store in a cool, dark place for up to 2 months   Refrigeration can extend shelf life to a year (but the oil may solidify—just warm it before use)     How to Use It     Use it as you would any high-quality finishing oil:   Drizzle over roasted veggies or avocado toast 🥑   Swirl into hummus, soups, or pasta 🍝   Add to dressings or sauces (off heat!)   Take a spoonful before your in-laws arrive (kidding… mostly)     ⚠️ Avoid high-heat cooking (above 300°F/150°C) to preserve cannabinoid content.     Dosing Guide: Don’t Wing It, Measure It     💡 Dosing is not one-size-fits-all—but here’s a solid starting point.   Assuming your cannabis is 20% THC:   3.5g = ~700mg THC total   1 cup = 16 tbsp = 48 tsp   1 tbsp = ~43.75mg THC   1 tsp = ~14.6mg THC       🧂 Recommended Starting Doses:     Beginner: ¼ tsp (~3.6mg THC)   Moderate: ½ tsp (~7.3mg THC)   Strong: 1 tsp (~14.6mg THC)   ⚠️ Start low and slow. Edibles take 30–120 minutes to kick in, and the effects can last 4–8 hours. Patience prevents panic. 💡 Pro Tip: Want to be sure about your oil’s potency? Consider having it tested by a local lab for accurate dosing. If you’re an experienced consumer and choose to skip testing, start with a very small amount and increase gradually—unexpectedly high doses can turn a relaxing experience into an uncomfortable one.     Storage & Safety Tips   Keep away from kids, pets, and unsuspecting guests   Label clearly (no accidental salad surprises)   Cloudiness from refrigeration is normal—just warm it up before use     Why Olive Oil?   Extra-virgin olive oil is rich in healthy fats, antioxidants, and anti-inflammatory compounds. It’s stable at room temp, delicious raw, and an ideal carrier for cannabinoids. In other words, it’s not just tasty—it’s smart.     Downloadable recipe card for Cannabis-Infused Olive Oil:   📥 Cannabis_Infused_Olive_Oil_Recipe_Card         [...] Read more...
April 1, 2025Cannabis-Infused Honey Recipe — Sweet, Sticky, and Blissfully Effective Why You’ll Love This Cannabis-Infused Honey Honey has been a trusted natural remedy for centuries, but when combined with cannabis, it transforms into one of the most versatile, easy-to-make edibles. This cannabis-infused honey recipe is perfect for sweetening tea, drizzling on toast, enriching salad dressings, or even enjoying straight off the spoon. Unlike baked edibles, infused honey is easy to dose, gentle on digestion, and offers all the soothing benefits of cannabis without turning on your oven every time you want a treat.   Health Benefits of Cannabis-Infused Honey This isn’t just about getting buzzed — it’s about enhancing your wellness with the natural powers of both honey and cannabis: 🍯 Antibacterial properties — soothes sore throats and supports immune health. 🧘 Digestive support — gentle on your gut and helpful for calming upset stomachs. 💖 Rich in antioxidants — promotes skin, heart, and brain health. 🍃 Natural sweetener — say goodbye to refined sugar guilt. 🌿 Cannabis effects — promotes stress relief, relaxation, and calm.   Ingredients & Equipment for Homemade Cannabis Honey   🧂 Ingredients: 3.5 grams decarboxylated cannabis (roughly 20% THC recommended) 1 cup raw or local honey   🛠️ Tools: Small saucepan or double boiler Cheesecloth or fine mesh strainer Mason jar or glass storage jar (bonus points for style)   How to Make Cannabis-Infused Honey (Step-by-Step)   Step 1: Decarboxylate the Cannabis Before you can infuse cannabis into honey, you need to activate the THC through a process called decarboxylation. 1.Preheat oven to 225°F (105°C). 2.Break up cannabis into small pieces and spread on a parchment-lined baking sheet. 3.Bake for 30–40 minutes, stirring every 10 minutes, until light golden and aromatic.   Step 2: Infuse the Honey 1.Combine decarboxylated cannabis and honey in a small saucepan or double boiler over low heat. 2.Simmer gently for 40–60 minutes, stirring occasionally. Keep the heat low to preserve cannabinoids.   Step 3: Strain & Store 1.Allow the mixture to cool slightly. 2.Strain through cheesecloth into a clean mason jar. 3.Store at room temperature for up to 6 months or in the fridge for even longer freshness.   Dosing Guide: How Potent is Your Cannabis Honey?   💡 Potency Calculation (assuming 20% THC cannabis) 3.5 grams cannabis = ~700 mg THC total 1 cup honey = 16 tablespoons = 48 teaspoons Approximate THC per serving: 1 tablespoon ≈ 43.75 mg THC 1 teaspoon ≈ 14.6 mg THC ½ teaspoon ≈ 7.3 mg THC ¼ teaspoon ≈ 3.6 mg THC (great beginner dose) ⚠️ Dosing Caveat: Please note that this dosing guide is an estimate and should be used cautiously. Factors like the exact potency of your cannabis, decarboxylation efficiency, infusion temperature, and individual tolerance can all significantly affect the final strength of your honey. Variables such as the actual THC percentage of your cannabis, how well you decarboxylate it, infusion time and temperature, and even how thoroughly you strain your honey can all influence the final potency. When in doubt, start with a very small dose and gradually adjust only after observing the full effects.     Pro Tip: Honey-based edibles may take 30–90 minutes to fully kick in, so be patient before reaching for another spoonful.   Creative Ways to Use Cannabis-Infused Honey   Stir into tea, coffee, or warm milk ☕ Drizzle on pancakes, yogurt, or fresh fruit 🥞🍓 Whisk into homemade salad dressings or marinades 🥗 Spread on warm biscuits, toast, or cornbread Or — no shame — enjoy it straight from the spoon 🍯   💬 Cannabis-Infused Honey FAQs   How do you make cannabis-infused honey at home?  To make cannabis-infused honey at home, simply decarboxylate your cannabis, gently heat it with honey for about an hour, strain it, and store. This easy cannabis honey recipe only requires cannabis, honey, and basic kitchen tools. How do you decarboxylate cannabis for honey infusion? Decarboxylation is the process of activating THC. Bake broken-up cannabis buds on parchment paper at 225°F (105°C) for 30–40 minutes, stirring every 10 minutes until lightly golden and aromatic. Can you make edibles with honey instead of butter? Yes, cannabis-infused honey is a popular alternative to cannabutter, allowing you to make edibles without butter or oil. It’s perfect for sweet recipes, beverages, and microdosing. How long does cannabis-infused honey last? When stored in a sealed jar away from light and heat, cannabis-infused honey can last up to 6 months at room temperature and even longer if refrigerated. How strong is homemade cannabis honey? The strength depends on how much cannabis you use and its THC percentage. A typical batch with 3.5 grams of 20% THC cannabis yields about 700 mg THC total. Refer to the dosing guide above for per-teaspoon breakdowns. What is the best beginner dose for cannabis honey? For beginners, start with ¼ teaspoon of cannabis honey, which typically contains around 3.6 mg of THC. This allows you to experience mild effects without overwhelming potency. What are the benefits of cannabis-infused honey? Cannabis-infused honey combines the natural antibacterial, antioxidant, and digestive benefits of honey with the relaxing, stress-reducing, and soothing effects of cannabis. Can I microdose with cannabis honey? Yes, cannabis honey is excellent for microdosing. Small amounts, such as ¼ to ½ teaspoon, can offer subtle relaxation and wellness benefits without strong psychoactive effects. What are the best ways to use cannabis honey? The best ways to use cannabis honey include stirring it into tea, drizzling on toast, adding to yogurt or oatmeal, using it in salad dressings, or enjoying it straight from the spoon. Does cannabis honey help with stress and relaxation? Yes, many people use cannabis honey to naturally reduce stress and promote relaxation. It is especially popular in bedtime teas and calming rituals.   Final Thoughts: The Liquid Gold of Cannabis Edibles ✅ Easy to make, even easier to enjoy. ✅ Versatile for recipes, drinks, or direct consumption. ✅ Potent, but microdose-friendly. ✅ Stores beautifully — no freezer required. ✅ An herbal remedy that has stood the test of time, now with a modern twist.   Join the Conversation Made this recipe? Share your favorite way to use cannabis-infused honey in the comments. Tag your creations with #CannabisHoney and share the sticky, sweet love.   Contact Us!       [...] Read more...
August 3, 2023Ingredients 4 Pork chops Salt and pepper 1 Tbsp minced rosemary 2 Cloves minced garlic 1/2 Cup canna-butter 1 Tbps canna-oil Instructions 1. Preheat oven to 375°F. Season pork chops with salt and pepper 2. In a small bowl, combine canna-butter with rosemary and garlic. Set aside 3. In an oven-safe skillet over medium heat, heat canna-oil and add pork chops. Sear until golden, about 4 minutes, flip and cook for another 4 minutes. 4. Brush pork-chops generously with the garlic canna-butter mixture and place skillet in the oven to bake for 10–12 minutes. Serve with more garlic butter. ​If you do not have an oven-safe skillet, you may use a regular one and transfer to a baking dish. Be sure to collect all the oil from the pan when transferring. This recipe is available for download HERE Original recipe from Eat Your Cannabis.com [...] Read more...
August 3, 2023Ingredients 4 eggs 1 cup white sugar ½ cup brown sugar, packed 1 ¼ cups grapeseed oil ¼ cup canna-oil 2 tsp vanilla extract 1 ¾ cups pure pumpkin puree 3 cups all-purpose flour 1 tbsp ground cinnamon 1 tbsp pumpkin spice 2 tsp baking powder 2 tsp baking soda 1 tbsp orange zest, optional Directions Preheat the oven to 350°F/175°C. Line a jumbo muffin tin with liners. Place the eggs, white sugar, brown sugar, grapeseed oil & canna-oil into a bowl fitted for a stand mixer or use a whisk to thoroughly beat ingredients together. Blend in the pumpkin & vanilla extract. In a small bowl mix the dry ingredients together. Add to the wet ingredients & mix until just blended. Stir in the orange zest (optional). Divide the batter evenly between 12 muffin cups using a muffin scoop, about 3 ounces each. Sprinkle with pumpkin seeds. Bake for 22–25 minutes or until a toothpick inserted into the middle comes out clean. ​ Allow to cool, remove from the tins & sprinkle with cinnamon. This recipe is available for download HERE Original recipe from myedibleschef.com [...] Read more...